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ABSTRACT 
 
The fused [n]polynorbornane scaffold is a preorganised, rigid and accessible 
molecular framework. This project focuses on both i) understanding the role that 
the fused [n]polynorbornane scaffold plays in anion recognition and ii) applying 
the fused [n]polynorbornane scaffold in a biochemical setting as a peptide ‘super-
staple’. 
The anion recognition aspect focuses on understanding the binding mode and 
exploiting the stepwise assembly of anions onto tris-thiouredioethyl 
functionalised [3] and [5]polynorbornane hosts 1 and 2 (chapter 2). A 
regioselective assembly of two different anion species to hosts 1 and 2 was 
demonstrated. 
To better understand the effect that the [n]polynorbornane scaffold itself has on 
the binding of anions, a series of hosts (4, 5, 7 and 8) were synthesised and 
titrated against a range of anions using 1H NMR (chapter 3). Both diffusion NMR 
and molecular modelling were used to help understand the binding.  
As a rigid preorganised molecular framework, a [5]polynorbornane scaffold was 
employed as a ‘super-staple’ to stabilise peptide secondary structure (chapter 4). 
Three staples suitable for attachment to a peptide were synthesised using a high 
yielding one-pot methodology for [5]polynorbornane construction. A diazide 
functionalised [5]polynorbornane (11) was then conjugated to a pseudo-
hexaalanine peptide (13) using copper catalysed azide-alkyne cycloaddition. The 
stapled peptide (14) was then characterised using HPLC, MS and IR spectroscopy. 
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The resulting peptide was tentatively assigned β-strand structure, whereas the 
non-stapled peptide was predominantly random coil.   
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PLAIN ENGLISH SUMMARY 
 
Molecular frameworks, in general, perform a central role in both the biological 
realm and in modern synthetic chemistry. The goal of this thesis was to provide 
a better understanding of the effect that fused [n]polynorbornane frameworks 
have on the binding of anions as well as explore new ways of incorporating the 
rigid framework into a natural setting. 
The introduction provides a background into common molecular frameworks, 
anion recognition and the chemistry involved in synthesising and using fused 
[n]polynorbornane scaffolds. In addition, the specific aims of the thesis will be 
outlined.  
Chapter 2 focuses on a unique case of regioselective binding of anions exhibited 
by ‘three-armed’ [n]polynorbornanes and will explore the mode of binding.  
Chapter 3 investigates the features of the hosts, which helped to facilitate the 
binding initially discussed in chapter 2. The chapter firstly describes the 
synthesis of a new series of hosts; before analysing their physical and anion 
recognition properties (employing NMR techniques). 
Chapter 4 will then change focus from pure anion recognition to the 
incorporation of the [n]polynorbornane scaffold in a natural setting. As a 
framework, [n]polynorbornanes are rigid and well defined geometrically. As 
such, [n]polynorbornanes lend themselves well to preorganising polypeptides. 
Chapter 4 firstly describes the synthesis and analysis of a series of vancomycin 
mimetics and secondly investigates the attachment of a [5]polynorbornane 
scaffold to a peptide sequence. The peptide section entails the synthesis of the 
xix | 
 
appropriate [5]polynorbornane scaffold and finally the synthesis and 
characterisation of a [5]polynorbornane peptide hybrid (‘super-stapled’ 
peptide).  
While conclusions are drawn at the end of each specific chapter, chapter 5 makes 
some concluding remarks about the use of the [n]polynorbornane scaffold in both 
anion recognition and in a natural setting, providing insight into new research 
directions. 
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“Science is made up of so many things that appear obvious after they are 
explained.” 
– Pardot Kynes 
Dune, Frank Herbert (1965) 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 PREAMBLE 
The use and understanding of how preorganised molecular frameworks interact 
with other chemical entities and themselves is an overarching theme of the thesis. 
The introduction chapter will outline topics that are integral to the understanding 
of the chemistry within this thesis including a brief introduction to molecular 
frameworks before specialising into i) anion recognition and ii) frameworks from 
nature. 
An introduction to anion recognition and the concepts integral to supramolecular 
host-guest chemistry are outlined as are methods by which supramolecular 
interactions can be evaluated. A range of scaffolds are discussed before 
highlighting fused [n]polynorbornanes and their use in anion recognition 
chemistry. 
The frameworks from nature section outlines a few natural examples of how 
preorganisation is used in a biological setting and will highlight previous 
literature attempts using synthetic molecular frameworks to create artificial 
versions of the biological components. 
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1.1.1  STRUCTURES OF ANION HOSTS 
 
 
 
Figure 1: Anion hosts, chapter 2. 
 
 
 
 
Figure 2: Anion hosts, chapter 3. 
  
   Chapter 1 
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1.1.2  STRUCTURES OF ‘STAPLE’ COMPOUNDS AND PEPTIDES 
 
 
Figure 3:Peptide staple candidates 9–11.  
 
 
Figure 4: Resin bound peptide 12 and free peptide  13.  
 
 
Figure 5: Stapled peptide 14. 
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1.2 THE ROLE OF MOLECULAR FRAMEWORKS 
Molecular frameworks are chemical skeletons to which functional groups of 
interest can be attached.[1] Frameworks provide a base to spatially arrange these 
functional groups as well as link key chemical moieties. Due to the broad 
definition there are a large number of these scaffolds and in this introduction 
some of the more common frameworks will be highlighted.  
1.2.1 ANION RECOGNITION 
In anion recognition chemistry, the need for a framework to link and spatially 
arrange anionophoric moieties is paramount. Two of the key concepts in anion 
recognition are preorganisation and complementarity. Before discussing the role 
of the framework, these essential concepts must be introduced.  
1.2.1.1 SUPRAMOLE CUL AR CHE MIS TRY AN D ANION  RE COGNI TI ON  
Supramolecular chemistry (“chemistry beyond the molecule”[2]) is the study of 
the interactions between molecules. It is within this larger discipline that anion 
recognition chemistry resides. The important interactions in supramolecular 
chemistry are intermolecular: hydrogen bonding, ion-dipole, dipole-dipole and 
dispersion forces to list a few.[3] Recently supramolecular chemists have 
identified and taken advantage of non-classical interactions such as C-H hydrogen 
bonding[4] and halogen-anion bonding[5-7].  
Anion recognition chemistry is also a form of Host-Guest chemistry. The field of 
host-guest chemistry studies and uses the supramolecular interaction between a 
designed ‘host’ molecule and a target ‘guest’ molecule (figure 6).[8] The species 
that forms from the association of host and guest is referred to as the host-guest 
complex. 
   Chapter 1 
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Figure 6: A cartoon of a host binding a guest to for a host guest complex . 
Anion recognition is again a subset of the host-guest discipline, where the guest 
is an anionic species. Anions are important chemical moieties; DNA is essential 
for life and is anionic and the cyanide anion is a dangerous poison to humans.[9, 
10] The binding of biologically relevant anions is important to the function of many 
enzymes, e.g. ion channels and their interaction with chloride, and ATP and 
pyrophosphate in providing energy.[11] 
 
Figure 7: Examples of anions and their geometries: chloride (spherical), cyanide ( linear), acetate 
(trigonal planar), phosphate (tetrahedral) and phosphorus hexafluoride (octahedral).  
There are different anion geometries: spherical, linear, trigonal planar, 
tetrahedral, octahedral and structurally more elaborate (figure 7).[12, 13] Within 
each geometrical class there can also be variation. For example, spherical anions 
vary by atomic radii. The radius of an iodide anion (2.06 Å) is much larger than 
that of fluoride (1.19 Å).[14] Size and shape are essential criteria to consider when 
designing a suitable host. Having a host to complement the guest’s size is vital for 
a strong interaction.  
Polyanionic species have two or more anionic sites. For example, depending on 
the level of deprotonation (pH), terephthalic acid 15 can be neutral, anionic or 
dianionic (figure 8).  
 Chapter 1 
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Figure 8: Terephthalic acid 15 showing three levels of deprotonation. [ 15]  
1.2.1.2 HOST DESI GN  
Emil Fischer first noted in 1890 that for molecules to approach each other as to 
initiate a chemical action they must fit as a lock and key.[16, 17] This theory was 
further refined by Koshland to an induced fit—hand in glove—analogy,[18, 19] 
through these models Fischer and Koshland pioneered two important concepts 
which have been adapted for the field of host-guest chemistry: preorganisation 
and complementarity. Preorganisation is as the lock (i.e. host), rigid and 
perpetually held in a state which is ready to receive the key (i.e. guest). For a host 
to be complementary to a guest, the host must (i) effectively interact with the 
guest and (ii) be of the appropriate size and shape (or have the ability to 
reorganise into the appropriate shape).[3]  
To achieve complementarity the host can be designed with both (i) clever choice 
and positioning of functional groups to facilitate binding (i.e. effective 
interaction) and (ii) preorganisation of the host for the guest (i.e. size and shape). 
Preorganisation can be imposed with an appropriate molecular framework; 
interaction must be achieved by key functional groups. The key functional groups 
may be either built into the scaffold or attached via a linker group which can infer 
an effective ‘induced fit’ quality to the host.  
Intermolecular forces govern the interaction between host and guest. While 
anion recognition can employ many of these interactions (ionic, dipole, 
dispersion forces halogen bonding, π-π stacking, etc.), hydrogen bonding is 
   Chapter 1 
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common. In this project hydrogen bonding is extensively used and therefore will 
be discussed in more depth. 
1.2.1.3 HYD ROGEN  BONDING  
In fundamental terms hydrogen bonding is an electrostatic interaction between 
an electron rich moiety (Accepter, A) and a hydrogen atom (H) covalently bonded 
to an electronegative atom (Donor, X, figure 9).  
 
Figure 9: A hydrogen bond. X = Donor, H = hydrogen, A = Acceptor . 
Hydrogen bond Acceptors can be any electron rich atom or moiety.[8] Lone pairs 
from such atoms donate to the electron deficient hydrogen. Traditional hydrogen 
bond Donors are comprised of a hydrogen covalently bonded to nitrogen, oxygen 
or fluorine. The electronegative atom inductively draws electron density from the 
covalent bond, and thus the hydrogen. If a suitable Donor and Acceptor pair are 
present the electron deficient hydrogen and electron rich acceptor atom can 
interact to form a hydrogen bond.[8, 14, 20] The three atom bridge is what 
constitutes a hydrogen bond. The hydrogen atom can be effectively shared 
between the Donor and Acceptor depending on the strength of the interaction. 
Due to this property, strong hydrogen bonds are linear. While above describes 
the archetypal hydrogen bond, there are also many non-traditional hydrogen 
bond donors, such as those comprised of electron poor C–H bonds.[21] 
Hydrogen bonding is classified as a weak interaction (2–62 kcal/mol[21] vs. 348 
kcal/mol[20] as an average value for single C–C covalent bonds) but is essential to 
some of the chemical properties of common molecules and macromolecules.[20] 
 Chapter 1 
| 8 
Within proteins and DNA there are intermolecular as well as intramolecular 
hydrogen bonding. In proteins intermolecular hydrogen bonding is crucial for the 
quaternary structures (structure composed of more than one peptide chain) 
whereas intramolecular hydrogen bonding is responsible for secondary 
structure (α-helices and β-sheets, figure 10).[22]  
 
 
Figure 10: From Top: α-Helix example, antiparallel β-sheet example, A synthetic antiparallel β-
sheet dimer (16) facilitated by hydrogen bonding.[22] 
In the field anion recognition, the hydrogen bond is a powerful tool used to bind 
the anion of interest. Ureas, thioureas and guanidines are efficient hydrogen 
bonding moieties affording two preorganised hydrogen bond Donors and one 
Acceptor in a six atom unit. The interaction of ureas with carboxylate anions is 
especially strong.[14, 23, 24] The interaction is strong as there are two 
complementary hydrogen bond Donor-Accepter pairs (figure 11). They are 
preorganised such that both hydrogen bonds lie in the same plane with the 
correct distance for optimal binding interaction with carboxylates (figure 11).  
 
   Chapter 1 
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Figure 11: A thiourea hydrogen bonding to a carboxylate anion. 
Because of this strong interaction, the ureas, thioureas and guanidines have been 
widely exploited in order to selectively bind carboxylate anions along with other 
oxoanions (phosphates and sulphates).[14, 25, 26] While the urea type functional 
group affords strong interactions with oxoanionic species, they have also been 
shown to effectively bind spherical anions.[14, 27]  
While this thesis focuses on the use of the thiourea functional group, there are 
many hydrogen bonding functional groups which are useful in anion recognition 
(figure 12). The amide functional group contains an N–H which provides a 
hydrogen bond Donor as well as a carbonyl Acceptor.[28] Carbonyls are also useful 
as hydrogen bond Acceptors when the target guest contains hydrogen bond 
Donors. The calixpyrrole scaffolds take advantage of the N–H from the pyrrole 
moiety to hydrogen bond.[29-34] Flood et al. effectively used triazoles (containing 
electron poor C–H bonds) in order to bind spherical anions. [4, 35-39] Phosphoric 
triamide and sulphamide functional groups have also recently been utilised by 
Gale et al. in anion recognition chemistry.[40] The tetrahedral phosphoric triamide 
binds strongly to tetrahedral anions (e.g. SO32– : LogKa > 4).[40] Squaramides have 
also been identified as potent hydrogen bond Donors[41-44] and have found use 
within anion transport applications.[45] 
 
Figure 12: Examples of other anionophoric functional groups (hydrogen bond donor highlighted in 
red) from Left: Triazole, Sulfonamide, phosphoric triamide, sulfamide, and squaramide. 
 Chapter 1 
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1.2.1.4 PRE ORG ANIS ATION  
Preorganisation is an important fundamental concept in supramolecular 
systems. Cram eloquently wrote in his Nobel lecture[46, 47]:  
“The more highly hosts and guests are organized for binding and low 
solvation prior to their complexation, the more stable will be their 
complexes.” 
To elaborate, a negative Gibbs free energy for any given interaction (or reaction) 
indicates a favoured process. The Gibbs free energy is given by equation 1; where 
H is enthalpy, T is temperature in Kelvin and S is entropy. 
 οܩ ൌ οܪ െ ܶ ή οܵ (1) 
A loss of entropy (ignoring enthalpy) will result in a positive Gibbs free energy. 
Entropy loss during binding is greater if the host molecule has to change 
conformation from a random geometry to an organised bound state. Therefore, 
the binding event will be more entropically favourable if the host is already 
preorganised to bind the guest. In the theoretical example in figure 13, the 
entropy penalty is considerable as the podand (a flexible host) has to change  
 
 
Figure 13: Host preorganisation and complementarity. Adapted from Steed .[48]  
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conformation, displace solvent molecules and finally bind the anion. In the case 
of the coronand (a macrocyclic host), the host is preorganised for the guest and 
there is no need for large conformational changes, thus lowering the entropic cost 
and causing the binding to be more thermodynamically favoured.[48] The 
enhanced binding affinity for a target by a macrocycle over a linear host is also 
known as the macrocyclic effect. More preorganisation can be introduced by 
forming a macrobicyclic system to form what is known as a cryptand. 
In terms of anion recognition, there is a profound increase in strength of 
association due to preorganisation of the interacting groups for the target guest. 
One can easily appreciate how important a suitable framework is to facilitate the 
preorganisation of the anion recognition groups.  
1.2.2 FRAMEWORKS FOR ANION RECOGNITION 
There are many molecular architectures that can serve as molecular 
frameworks.[49] In this section a few common frameworks used in anion 
recognition and their applications will be presented. 
1.2.2.1 SI M PLE FRAM EWO RKS  
The benzene ring is one of the simplest examples of a scaffold. Benzene provides 
a base which is rigid and able to be regioselectively functionalised. As such 
trialkyl benzene scaffolds have found use within anion recognition chemistry.[50-
55] Ansyln et al. utilised 1,3,5-triguanidinyl benzene 17 and 18 in order to bind 
citrate (figure 14). Suitably functionalised with guanidinium groups host 17 was 
able to bind citrate in water (18, LogKa 3.8).[56] The preorganisation induced by 
the 2,4,6-ethyl groups of the scaffold provide an appreciable increase in binding. 
Without the ethyl groups the binding constant for citrate was LogKa 3.4.[56] 
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Figure 14: Ansyln’s trialkylbenzene based host 17 and 18 and the targeted guest citrate. 
As discussed above, a small degree of preorganisation induces a measurable 
change in binding strength. The extra preorganisation and rigidity of cryptands 
(and spherands) has been well noted.[46, 47] Kang et al. developed a heterocyclic 
cryptand for the binding of fluoride.[57] Cryptand 19 bound chloride strongly in 
DMSO-d6 (LogKa = 3.47). For fluoride, the host bound and retained the anion 
stronger than what can be measured by 1H NMR titration[58] (LogKa > 5, figure 
15).[57] The strong binding indicates an anion recognition cavity that was 
complementary for the size of fluoride. 
 
Figure 15: Kang’s host 19 bound to fluoride.[59]  
Larger aryl scaffolds that are fluorescent have been widely utilised in both anion 
recognition and supramolecular chemistry in general.[60, 61] The large interest in 
these scaffolds has been due to the ability to turn an anion recognition scaffold 
into a colourimetric or fluorescent anion sensor.[60-68] Colourimetric sensors have 
been developed based on these scaffolds such as Langford’s naphthalene diimide 
based sensor 20[68] and Lin’s anthracene based sensor 21 (figure 16).[69] 
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Figure 16: Langford’s naphthalene diimide sensor 20 bound to fluoride and Lin’s anthracene based 
colourimetric sensor 21 bound to acetate.[ 69]  
1.2.2.2 MACRO CY CLI C FR AMEW O RKS  
Macrocyclic frameworks have been used in anion recognition as molecular 
scaffolds. Advantages of macrocyclic frameworks are that the macrocycle induces 
extra preorganisation for the binding of anions. Jolliffe et al. developed rigidified 
macrocyclic peptidic scaffolds 22.[70-73] Such scaffolds preorganise thiourea 
groups to bind sulfonate anions (figure 17, LogKa > 5).[72] The framework both 
preorganises the thiourea arms to bind anions but also participates in binding 
(through the amides). The four anionophores are positioned such that they are 
complementary for tetrahedral anions such as sulfate2− .   
 
Figure 17: Sulphate bound to Jolliffe’s peptidomimetic scaffold 22.  
The macrocyclic effect can organise normally weak intermolecular interactions 
into a significant force. Macrocyclic C–H Receptors,[4, 35-39] such as those 
synthesised by Flood et al. (23[35, 36]), are able to bind chloride strongly in CD2Cl2 
(LogKa = 5.1, figure 18). Due to the macrocyclic nature, the receptors are shape 
persistent and thus are size selective for anions. Chloride is bound strongly by 
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receptor 24 (LogKa = 7.0) whereas the binding of iodide was weaker by several 
orders of magnitude (LogKa = 4.2).[4, 35] 
 
Figure 18: Macrocyclic receptor 23  and 24 bound to chloride. 
1.2.2.3 CALIX  FRAME WO RKS  
Many examples exist of anion hosts based on the calix[n]arenes[27, 74-85] and also 
the calix[n]pyrroles.[30-33] The ability to construct related frameworks in varying 
sizes is an advantage of the calix based hosts and typically [n] = 4 or 6 for these 
systems (e.g. calix[n]arene, figure 19). An advantage of the calix-based scaffolds 
is that they naturally preorganise any attached functionality to form an anion 
recognition cavity. Depending of the intended application either the wide ‘upper 
rim’ or narrow ‘lower rim’ can be functionalised.[76]   
 
Figure 19: Various calix scaffolds. 
Suitably functionalised calix[n]arenes have been used to selectively bind a range 
of anions. Beer et al. used a functionalised calix[4]arene as the macrocyclic 
component of a [2]rotaxane for anion recognition.[76] [2]Rotaxane 25 provides a 
three-dimensional binding pocket for the binding of anions (figure 20). The 
binding pocket is both complementary and preorganised for binding spherical 
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anions, taking advantage of the hand in glove type analogy as the binding pocket 
has to ‘close’ around the anion. Chloride was used to passively template the 
synthesis of the [2]rotaxane, and after anion exchange for a non-coordinating 
anion (PF6−) bound chloride (LogKa = 3.6) preferentially over the other spherical 
anions and acetate.[76]  
 
Figure 20: Chloride bound by rotaxane 25.[76]  
Calix[n]pyrroles contain a macrocyclic cavity which is capable of binding an anion 
in its own right and can be further functionalised with other anion binding groups 
(upper rim functionalisation). Lee and Sessler developed Calix[4]pyrrole 26 to 
have both the anion binding cavity as well as further functionalisation designed 
to chirally discriminate between anions (figure 21).[32] Calix[4]pyrrole 26 was 
able to bind (S)-2-phenylbutyrate 27 (S) preferentially over the (R) enantiomer 
(LogKa (S) =  5.0, LogKa (R) = 4.0) by an order of magnitude.[32] 
 
Figure 21: Binol functionalised calix[4]pyrrole 26 and chiral discrimination of 2-phenylbutyrate 27 
anions.  
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Other macrocyclic frameworks akin to the calix, such as cucurbit[n]urils[86] and 
pillar[n]arenes[87, 88] have been more recently used in supramolecular chemistry. 
Much of the literature contains examples of molecular recognition of neutral and 
cationic guests; although cases of anion recognition do exist.[89-92] In the case of 
the cucurbit[n]urils, many of their interactions with anions are examples of ion-
pair recognition where the anion was included into the macrocyclic  
cavity.[90, 91] 
1.2.2.4 CHOLI C ACID 
Davis and others[93-102] have performed comprehensive studies on cholic acid 
derivatives known as ‘cholapods’ by varying the number of attachment points 
and the number and nature of H-bond donors. Strong binding of chloride was 
noted for these receptors. Cholapod 28 (figure 22)[101] bound chloride with 
selectivity over bromide up to an order of magnitude in CHCl3 (Cl− LogKa = 11.0, 
Br− LogKa = 10.4 ). The selectivity resulted from a well preorganised binding site. 
Cationic cyclocholamides such as 29 have been used for anion transport though 
lipid membranes.[93] 
 
Figure 22: Cholapod 28 and macrocyclic cyclocholamide 29.  
1.2.2.5 FUSED  [n]PO LYNORBORN ANES  
The fused [n]polynorbornane scaffold is a framework consisting of n repeating 
units of the basic norbornane structure (figure 23). Fused [n]polynorbornane 
synthesis (discussed later, page 18) is modular, hence, size and shape can be 
tailored to the project at hand. For anion recognition, the modular nature means 
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that a polynorbornane host can be custom-made to be preorganised to bind an 
anion of particular size. 
 
Figure 23: Norbornane 30, fused [3]polynorbornane 31 and fused [5]polynorbornane 32.  
Fused [n]polynorbornanes can be functionalised in a variety of ways. 
Terminology has been developed to help describe the regiochemistry of 
functionalisation.[103] Edge, End and hetero functionalisation is common amongst 
functionalised poly[n]norbornanes (figure 24).  
 
 
Figure 24: Edge, end and hetero functionalisation. 
Fused [n]polynorbornanes are curved in nature (33, figure 25).[104] Linear 
variants can be accessed through the use of the dihydrofulvalene ‘pincer’ (34) 
and the degree of curvature can also be tailored through the amount of hetero 
functionality (35).[104] Relatively simple levels of theory (AM1) can efficiently 
model this arc-shaped topology[104] giving the molecular architect significant 
control over final scaffold dimensions and degree of curvature. The range of 
geometry and size available provides an excellent base on which to design both 
preorganised and complementary anion hosts. 
 
Figure 25: Examples of [n]polynorbornane frameworks with curved and linear geometries as 
predicted by molecular modelling (r is the calculated radius of curvature).[104]  
End 
 
Hetero 
Edge 
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A collection of researchers including Warrener, Russell, Paddon-Row, Johnston 
Klärner and Stoddart (amongst others) have produced a remarkable arsenal of 
frameworks of varying, though predictable, dimensions (including tweezers, 
clips, binanes, molracs, ladderanes, norbornylogs, alicyclophanes, 
regioselectively addressable frameworks molecular clips and belts).[103, 105-113] 
These versatile scaffolds have been used in a number of settings including (i) 
single molecule conductivity switching (e.g. tetrasulfide 36,[114] figure 26), (ii) 
DNA bis-intercalators to mimic the properties of ditercalinium (e.g. ‘staple-like’ 
bis-acridine 37[115]) and (iii) molecular capsules (e.g. bis-porphyrin tweezers 
38[116]). 
  
Figure 26: tetrasulfide 36[114]  ‘staple-like’ bis-acridine 37[115] and bis-porphyrin tweezers 38[116]). 
SYNT HESI S OF FUS ED [n]POLYNOR BO RN AN E FRAMEWO RK S 
Several cycloaddition strategies have been developed to access these fused 
polynorbornane structures[112, 113, 117-131] and inventive descriptions such as 
LEGO[113, 132] are used to describe their construction.  Other monikers including 
molecular glue’ have been used to describe oxadiazole coupling[118, 119, 133] and 
also BLOCK as an acronym for ‘bonzer little organic construction kit’.[108] This 
terminology hints at the modular nature of the various approaches to the ready  
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Scheme 1: Construction of a polynorbornane scaffold using oxadiazole coupling. [133] 
assembly of these large molecular architectures. The use of oxadiazole coupling 
(‘molecular glue’), provides a simple one step route to the formation of 
‘symmetrical’ polynorbornanes from two suitable norbornene building blocks 
using oxadiazole 40 (scheme 1). The conditions required for such oxadiazole 
coupling reactions are somewhat harsh with temperatures typically >180 °C.[118, 
119, 133] 
The use of tetrazine 44 provides one approach to extended bridged 
polynorbornanes and diaza-bridged polynorbornanes (scheme 2).[134, 135] 
Tetrazine 44 reacts under milder conditions than many of the other methods to  
 
 
Scheme 2: Top: Tetrazine coupling to form reactive intermediate 47 to synthesise an extended 
aza-bridged polynorbornane and bottom: Reaction of tetrazine 44 to form a diaza-bridged fused 
polynorbornanes.[ 134] 
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generate polynorbornanes (reflux, CHCl3). Both the aza and diaza bridge provide 
handles for further functionalisation of the polynorbornane scaffold (i.e. though 
hetero functionalisation). 
 
Scheme 3: Mechanism of the ACE cycloaddition of an electron deficient cyclobutane epoxide with 
a norbornene.[ 136, 13 7]  
The key cycloaddition used within this thesis to access fused [n]polynorbornanes 
is the [3+2] 1,3 dipolar cycloaddition of a resonance stabilised, electron deficient, 
carbonyl ylide (such as 53, scheme 3), generated by electrocyclic ring opening of 
a cyclobutane epoxide (52), to a norbornene partner (39).[137] The reaction of an 
alkene with a cyclobutane epoxide is termed the ACE reaction. More recently, a 
microwave-assisted version of the ACE cycloaddition has been used to effect the 
transformation in high yields and reduced reaction times (10–15 minutes).[136]  
 
Scheme 4: Two step protocol for the synthesis of cyclobutane epoxides.  Reagents and conditions : 
(i) RuH2(CO)(PPh3)3, THF, 80  °C (ii) TBHP, KO tBu, THF, 0 °C.[138-140] 
A simple two-step methodology has been developed for the construction of the 
requisite epoxides (scheme 4). First is a ruthenium (II) catalysed Mitsudo 
reaction[141] of a norbornene with an acetylene dicarboxylate diester (equivalent 
to a [2+2] cycloaddition) which affords cyclobutene diesters (such as 48). As the 
ruthenium (II) catalyst 59 approaches from the more electron dense and  
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Scheme 5: Proposed catalytic cycle of the Mitsudo reaction. [141]  
sterically accessible exo face[142] only the desired exo product is formed  
(scheme 5).[141] The Mitsudo reaction can also be performed in a microwave 
reactor and near quantitative yields are achieved in under 5 minutes.[143] 
The second step is a modified Weitz-Scheffer epoxidation[144, 145] of the electron 
deficient alkene using tert-butylhydroperoxide (TBHP) with a catalytic amount 
of potassium tert-butoxide in THF.[146] While known stereospecific versions of the 
Weitz-Scheffer epoxidation exist;[144, 147-149] in epoxidations of Mitsudo adducts 
only one stereoisomer is produced due to the endo face being more sterically 
accessible.[146] For the purpose of constructing cyclobutene epoxides for use in 
the ACE reaction, generation of specific stereochemistry during the epoxidation 
is moot. Any stereochemistry is lost upon generation of the ylide during the ACE 
reaction (53, scheme 3, page 20). 
 
Scheme 6: Mechanism of the Weitz-Scheffer epoxidation.[ 144] 
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The use of epoxide 57 and bis-epoxide 58 in reaction with suitable norbornene 
alkene partners provides access to a range of fused [n]polynorbornanes 
frameworks (scheme 4).  
[n]PO LYNO R BORN AN ES  IN  ANION  RECO GNITIO N 
Pfeffer and Lowe investigated the anion binding properties of a range of single 
norbornane and fused [n]polynorbornane hosts.[138, 150-152] The single 
norbornane hosts 3, 63 and 64 bound a range of anions (F−, Cl−, Br−, HSO4−, 
H2PO4− and AcO−). The strongest binding observed for the series was for endo-exo 
host 64a and acetate in a 1:2 H:G ratio (LogK1 = 4.2; LogK2 =2.5). All hosts 3, 63 
and 64 bound in a 1:2 H:G ratio with one exception: host 64b bound acetate in a 
1:1 ratio. The change in binding mode was curious as the only difference between 
hosts 64a (bound acetate 1:2 H:G ratio) and 64b (bound acetate 1:1 H:G ratio) 
was the electron withdrawing groups on the phenyl rings (F vs. NO2, figure 
27).[138] 
  
Figure 27: Left: Single norbornane hosts 3, 63 and 64. Right: Change in binding stoichiometry due 
to electron withdrawing group.[138, 150 , 151]  
Experiments testing the anion recognition properties of Pfeffer and Lowe’s fused 
[n]polynorbornane scaffolds provided some interesting results.[138] A series of 
thiourea based anion receptors 1, 2, 65, 66, 67 and 68 (both symmetric and non-
symmetric, figure 28) were designed. Using molecular modelling (AM1) it was 
calculated that the [3]polynorbornane spans ca. 6.6 Å between imides and the [5] 
polynorbornane spans 10.4 Å.[138, 153] Thus the cleft dimensions of these 
   Chapter 1 
23 | 
polynorbornanes are significantly different and ideally suited to recognition of 
larger/longer anions. Polynorbornanes 1, 2, 65, 66, 67 and 68 were 
functionalised at the end position with 2-ureidoethylamido substituents. The 
substituents are referred to as ‘arms’ and as such the hosts are referred to as 2, 3 
or 4-armed [n]polynorbornanes, for example host 67 (figure 28) is a 4-armed 
[3]polynorbornane.* 
 
Figure 28: Pfeffer and Lowes polynorbornane series 1, 2, 65, 66, 67 and 68.[138]  
In the two-armed series of hosts the larger [5]polynorbornane hosts were 
expected to bind larger dicarboxylate anions (e.g. pimelate – −O2C(CH2)5CO2−)  
 
                                                        
* The ‘arm’ nomenclature is common throughout this thesis and indeed is commonly used in the 
field of supramolecular chemistry. 
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Figure 29: Binding arrangement of 65 with suberate (left) and 66 with succinate (right) strong 
binding was regardless of dicarboxylate length or cleft width. [138]  
stronger than smaller anions (e.g. Suberate – −O2C(CH2)2CO2−). However, due to 
the flexibility of both host and guests there was little difference in the binding 
constants in DMSO-d6 (figure 29). 
The four-armed hosts 67 and 68 bound the flexible dicarboxylates in a 1:2 host 
guest ratio. Some of the dicarboxylates (e.g. adipate – −O2C(CH2)4CO2−) first bound 
in a 1:1 complex before switching to a 1:2 complex. The change was noted by a 
unique ‘bump’ in the isotherm (point ①, figure 30). 
 
Figure 30: Binding isotherm for the titration of host 67b with adipate (n=4) and binding 
arrangements ([H] = 2.5 × 10 -3 M).[138]  
One of the interesting phenomena noted by Pfeffer and Lowe, were the results 
obtained from the titrations of the 3-armed hosts with anions. In these titrations 
① 
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the three-armed hosts 1 and 2 bound a range of anions in a 1:2 H:G ratio.[138] The 
binding isotherm generated from these titrations indicated that one anion was 
binding, and only after one equivalent would another anion bind. In the original 
study by Pfeffer and Lowe both the binding mode and stepwise recognition 
phenomenon were not fully explored. To follow on from the original work, the 
full interpretation and further understanding of the interaction between hosts 1 
and 2 with anions (in particular pimelate, acetate, and pyrophosphate) was 
explored herein and the results of these efforts are presented in chapter 2 and 3 
(see aim 1, section 1.3). 
1.2.2.6 AN ALYSIS  OF  HOS T-GUES T IN TE RACTION  
There are many tools for studying and evaluating host-guest interactions in anion 
recognition. The classical method of measuring the interactions and calculating 
an association constant (Ka) is by titration of a guest solution into a solution of a 
host. There are several methods for analysing the progress of these titrations, 
such as, ultraviolet-visible spectroscopy (UV-Vis), fluorescence spectroscopy, 
isothermal titration calorimetry (ITC) and nuclear magnetic resonance 
spectroscopy (NMR). In UV-Vis/fluorescence spectroscopy a change in 
absorbance/emission of light is recorded as a way to measure an overall binding 
event. UV-Vis and fluorescence titration provides a ‘global’ picture of interactions 
but no information about which atoms are involved in binding. ITC measures the 
heat of formation of the H:G complex providing thermodynamic ΔH and ΔS for the 
interaction. As with the light based analysis methods, there is no information 
about which atoms are involved in binding. NMR titration provides information 
about the atoms involved in binding and as anion recognition typically employs 
hydrogen bond donors (which are easily monitored by 1H NMR) it is therefore 
commonly used and it is the technique of choice for the current project.  
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Diffusion NMR, is an emerging tool for the analysis of host-guest interactions. Like 
the other global methods, diffusion NMR gives no information about which atoms 
are involved in binding, but does provide information about the size of the H:G 
complex, and hence can provide additional information pertaining to the binding 
stoichiometry (e.g. 1:1 or 2:2 H:G stoichiometry).[154] Job’s method of continuous 
variation for analysis of binding stoichiometry of can be used in conjunction with 
any of the methods described above to also give information about binding 
stoichiometry (typically 1:1, 1:2 or 2:1).[155] 
As NMR titration, Jobs plot analysis and diffusion NMR are techniques used within 
this thesis they will be described in further detail.  
NMR TIT R ATION 
Using NMR titration a binding event can be viewed directly through the chemical 
shift change of an atom that is involved in the binding event (figure 31). Thus it is 
ideal for protons involved in hydrogen bonding. However, aromatic and aliphatic 
protons can also shift from anisotropic effects (or C–H hydrogen bonding). NMR 
titration is advantageous as binding atoms as well as Ka can be identified and 
measured.  
 
Figure 31: A 1H NMR titration experiment showing the migration of proton signals as aliquots of 
acetate are added to a thiourea compound (example from section 4.2.2). 
A binding isotherm is determined from NMR data by plotting the change in 
chemical shift verses the number of moles of titrant (figure 32). Nonlinear least 
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squares regression analysis is used calculate the binding strength from the 
isotherm.[58, 156, 157] Using the isotherm it is also possible to determine 
approximate binding stoichiometry from extrapolating the apparent linear 
sections of the isotherm (beginning and end) to find the titration end-point. The 
end-point is related to the stoichiometry, for a 1:1 H:G interaction the end-point 
is at 1 equivalent of anion (figure 32) for a 1:2 it is at 2 equivalents of anion.[157] 
 
Figure 32: A titration isotherm of an acetate–thiourea interaction (example from section 4.2.2) : 
change in chemical shift vs. anion added. Endpoint overlay for estimation of H:G stoichiometry.  
In summary, using NMR titration it is possible to gain information about 
stoichiometry, the atoms involved in binding (i.e. region of binding) and also 
binding strength. 
JOB PLOT  AN A LY SI S  
Job plot analysis uses an experiment of continuous variation of the 
concentrations of both host and guest to calculate binding stoichiometry.[155, 157-
159] The method relies upon the assumption that the concentration of the Hm:Gn 
complex is highest at the point where m[H]:n[G].[157] That is, the complex of 
interest is the dominant species at the titration endpoint. Using 1H NMR, the 
molar fraction of host is multiplied by the change in chemical shift (equation 2) 
and plotted against the molar fraction of host ([H]/[H+G]) to give a graph where 
the maxima at the molar fraction of host indicates H:G stoichiometry. For 
example, a maxima at 0.5 indicates a 1:1 stoichiometry (figure 33).  
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Job’s method relies upon a number of solutions with continuous variation of the 
concentrations of both host and guest but the total molar concentration is kept 
the same. Job’s original method requires a large amount of both host and guest. A 
modified method, has gained literature acceptance, where guest is added to a 
solution of host, and alleviates the requirement for a large amount of material.[158, 
160] The modified method closely approximates the ratios outlined by Job and 
allows for simple transformation of titration data into a Job  
plot.[155, 157] Using the modified method ratios of host and guest are extrapolated 
from titration data based on the equivelents of anion added to the known amount 
of host; this approximates Job’s ratios but does not keep the total molar 
concentration constant as the original does. 
 
Figure 33: A modified Job plot constructed from a dithiourea–dicarboxylate interaction with a 1:1 
binding stoichiometry (example from section 3.3.1). 
Using Job’s method it has also been shown to be possible to gain information 
about binding strength[161-163] and the shape of the curve has been linked to 
higher binding stoichiometries (e.g. 1:1 or 2:2).[159] 
DIFFUSIO N NMR 
Diffusion NMR is a technique for measuring the diffusion rate of chemical species 
in solution.[74, 164-169] The adoption of diffusion NMR techniques has been slow 
and its power somewhat underutilised in supramolecular chemistry.[154] As 
1:1 
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diffusion through solution is related to the size of the hydrodynamic radius of the 
analyte,[170] supramolecular complex size can be readily estimated from diffusion 
measurements and compared against the individual components of the complex. 
From the diffusion information, H:G complexes can be inferred (i.e. 1:1 binding or 
2:2 binding), host self-aggregation can be measured and even Ka can be 
calculated. [74, 116, 154, 164-169, 171, 172] 
Stilbs et al. were the first to show that the Ka of a host-guest interaction can be 
calculated through the change in diffusion of a small guest in relation to a larger 
host.[169] While the seminal research was published in 1983, there has not been 
much interest until more recently.[154]  
1.2.3 FRAMEWORKS IN NATURE 
In nature, molecular frameworks perform much the same role as in 
supramolecular chemistry and anion recognition; preorganisation is important 
for enzyme based interactions and functional protein interactions. Much 
biochemistry relies upon the same interactions as supramolecular chemistry. 
Enzyme-substrate interactions and receptor-ligand interactions begin as 
supramolecular interactions. Natural frameworks preorganise both the binding 
sites of proteins and the receptors molecules for intermolecular binding. In this 
section examples of natural frameworks and their roles within the setting will be 
discussed. 
In the biological realm an immense number of potential frameworks exist. Herein 
discussion of biological frameworks will be limited to a few peptidic examples: 
Phosphoesterase enzymes, polymyxins, Vancomycin and α-helix stapled 
peptides. Accompanying each example are also examples of synthetically made 
frameworks used to mimic the action of the natural frameworks.  
 Chapter 1 
| 30 
1.2.3.1 ENZY MES 
Many phosphatase enzymes contain metal centres which are preorganised by a 
large peptidic framework to catalyse the hydrolysis of a phosphoester.[173] 
Alkaline phosphatase 69 contains two zinc ions and a magnesium ion in the active 
site which catalyse the hydrolysis.[174] The enzyme works as a dimer and contains 
450 amino acids (94 kDa).[174] The large peptidic backbone preorganises the 
metal ions to sit within 3.9 Å of each other (figure 34).[174] The close proximity is 
crucial in the catalysis of phosphoester cleavage.[174] 
 
Figure 34: The structure of alkaline phosphatase.  Shown is the close proximity of the metal ions. 
Reproduced from Kim.[ 174]  
The peptide backbone which preorganises the zinc ions has been mimicked by a 
simple calix[n]arene scaffold (figure 35).[173] The calix[4]arene scaffold 
preorganises two zinc complexes to catalyse the cleavage of a phosphoester. At 
0.48 mM concentration calix[4]arene 70 induces a 23000 fold rate enhancement 
of the cleavage of phosphoester 71 against a zinc tetramethyl 
pyridinedimethanamine control.[173] Ungaro et al. have demonstrated that 
guanidinium functionalised calix[4]arenes are also able to catalyse the 
phosphoester cleavage.[175] 
69  
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Figure 35: Cleavage of a phosphoester by bis-zinc functionalised calixarene 70.[173]  
1.2.3.2 POLYMY XINS  
Many potent antimicrobial agents interact strongly with the anionic lipid A 
portion of the bacterial outer membrane lipopolysaccharide (LPS). Examples 
include the naturally occurring polymyxins, in particular polymyxin B (74 – 
figure 36).[176] Polymyxin compounds are facially ampiphillic; the large peptidic 
backbone preorganises both the cationic groups (ammonium) and the 
hydrophobic groups to different faces of the peptide.  
The facial amphiphilicity is essential for antibacterial activity. The polymyxins 
target lipid A 75 in the bacterial outer membrane. By binding to lipid A 75, the 
membrane is destabilised, ultimately causing lysis.[176] The cationic groups 
interact with the anionic phosphate groups of lipid A 74[176] and hydrophobic 
residues penetrate the hydrophobic layer of the bacterial cell wall.[177]  
To mimic these features, norbornane 76 was functionalised with an octyl ‘tail’ 
and guanidine groups for anion recognition (see 76, figure 36). Like the 
polymyxins, the norbornane framework preorganises the cationic groups and 
hydrophobic regions to be ampiphillic.[178] A fluorescent displacement assay 
confirmed binding to the LPS target and compound 76 had an IC50 of 9.5 μM 
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Figure 36: Structures of polymyxin B 74 (left: flat structure, right: solution state structure to 
highlight amphiphilicity[176 , 179]), norbornane 76 (highlighting amphiphilicity) and Lipid A 75.[178]  
(polymyxin E IC50 = 6.0 μM).  Simple disk diffusion studies identified that 
compound 76 was active (particularly against Pseudomonas aeruginosa ATCC 
27853) and haemolytic tests confirmed that 76 did not lyse red blood cells at 
concentrations up to 125 μM.[178] 
1.2.3.3 VAN COMY CIN  
Vancomycin 77 is a naturally occurring antibacterial and is an elegant example of 
the key concepts discussed in this introduction (1.2.1.1). The antimicrobial 
activity of Vancomycin against gram positive bacteria relies on anion 
recognition.[180] The hydrogen bond donors provided by a heptapeptide chain 
interact with a carboxylate anion. Vancomycin is highly preorganised and 
complementary to its anionic biological target (figure 37). The preorganisation of 
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the heptapeptide is achieved largely by a series of rigid aromatic rings contained 
within its structure (figure 37, highlighted green). 
 
Figure 37: Vancomycin, a glycopeptide antibiotic, binds its substrate ( D-Ala-D-Ala) through five 
hydrogen bonds. Aromatic scaffold highlighted in green. 
Vancomycin’s target ‘guest’ is a terminal D-Alanine-D-Alaninate (D-Ala-D-Ala 78) 
moiety of Lipid II, a portion of the gram positive cell wall (peptidoglycan 
layer).[180, 181] D-Ala-D-Ala is one substrate in an enzymatic crosslinking of the 
peptidoglycan layer. The transpeptidase enzyme is unable to access its substrate 
when D-Ala-D-Ala is sequestered by Vancomycin. Thus, D-Ala-D-Ala is unable to 
participate in cell wall crosslinking and bacteria are susceptible to lysis and cell 
death.  
Vancomycin interacts with D-Ala-D-Ala through five hydrogen bonds.[180, 181] 
These hydrogen bonds are specifically preorganised to compliment D-Ala-D-Ala. 
As a result, Vancomycin binds to a model of the peptide portion of Lipid II (TBA 
diacetyl-L-Lys-D-Ala-D-Ala) with a LogKa of 5.6 in an aqueous environment.[182] 
 
Figure 38: The simple vancomycin mimic synthesised by Pieters 79[183] and by Liskamp 80.[184] 
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Smaller Vancomycin mimetics have been developed. Pieters et al. synthesised a 
simple diphenyl macrocycle to preorganise the vancomycin active peptide chain 
79 (figure 38).[183] Pieters demonstrated that the vancomycin chain bound to Ac-
D-Alanine in CD3CN with a LogKa of 4.5.[183] Other diaromatic macrocycles 80 have 
been developed by Liskamp et al. using “click” chemistry (figure 38).[184] 
Schumuck amongst others have also produced vancomycin mimetic compounds 
that have shown antimicrobial activity.[180, 181, 185-193] Cationic amino acid 
sequences bound to a chiral binol (81, figure 39) have been shown to have 
activity against vancomycin susceptible S. aureus and vancomycin resistant 
 S. aureus.[186, 194] Cohen et al. developed a vancomycin mimetic based of the 
calix[4]arene scaffold (82, figure 39) and studied it’s binding to D-alanine using 
diffusion NMR.[74]  
 
Figure 39: Chiral binol Vancomycin mimic 81[ 194] and calix based mimic 82 [ 74, 164- 169] 
1.2.3.4 STAPLED  PE PTIDES 
Stapled peptides are a class of molecule where a short peptide chain is covalently 
linked between two positions (figure 40). Vancomycin is an example of a natural 
stapled peptide. Many α-helix sections of large proteins impart biological activity. 
If the α-helix section is synthetically reproduced without the large peptide 
scaffold to preorganise it, the secondary structure is unstable.[195] By stapling two 
or more positions along the alpha helix, it is possible to stabilise the secondary  
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Figure 40: A stapled peptide cartoon displaying the i and i+4 stapling positions.  
structure without the requirement of a larger peptide framework.[195] By 
including a peptide staple in an α-helical peptide, is has also been shown to 
enhance cell permeability in some peptides[196] and retard cleavage by 
proteases.[197] 
The α-helical peptides can be stapled in a variety of positions. By stapling at an i 
and i+4 or i+7 positions (where i is the first amino acid involved in the staple) 
along the peptide chain it is possible to stabilise the α-helix (figure 40).[198, 199] 
The short stapled peptide (23 residue[198]) has similar therapeutic activity to the 
much larger parent protein (87 residue[200]).[198] Stapling of a peptide does not 
always guarantee retention of the biological activity.[201, 202] Regardless there is 
significant interest in stapled peptides, indeed a stapled peptide drug candidate 
(ALRN-5281: Aileron Therapeutics) has entered phase I clinical trials in 2013.[203]  
There are several key methods for stapling peptides. Ring closing metathesis 
(RCM) dominates the literature (figure 41).[195, 197-199, 201, 203-206] By replacing the 
i and i+4 amino acids with alkene functionalised amino acids it is possible to link 
the two amino acids through an alkene. The alkene staple can be further 
hydrogenated to a hydrocarbon.  
 
Figure 41: Hydrocarbon stapling using RCM.[ 195]  
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Triazole linkers have also been used to synthesise stapled peptides. The triazole 
is formed using the copper catalysed 1,3-dipolar azide-alkene cycloaddition 
(CuAAC).[207, 208] Using the CuAAC methodology a doubly i + 4 stapled 24 amino 
acid peptide was synthesised with over 90% helicity (figure 42).[207] Liskamp 
vancomycin mimetic scaffold[184] can also be described as a peptide staple 
(mentioned section 1.2.3.3). Liskamp’s short peptide structure was preorganised 
by a triazole much like the α-helical peptides of this section. 
 
Figure 42: A doubly i + 4 triazole stapled peptide.[207]  
More biochemically based disulfides[209-211] and lactams[211-214] have been used to 
staple peptides to stabilise secondary structure. In nature, disulfides stabilise 
secondary structure (β-Sheet) by crosslinking cyclic peptides (θ-defensins[215]) 
and tertiary structure by covalently linking peptides (Antigens[216]). Two 
synthetic disulphide staples were able to stabilise tertiary β-sheet structure 
dimers (83, figure 43).[217] 
 
 
Figure 43: β-sheet dimer 83 developed by Norwick.[217]  
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While the methods outlined for stapled peptide synthesis have been successful, 
the majority of the linkers used as a peptide staple are flexible. Larger, more 
highly rigid synthetic frameworks, such as [n]polynorbornane scaffolds, have not 
been incorporated as peptide staples. As these structures are extremely rigid and 
preorganised (compared to flexible alkyl staples) they have the potential to 
function as ‘super-staples.’  
1.3 AIMS OF THIS PROJECT 
The current project has two main aims:  
1. To further explore the use of functionalised [n]polynorbornane 
frameworks in the field of anion recognition. Specifically to understand 
the effect of the [n]polynorbornane scaffold has on the anion binding 
event. To achieve this aim, two projects were undertaken: 
i. The further investigation of the stepwise anion binding displayed 
by three-armed polynorbornane scaffolds 1 and 2. (chapter 2). 
 
Figure 44: A proposed interaction of Host 1a  with TBA pimelate to be further 
studied in chapter 2.  
ii. The synthesis and evaluation of a series of [n]polynorbornane 
based hosts with increasing framework size to ‘pinpoint’ the effect 
that the [n]polynorbornane scaffold has on the strength of binding 
and the mode of binding (Hosts 3a–8, 1a: chapter 3). 
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Figure 45: Norbornane hosts 1a and 3a–8, designed to assess the effect of 
increasing framework size on anion binding. Previously synthesised hosts 
encircled. 
2. To incorporate an [n]polynorbornane in a biochemical setting, specifically 
by the synthesis of a ‘super-stapled’ peptide. Then to characterise the 
effect that the [5]polynorbornane framework has on the secondary 
structure of the peptide chain (chapter 4). 
 
Figure 46: A cartoon of a [5]polynorbornane ‘super-stapled’ peptide.  
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CHAPTER 2 
 
REGIOSELECTIVE 
RECOGNITION OF ANIONS 
 
2.1 PREAMBLE 
In the current chapter, the ability of some previously synthesised three-armed 
[n]polynorbornane hosts to regioselectively bind anions was explored. Firstly, 
the regioselective and stepwise assembly of dicarboxylate anions to hosts 1–2 
were investigated by 1H NMR titration. Secondly, the stepwise binding mode was 
then probed further using dual anion titrations. Lastly, the regioselective binding 
of pyrophosphate by the three-armed hosts was explored using both standard 1H 
NMR titration and a series of dual-anion titrations. Aspects of the work 
performed in this chapter have been published in The Journal of Organic 
Chemistry[218] and Chemical Communications[219] 
2.2 INTRODUCTION 
The use of thiourea functionalised fused [n]polynorbornanes as scaffolds for 
anion recognition was presented in the introduction. In summary, a family of 
[n]polynorbornane anion hosts were synthesised and screened against a large 
library of anions,[138] and many of the unusual results from that study were not 
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Figure 47: Three-armed fused [n]polynorbornane hosts 1 and 2 for anion recognition. ‘Two-armed’ 
end in red, ‘single-armed’ end highlighted in blue. 
fully explored. One such set of results were those of the three-armed hosts 1 and 
2 (figure 47) and their interaction with dicarboxylates and pyrophosphate. 
In the previous study, binding of anions was not 1:1 and also did not correspond 
with a standard 1:2 model of binding. Due to the asymmetric nature of the three-
armed hosts, binding at each end of the host could be monitored independently 
by NMR titration (figure 48). It was noted in the previous study that each end of 
the hosts behaved differently during NMR titration. The end specific binding was 
unexpected and warranted further investigation. 
 
Figure 48: Above: Host 1a  with each end highlighted. Colours correspond to the arrows below. 
Below: Truncated NMR stackplot of host 1a highlighting the movement of the NH protons upon 
addition of pimelate (DMSO-d6, [H]0 = 2.5mM). 
0  E Q U I V .  P I M E L A T E  
0 . 1  E Q U I V .  P I M E L A T E  
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The three-armed hosts 1 and 2 feature three thioureidoethyl anionophoric 
‘arms’. Two ‘arms’ located at one ‘end’ of the polynorbornane (the ‘two-armed’ 
end, figure 47 – Red) and a third ‘arm’ positioned on the opposite end (the ‘single-
armed’ end, figure 47 – Blue).  
2.3 ACETATE AND DICARBOXYLATES 
2.3.1 STEPWISE AND REGIOSELECTIVE BINDING EVENTS 
In the current study, the interaction of previously synthesised hosts 1–2 with 
acetate (CH3CO2−) and pimelate (−O2C(CH2)5CO2−) were examined in more detail. 
While Pfeffer and Lowe had previously conducted titrations of 1–2 with pimelate 
and acetate the experiments were repeated to confirm their unusual interaction 
with the dicarboxylates. The anions were used as their tetrabutylammonium 
(TBA) salts. The titrations were conducted in DMSO-d6 using an initial host 
concentration of 2.5 mM.  
 
Figure 49: Titration isotherm of host 1a against TBA acetate and the proposed binding 
arrangement of 1a with acetate (DMSO-d6, [H]0 = 2.5mM). 
ACETA TE 
When acetate was titrated against host 1a (figure 49), initially (<1 equiv. anion), 
there was a moderate change in chemical shift (Δδ = 1.2 ppm) of the N–H of the 
‘two-armed’ end of the scaffold. In addition there were also smaller changes in 
chemical shifts corresponding to of the urea protons of the ‘single-armed’ end (Δδ 
= 0.44 ppm), indicating that binding was also occurring at that end. After one 
① 
③ 
② 
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equivalent was added, the signals correlating to the ‘two-armed’ end started to 
plateau (point ①, figure 49). In contrast, the chemical shifts for the ‘single-armed’ 
end increased slowly to one equivalent (point ②, figure 49) and started to 
plateau only after 2 equivalents of anion had been added (point ③, figure 49). 
The data suggests that while anions bind preferentially to the ‘two-armed’ end, 
the ‘single-armed’ end was still available to bind an anion and does so when the 
binding sites of the ‘two-armed’ end are occupied. 
PIMELAT E 
When host 1a was titrated against the dicarboxylate pimelate the preference to 
bind at the ‘two-armed’ end was remarkable. On addition of pimelate (<1 equiv. 
of anion) there was a large change in chemical shift corresponding to the ‘two-
armed’ end (Δδ = 2.9 ppm, point ①, figure 50). In comparison the protons of the 
‘single-armed’ end experienced little change (Δδ = 0.52 ppm, point ②, figure 50), 
which indicated little or no binding. After 1 equivalent of pimelate was added, 
there was no further change in chemical shift of the protons of the  
 
 
 
Figure 50: Titration isotherm of host 1a against TBA pimelate and the proposed binding 
arrangement of 1a with pimelate (DMSO-d6, [H]0 = 2.5mM).  
① 
② 
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‘two- armed’ end.  A sharp endpoint at 1 equivalent can be seen in the isotherm 
(point ①, figure 50). A surprising ‘jump’ in chemical shift was seen at the ‘single-
armed’ end (point ②, figure 50), indicating that after 1 equivalent there was 
significant binding at that end.  
In summary, the titration of 1a vs. pimelate, at anion concentration less than that 
of the host, featured a large preference for binding pimelate at the ‘two-armed’ 
end without any significant binding at the ‘single-armed’ end. In the presence of 
an excess of pimelate (> 1 equiv.), the ‘single-armed’ end would then begin to 
interact. After the one equivalent point the binding isotherm of the ‘single-armed’ 
end resembled what would be expected of a standard 1:1 binding curve (figure 
51).  
 
Figure 51:  Titration isotherm of 1a  and pimelate (DMSO-d6, [H]0 = 2.5mM) and a simulated 1:1 
Binding curve (fittingprogram[58]). 
The binding that was seen for 1a with pimelate was also observed for all three-
armed hosts 1–2 with all alkyl dicarboxylates (figure 52).[138] First, a binding 
event at the ‘two-armed’ end, and only then, a second binding event at the ‘single-
armed’ end in a stepwise process. The anions also bind to a specific end, or region 
at each stage of the titration (‘two-armed’ end first and ‘single-armed’ end 
second), thus the binding can be called regioselective. Hence, the overall process 
can be described as a regioselective stepwise interaction (as seen in figure 50, page 
42).  
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a) b)  
c) d)  
 
Figure 52: Titration isotherms of the four three-armed anion hosts 1–2with 
 pimelate (DMSO-d6, [H]0 = 2.5mM). 
Both the cleft width of the fused [n]polynorbornane scaffold and the electron 
withdrawing group from the phenylthioureido ‘arms’ effected the extent that a 
host would regioselectively bind an anion (figure 52). Unfortunately, 
deprotonation and aggregation made interpretation of some titrations difficult, 
but in these instances (1b and 2b) a similar trend could be found. The 
[3]polynorbornane hosts 1a and 1b displayed an increased preference for 
binding anions at the ‘two-armed’ end over the [5]polynorbornane hosts 2a and 
1a + Pimelate 1b + Pimelate 
2b + Pimelate 
2a + Pimelate 
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2b (figure 52). Due to the greater distance between the two ends in the 
[5]polynorbornane hosts (2a,b), the regions can act more independently and 
bind anions individually. The [3]polynorbornane hosts have a decreased distance 
between the ends which forced the ends to interact. The close proximity ensures 
that the anion was bound at the more favoured ‘two-armed’ end and not at the 
‘single-armed’ end. Therefore regioselective binding was more evident in the 
smaller hosts.  
The 4-fluorophenyl hosts 1a and 2a were able to better bind anions 
regioselectively. The 4-fluorophenyl (Ph-F) substituent has less electron 
withdrawing power than the 4-nitrophenyl (Ph-NO2).[220, 221] The nitro variant 
was less able to dictate the region of binding. As mentioned in the introduction 
(section 1.2.2.5), a subtle change in electron withdrawing group (from Ph–F to 
Ph–NO2) has been shown to effect binding mode.[151]  
With both electron withdrawing group and cleft width factors combined, host 1a 
(figure 52a, [3]polynorbornane, Ph–F) displayed the clearest example of 
regioselective binding. While regioselective binding was possible and certainly a 
trend was noted, there was no clear evidence in 1H NMR titration spectra for a 
regioselective stepwise interaction involving host 2b (figure 52d, 
[5]polynorbornane, Ph–NO2) and dicarboxylate anions. 
2.3.1.1 ‘SPA N TH E CL EFT ’  VS.  ‘BET WEEN TH E ARMS ’  BINDIN G 
It could be postulated that instead of binding between the arms at the ‘two-armed’ 
end the anion could ‘span the cleft’ (figure 53). For the span the cleft binding mode 
the anion binds between one thiourea of the ‘two-armed’ end and the thiourea of 
the ‘single-armed’ end. While no crystallographic evidence could be obtained to 
prove/disprove either of the binding modes, in silico experiments (HF – 3-21G*) 
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were performed to establish the feasibility of the between the arms binding 
arrangement. Similar binding energies were calculated for both arrangements 
(between the arms = -5199.19 Eh; span the cleft = -5199.14 Eh). While the energy 
gap was small, the between the arms binding provided a more realistic 
arrangement with hydrogen bond geometry closer to what is expected of 
carboxylate-thiourea binding[28] (H-Bond angle = 171°; H-Bond length = 1.73 Å 
vs. the span the cleft arrangement H-Bond angle = 150°; H-Bond length = 1.79 Å; 
figure 53).  
 
Figure 53: The two possible binding modes for 1a  and suberate as determined by Molecular 
modelling (HF – 3-21G*). 
The between the arms arrangement was also supported by NMR spectroscopy. 
NMR spectroscopy showed that the signal associated with the ‘single-armed’ end 
did not shift upon the initial addition of anion whereas the signal associated with 
the ‘two-armed’ end shifted downfield (figure 54). If the converse were true and 
the signal corresponding to the ‘single-armed’ end shifted, the signal for the ‘two-
armed’ end would have to undergo an unlikely up-field shift (lower ppm).  
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Figure 54: 1H NMR evidence for the between the arms  binding mode (DMSO-d6, [H]0 = 2.5mM).  
a) Thiourea NH region 
b) Aryl region, protons split into doublets of doublets due to both 1H and 19F Coupling 
In addition to the urea N–H chemical shift change, there was also a slight change 
in the aryl C–H protons which also supported the between the arms arrangement. 
For host 1a the aryl proton resonances from both the ‘two-armed’ end and the 
‘single-armed’ end were well resolved in the 1H NMR spectrum (particularly the 
3JF protons, figure 54b); this is in contrast to the N–H resonances which become 
fully resolved only after anion has been added. The aryl C–H resonances 
associated to the ‘two-armed’ end (determined by 1H, gHMBC and gHSQC NMR 
spectroscopy techniques) mirror the movement of the N–H resonances in a 1H 
NMR titration with pimelate and both have a sharp endpoint at one equivalent 
Down-field Up-field 
0  E Q U I V .  P I M E L A T E  
0 . 1  E Q U I V .  P I M E L A T E  
0  E Q U I V .  P I M E L A T E  
a) 
b) 
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(point ①, figure 55a). The shift of the aryl proton resonances associated with the 
‘single-armed’ end also follow the trend of their N–H counterparts when titrated 
with pimelate; the change in chemical shift is slight until the one equivalent point, 
followed by a ‘jump’ in the titration isotherm (point ②, figure 55a) after the one 
equivalent point.  
 
Figure 55: a) Titration isotherm of host 1a and pimelate following the aryl resonances.  
b) Proposed binding of pimelate by host 1a.  
c) 1H NMR titration stackplot of host 1a and pimelate (DMSO-d6, [H]0 = 2.5mM). 
If the span the cleft binding mode was observed there would be desymmetrisation 
of the aryl protons associated with the ‘two-armed’ end upon addition of 
pimelate. The change in chemical shift of the aryl resonances of ‘single-armed’ 
end would also provide a titration isotherm containing a sharp endpoint at one 
equivalent. As neither of these phenomena were observed and the titration 
① 
② 
0 . 6  E Q .  P I M E L A T E  
0 . 3  E Q .  P I M E L A T E  
1 . 0  E Q .  P I M E L A T E  
1 . 4  E Q  P I M E L A T E  
1 . 8  E Q .  P I M E L A T E  
2 . 4  E Q .  P I M E L A T E  
3 . 6  E Q .  P I M E L A T E  
4 . 8  E Q .  P I M E L A T E  
0 . 0  E Q .  P I M E L A T E  
a) 
b) 
c) 
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isotherms that were observed are consistent with the between the arms mode of 
binding, it was concluded that the initially proposed between the arms binding 
mode was in fact the most plausible. 
2.3.2 DUAL ANION TITRATIONS (CARBOXYLATES) 
In order to further examine and potentially exploit the regioselective binding of 
the three-armed anion hosts, dual anion titrations were conducted. The dual 
anion titrations consisted of the addition of one anion to bind within the ‘two-
armed’ end, then the addition of a second anion species to bind to the ‘single-
armed’ end. As host 2b displayed no regioselective binding tendencies that were 
observable by NMR titration; no dual anion titrations were performed on this 
host. 
As with the previous titrations for these host and guest combinations, the dual 
anion titrations were performed using an initial host concentration of 2.5 mM in 
DMSO-d6, and the anions were used as their TBA salts. The same methodology of 
a standard NMR titration of a host-guest system was used, i.e. aliquots of guest 
were added to a host solution. At a specified point in the titration (e.g. 1.0 equiv. 
anion added) the first guest solution (e.g. pimelate) was replaced by the second 
guest solution (e.g. acetate) and the titration was completed with addition of the 
second guest.  
The first dual anion titration to be conducted with the three-armed hosts 1a used 
pimelate (first guest) and acetate (second guest, figure 56 isotherm and figure 57 
for a stack plot). One equivalent of pimelate was added to host 1a. Up until this 
point the titration behaved exactly as the previous pimelate titration; a large 
change in chemical shift for the ‘two-armed’ end (Δδ = 2.9 ppm), and 
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Figure 56: Left: Dual anion titration isotherm of pimelate (0-1 equiv.) and acetate (>1 equiv.) with 
host 1a (DMSO-d6, [H]0 = 2.5mM). 
minimal change in chemical shift in the ‘single-armed’ end (Δδ = 0.51 ppm). After 
one equivalent of pimelate, an excess of acetate was added. From this point, there 
was no further change in chemical shift for the signals associated with the ‘two-
armed’ end (Δδ < 0.01 ppm, point ①, figure 55); this indicated that the pimelate 
was ‘locked In’ and bound at the ‘two-armed’ end. The signals associated with the 
‘single-armed’ end behaved much like a standard 1:1 interaction with acetate as 
seen in the previous titrations (point ②, figure 56;  
 
 
Figure 57: 1H NMR stackplot of the dual anion titration of Host 1a with pimelate (0-1 equiv.) and 
acetate (1-9 equiv.: DMSO-d6, [H]0 = 2.5mM). 
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Figure 58: Comparison of titration isotherms (DMSO-d6, [H]0 = 2.5mM).  
Titration isotherm of a) 1a with pimelate b) 1a and acetate c) host 1a with pimelate. ‘Two-armed’ 
end only. d) host 1a with acetate. ‘Single-armed’ end only.  
Dual anion titration of e) host 1a with pimelate (0-1 equiv.) and acetate (>1 equiv.). ‘Two-armed’ 
end only. f) host 1a with pimelate (0-1 equiv.) and acetate (>1 equiv.). ‘Single-armed’ end only. 
see also figure 58 for isotherm comparison) in which modest binding was 
observed. 
The same anions were added in the reverse order (acetate 0-1 equiv., pimelate 1-
9 equiv.) to further study the assembly of anions to host 1a (figure 59). Upon the 
addition of one equivalent of acetate to 1a, again, the resulting titration isotherms 
resembled what would be expected of a standard acetate titration  
(Δδtwo-armed end = 1.15 ppm; Δδsingle-armed end = 0.49 ppm). The addition of an excess 
of pimelate via aliquots facilitated a large ‘jump’ (figure 59, point ①) in the 
chemical shift of the ‘two-armed’ signals (Δδ = 1.68; 1-2 equiv. anion), indicating 
that pimelate was strongly binding to the ‘two-armed’ end of the host. A modest  
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Figure 59: Dual anion titration of acetate (0-1 equiv.) and pimelate (1-9 equiv.) with host 1a 
displaying the displacement of acetate by pimelate (DMSO-d6, [H]0 = 2.5mM). 
increase in chemical shift (Δδ = 1.1 ppm; 1-2 equiv. anion) was also observed for 
the ‘single-armed’ end of the host. While the large ‘jump’ in the isotherm was due 
to the pimelate, the modest rise at the ‘single-armed’ end (1-2 equiv. anion) was 
attributed to displaced acetate before more than one equivalent of pimelate was 
added. 
To further explore the process of the assembly of pimelate and acetate, dual anion 
titrations were repeated with anions swapped at 0.5 equivalents (figure 60). The 
addition of 0.5 equiv. of acetate to 1a elicited the expected response  
(Δδtwo-armed end = 0.63 ppm; Δδsingle-armed end = 0.15 ppm). This was followed by the 
addition of pimelate which revealed the same ‘jump’ in chemical shift  
 
AcO– Pim2– 
① 
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a) b)
Figure 60: Dual anion titration isotherms of a) pimelate (0 -0.5 equiv.) and acetate (0.5-9 equiv.) 
with host 1a (DMSO-d6, [H]0 = 2.5mM) and b) acetate (0-0.5 equiv.) and pimelate (0.5-9 equiv.) 
with host 1a (DMSO-d6, [H]0 = 2.5mM). 
corresponding to pimelate binding the ‘two-armed’ end (Δδ = 2.2 ppm) and 
modest rise at the ‘single-armed’ end due to displaced acetate (Δδ = 1.0 ppm). 
Unfortunately the reverse order, the addition of half an equivalent of pimelate 
followed by an excess of acetate, resulted in a broadening of the NMR signal of 
the ‘two-armed’ end. While the 1H NMR signal associated with the N–H protons 
of ‘two-armed’ end was poor, the ‘single-armed’ end was unaffected. The initial 
interaction of 1a with pimelate was identical to previous titrations, a sharp 
increase in chemical shift up until 0.5 equivalents of pimelate (Δδ = 1.8 ppm). The 
addition of excess acetate continued to effect the chemical shift of the ‘two-armed’ 
end throughout the titration (Δδ = 0.8 ppm; 0–4 equiv. acetate). The continued 
effect on the ‘two-armed’ end by acetate indicates that both acetate and pimelate 
compete to bind at the ‘two-armed’ end when there are sub-stoichiometric 
amounts of pimelate. Despite the poor binding at the ‘two- armed’ end, the 
binding of acetate at the ‘single-armed’ end was unaffected and bound 
comparably to previous single anion acetate titrations. 
Titrations were repeated with malonate (another dicarboxylate) and acetate 
against the three-armed host 1a (figure 61). In each case the titrations behaved 
much like those of pimelate/acetate. When acetate was added first and malonate  
  
Pim2– AcO– AcO– Pim2– 
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a) b)  
Figure 61: Dual anion titration isotherms of a) malonate (0 -1 equiv.) and acetate (1-9 equiv.) with 
host 1a  (DMSO-d6, [H]0 = 2.5mM) and b) acetate (0-0.5 equiv.) and malonate (1-9 equiv.) with 
host 1a  (DMSO-d6, [H]0 = 2.5mM).  
was used in excess, malonate (like pimelate) displaced acetate from the ‘two-
armed’ end. Unfortunately deprotonation occurred at the thiourea protons of the 
‘single-armed’ end when more than 2 equivalents of the malonate were added; 
due to a higher basicity than pimelate (pKB = 8.31, 11.17 vs pimelate pKB = 8.42, 
9.29).[222]  
Each of the titration examples shown thus far have all involved three-armed host 
1a. While host 1a was the clearest of all examples, hosts 1b and 2a both 
interacted with the anions in much the same way. For all titration isotherms of 
hosts 1a, 1b and 2a with pimelate and acetate and hosts 1a and 2a with malonate 
and acetate see the appendix (Chapter 7). 
2.4 PYROPHOSPHATE  
2.4.1 REGIOSELECTIVE BINDING 
Pfeffer and Lowe had previously conducted titrations of 1–2 with pyrophosphate, 
the experiments were again repeated to confirm their unusual interaction with 
Pyrophosphate (H2P2O52– = H2PPi2–). Pyrophosphate was titrated against the 
three-armed hosts 1–2, in DMSO-d6 using an initial host concentration of 2.5 mM. 
Unlike the previous examples with acetate and pimelate (In which the anions 
were used as tetrabutylammonium [TBA] salts), pyrophosphate was used as 
tributyl ammonium (TBAH) salt. 
Mal2– AcO– AcO– Mal2– 
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Figure 62: Titration isotherm of host 1a against TBAH pyrophosphate and the proposed binding 
arrangement of 1a with pyrophosphate (DMSO-d6, [H]0 = 2.5mM). 
In the titration of host 1a and pyrophosphate (figure 62) all hydrogen bond 
donors bound to pyrophosphate from the ‘two-armed’ end of the host. In fact, the 
participation of the amide donors was almost as strong as the thiourea donors 
(Δδthiourea = 1.4 ppm; Δδamide = 1.2 ppm) (in the titration of 1a against 
acetate/pimelate, the change in chemical shift of the amide protons was slight – 
Δδ = 0.5 ppm). The most interesting feature of this titration was that there was 
no significant change (Δδ < 0.1ppm) in the chemical shift of the thiourea protons 
of the ‘single-armed’ end. This indicated that even at high guest concentrations, 
host 1a was unable to bind more than one pyrophosphate anion. Hosts 1b and 
2a–b both interacted with pyrophosphate in the same manner. The 1:1 
Host:Guest (H:G) complex that was formed between host 1 and pyrophosphate 
(and also host 2) seem to ignore a perfectly accessible pair of hydrogen bond 
donors. 
2.4.2 DUAL ANION TITRATIONS (PHOSPHO ANIONS) 
In the previous section, pyrophosphate was shown to bind in a 1:1 complex in a 
between the arms binding mode. Unlike the interaction of hosts 1 and 2 with the 
dicarboxylates, pyrophosphate exclusively bound only to one end of the 
framework. Due to the lack of any hydrogen bonding at the ‘single-armed’ end of 
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Figure 63: Dual anion titration isotherm of pyrophosphate (0 -1 equiv.) and phosphate (1-9 equiv.) 
with host 1a (DMSO-d6, [H]0 = 2.5mM). 
the framework, it was theorised that the free urea might be available to bind 
another anion. To test this theory dual anion titrations were conducted with 
pyrophosphate and the smaller dihydrogen phosphate (H2PO4–) anion.  
Upon the addition of one equivalent of pyrophosphate to host 1a, the isotherm 
was identical to previous pyrophosphate titrations (figure 63). The addition of 
excess phosphate did not elicit a change in chemical shift at the ‘single-armed’ 
end.  
When the order of addition of anions was reversed in the titration, the resulting 
isotherm was striking (figure 65; figure 64 for stack plot). The initial 1 equivalent 
of phosphate clearly bound with preference to the ‘two-armed’ end. The addition 
of pyrophosphate, quickly ‘morphed’ the titration isotherm into what would be 
expected for pyrophosphate (figure 65, point ①). Including the large 
contribution of the amide protons (figure 65, point ②) While a small  
 
H2PPi2– H2PO42– 
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Figure 64: 1H NMR stackplot of the dual anion titration of Host 1a with phosphate (0-1 equiv.) and 
pyrophosphate (1-9 equiv.) (DMSO-d6, [H]0 = 2.5mM).  
change in chemical shift(Δδ = 0.11 ppm) was noted at the ‘single-armed’ end 
during the initial addition of phosphate, the change in chemical shift was 
completely ‘reset’ upon the addition of pyrophosphate (figure 65, point ③). 
Remarkably, regardless of the order of addition of phosphate and pyrophosphate 
the magnitude of the movement of the N–H protons was the same (figure 66). 
 
Figure 65: The dual anion titration of phosphate (0-1 equiv.) and pyrophosphate (1-9 equiv.) with 
host 1a showing the complete displacement of phosphate  (DMSO-d6, [H]0 = 2.5mM). 
 
 
Figure 66: Titration isotherm of pyrophosphate with 1a  and dual anion titration of 
pyrophosphate/phosphate and 1a  (DMSO-d6, [H]0 = 2.5mM). Regions of similarity highlighted. 
H2PO42– H2PPi2– 
① 
③ 
0 . 6  E Q . H 2 P O 4  
0 . 3  E Q . H 2 P O 4  
1 . 0  E Q . H 2 P O 4  
1 . 0  E Q . H 2 P O 4 ,  0 . 4  H 2 P P I  
1 . 0  E Q . H 2 P O 4 ,  0 . 8  H 2 P P I  
1 . 0  E Q . H 2 P O 4 ,  1 . 4  H 2 P P I  
1 . 0  E Q . H 2 P O 4 ,  2 . 6  H 2 P P I  
1 . 0  E Q . H 2 P O 4 ,  2 . 6  H 2 P P I  
0 . 0  E Q . H 2 P O 4  
② 
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Titration experiments were repeated with pyrophosphate and acetate. Host 1b 
bound pyrophosphate as expected, and initially the addition of acetate did not 
elicit a change in chemical shift at the ‘single-armed’ end. However, with an excess 
of acetate (>3.5 equiv.) interaction was seen at the ‘single-armed’ end indicating 
that binding was likely to be occurring (figure 67a, point ①). In titrations with 
pyrophosphate and acetate the ‘morph’ of the isotherm corresponding to the 
displacement of acetate by pyrophosphate was also more pronounced. Again the 
region between 2–4 equivalents of pyrophosphate was essentially identical to 
previous titrations (figure 67).  
a) b)  
Figure 67: a) Dual anion titration of pyrophosphate (0-1 equiv.) and acetate (1-9 equiv.) with host 
1b (DMSO-d6, [H]0 = 2.5mM) b) Two anion titration of acetate (0-1 equiv.) and pyrophosphate (1-9 
equiv.) with host 1b (DMSO-d6, [H]0 = 2.5mM). 
While titrations between hosts 1 and 2 with dicarboxylates and acetate used 
mono ionic compounds, titrations involving pyrophosphate and phosphate (or 
acetate) were more complicated systems. The phospho anions can exist in several 
states of ionisation, thus both acid and base interactions between guests as well 
as TBAH are feasible (equation 3–5). Due to comparable pKA values for the 
pyrophosphoric acid (pKA = 0.85, 1.96, 6.60 and 9.41[223])  and phosphoric acid 
(pKA = 2.15, 7.20, 12.33[223]), any guest-guest acid-base interactions can be 
discounted (equation 3).  Acid-base chemistry between the tributylammonium 
countercation (pKA = 10.89[224]) and phosphate was also not considered due to 
similar the pKA values of pyrophosphate and phosphate (equation 4).  Ruling out 
guest:guest or guest:countercation interactions as the cause of the extraordinary 
H2PPi2– AcO– AcO– H2PPi2– 
① 
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changes in the binding isotherm, only the formation of a stable 1:1 host-guest 
complex of hosts 1a, 1b and 2a with pyrophosphate could elicit such a result.  
 H2P2O72– + H2PO4– → HP2O73– + H3PO4  Unfavoured (3) 
 HNBu3+ + H2PO4– → H3PO4 + NBu3 Unfavoured (4) 
 H2P2O72– + AcO– → HP2O73– + AcOH Possible (5) 
Unfortunately while similar titration results were seen for the interaction of hosts 
1a, 1b and 2a with pyrophosphate and acetate, both guest:guest and 
guest:countercation acid-base interactions cannot be discounted due to the 
basicity of acetate (pKB = 9.26[225], equation 5). All the isotherms for the 
pyrophosphate/acetate titrations as well as the pyrophosphate/phosphate 
titration isotherms for hosts 1a, 1b and 2a are available in the appendix (Chapter 
7). 
As the host-guest complex formed between 1a and pyrophosphate ‘ignored’ the 
‘single-armed’ end of the host, additional experiments were performed to better 
understand the complex between 1a and pyrophosphate. X-ray crystallographic 
evidence would have provided an excellent solid-state model of the binding 
arrangement; however, all attempts at crystallisation of the complex thus far have 
been unsuccessful. As an alternative to help determine the nature of the 
supramolecular complex, both diffusion NMR experiments (to infer 
supramolecular size or aggregation[75, 170]) and molecular modelling experiments 
were conducted using three-armed host 1a. It was postulated that a higher order 
binding stoichiometry (e.g. 2:2 H:G or 3:3 H:G) or aggregation might ‘block’ the 
‘single-armed’ end from participation. Therefore diffusion dilution experiments 
were used to probe for (i) larger H:G stoichiometries and (ii) H:H aggregation.  
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i) A small guest binding to a large host does not significantly change the 
hydrodynamic radius of the host and therefore the diffusion coefficient 
would not be greatly affected.[170] Hence, a slight decrease or no change 
of diffusion coefficient upon the addition of anion to a host correlates 
with formation of a 1:1 H:G complex. However, if a 2:2 complex formed 
a large decrease in the diffusion coefficient would result due to an 
effective doubling in size of the complex. At both dilutions tested 
(2.5mM and 1.25 mM) for host 1a and pyrophosphate present, there 
was only a slight change in the diffusion coefficient  
(-0.70 × 10-9 m2·s-1) of the host/complex vs. the free host. The small 
change suggests formation of a 1:1 H:G complex 
ii) If aggregation was present, dilution of the host would cause 
‘separation’ of the aggregates and the reduction in aggregate size can 
be measured by an increase the diffusion coefficient. Upon dilution of 
the host the diffusion coefficient was actually smaller  
(0.98 × 10-9 m2·s-1) than at the titration concentration  
(1.10× 10-9 m2·s-1). As aggregation is associated with an increase in 
diffusion rate upon dilution host self-aggregation for 1a was 
discounted. 
With higher order complexes and/or aggregates unlikely, molecular modelling 
was performed in the hope that a better understanding of the H:G complex might 
be obtained. As the number of atoms and interactions was large, only low level 
modelling (MMFF) was possible. These calculations showed that the TBAH cation 
(HNBu3+) was capable of participation in a complex with 1a and  
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Figure 68: Cartoon of the binding arrangement (determined using MMFF) of host 1a (Black) with 
TBAH (green) pyrophosphate (blue) highlighting the possible H-Bond between countercation and 
guest and the close association of another countercation with the host-guest complex.  
pyrophosphate. A hydrogen bond formed between HNBu3+ and pyrophosphate in 
an ion pair type complex. The modelling results are summarised in figure 68, 
HNBu3+ was bound and another HNBu3+ was also closely held in a nonspecific 
association. The steric crowding by both countercations is one possible 
explanation for the inactivity of the ‘single-armed end’ 
A repeat titration with a non-protic countercation (e.g. TBA) might be able to 
provide evidence for the ion pairing involved in a 1a:HNBu3+:Pyrophosphate2− 
complex. The titration with TBA pyrophosphate would also potentially provide 
an example where the ‘single-armed’ end of 1 (and 2) is available to bind an anion 
in the presence of pyrophosphate. Unfortunately, the TBA salt of pyrophosphate 
was not commercially available throughout the project timeline and preparation 
of such salts in high purity (>99%) proved difficult (See section 2.6 for further 
information regarding preparation and evaluation of TBA pyrophosphate salts).  
2.5 SUMMARY AND CONCLUSIONS 
In this chapter a family of tris-thiourea fused [n]polynorbornane hosts 1a–b and 
2a–b were shown to bind anions (pimelate, malonate, acetate) in both a 
regioselective and stepwise fashion. A general trend in regioselective binding 
emerged. Firstly, the smaller the framework ([3] vs. [5]polynorbornanes) the 
more efficient the regioselective discrimination. Secondly, more electron 
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withdrawn thiourea anion binding groups (Ph–NO2) are less prone to bind in this 
regioselective manner.  
Dual anion titrations indicated that two different anions: acetate and a 
dicarboxylate (pimelate, malonate) can be assembled in a regioselective manner 
to hosts 1a–b and 2a. Specifically highlighted was a 1a:AcO–:Pimelate2– assembly 
that can be formed with the pimelate bound at the ‘two-armed’ end and the 
acetate at the ‘single-armed’ end (figure 69).  
 
Figure 69: The complex formed between 1a with pimelate and acetate.  
Host’s 1a–b and 2a bound pyrophosphate in a discrete complex that was 
unaffected by the addition of excess anions (excess pyrophosphate, phosphate or 
acetate, figure 70). The ‘single-armed’ end of these hosts did not participate in 
binding. Molecular modelling indicated that the ‘single-armed’ thiourea was 
sterically blocked by the countercation TBAH.  
 
Figure 70: 1:1 complex formed between 1a and pyrophosphate.  
The peculiar regioselective binding ability of hosts 1a–b and 2a was attributed to 
the ready cooperation of the thioureas of the ‘two-armed’ end for binding 
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carboxylates. The cooperativity of the thioureas of the ‘two-armed’ end is noted 
in not only the dicarboxylate titrations but also the acetate titrations. That is the 
‘two-armed’ end interacted with only one acetate molecule. The cooperative 
binding arrangement has only been noted in [n]polynorbornane hosts 1 and 2, 
and not in analogous simple norbornane hosts and was the subject of further 
examination in chapter 3. 
2.6 TETRABUTYLAMMONIUM PYROPHOSPHATE SYNTHESIS AND 
EVALUATION 
There are currently no commercial sources of TBA pyrophosphate. Alternative 
pyrophosphate salts (>99%), such as sodium pyrophosphate, were readily 
available; unfortunately these salts are not soluble in DMSO. Additives (such as 
crown ethers) failed to solubilise the sodium pyrophosphate salt. As such, several 
methods were trialled during the project to synthesise highly pure TBA 
pyrophosphate. These methods were only partially successful. Unfortunately 
pyrophosphate is susceptible to hydrolysis to phosphate and many of the 
methods trialled provided a mixture of pyrophosphate and phosphate. For NMR 
titration, any hydrolysis product is unacceptable. The ratio of pyrophosphate to 
phosphate was determined by integration of single pulse 31P NMR spectra (figure 
71, page 65). Method 3 (below) provided the highest purity TBA pyrophosphate 
(Purity = 95%). Unfortunately the purity of obtained pyrophosphate was not 
sufficient for these studies, due to the need for the discrimination between 
binding of pyrophosphate and phosphate. The addition of a mixture of anions 
would not allow for accurate analysis of binding. 
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Scheme 7:  Method 1 for TBA pyrophosphate. 
Method 1: Adapting a literature method,[226] A solution of tetrabutylammonium 
hydroxide (30 mL, 30 mmol, 1.0 M in MeOH) in methanol was added to a solution 
of pyrophosphoric acid (2.68 g, 15mmol) in methanol (50 mL). The resulting 
solution was stirred at 22 °C for 24 h under an N2 atmosphere. The mixture was 
concentrated in vacuo to afford tetrabutylammonium  dihydrogen 
pyrophosphate. (pyrophosphate:phosphate = 1:2). Upon analysis of the 
commercial source of pyrophosphoric acid no greater than the 1:2 ratio achieved 
could be reached due to the amount of phosphoric acid impurity in the source 
material. 
 
Scheme 8:  Method 3 for TBA pyrophosphate. 
Method 2: Anhydrous HCl gas was bubbled through a suspension of disodium 
pyrophosphate (500 mg, 2.3 mmol) in anhydrous THF (100 mL) for 30 min. The 
resulting slurry was filtered through a glass frit under N2 and the solution 
concentrated in vacuo. The resulting solid was redissolved in dry methanol and 
cooled to 0 °C. A solution of tetrabutylammonium hydroxide (7.2 mL, 7.2 mmol, 
1.0 M in MeOH) in methanol was slowly added and stirred at 22 °C for 24 h. The 
mixture was concentrated to dryness in vacuo to afford tetrabutylammonium 
dihydrogen pyrophosphate. (pyrophosphate:phosphate = 3:2) 
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Scheme 9:  Method 4 for TBA pyrophosphate. 
Method 3: To a solution of disodium pyrophosphate (100 mg, 0.45 mmol) in H2O 
(5 mL) was added HCl (aq) (813 μL, 0.90 mmol, 1.110 M) and the reaction shaken 
for 10 s. To the resulting solution was added tetrabutylammonium hydroxide 
(871 μL, 0.90 mmol, 1.0 M in MeOH) and again the mix was shaken for 10 s. The 
resulting solution was immediately frozen with N2 (l) and lyophilised. The 
resulting solid was triturated with dry acetone and the trituant concentrated in 
vacuo to afford tetrabutylammonium dihydrogen pyrophosphate 
(pyrophosphate:phosphate = 18:1 ). Removal of NaCl by-product was confirmed 
by atomic absorption spectroscopy (Max 0.22% w/w NaCl). 
Figure 71: 31P Single pulse NMR spectra of product isolated from method 4. 
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2.7 EXPERIMENTAL 
GENERAL EXPERIMENTAL 
NMR spectra were collected on a JEOL JNM-Ex 270 MHz. Stimulated echo 
diffusion experiments were performed using a Bruker AVANCE III 500 MHz FT-
NMR spectrometer. Hosts 1 and 2 were supplied by AJ Lowe[138-140] and used 
without further purification. 
NMR TITRATION - SINGLE-ANION TITRATION 
A stock solution of each host was made up to 2.5 × 10−3 M in DMSO-d6, and then 
600 μL of this solution was transferred to a 5 mm NMR tube and the 1H NMR 
spectrum acquired. The chemical shifts (ppm) of the resonances corresponding 
to the amide and both thiourea H-bond donors were recorded. An aliquot of the 
stock guest solution (5.0 μL of a 3.0 × 10−2 M in DMSO-d6 solution, 0.1 equiv of 
guest) was then added to the host solution in the NMR tube by autopipette. The 
NMR tube was recapped, the solution was shaken by hand, and then the 1H NMR 
spectrum was collected. Again, the chemical shifts of the resonances 
corresponding to the amide and both thiourea H–bond donors were recorded; 
this process was repeated until 2.0 equiv. of guest had been added. The aliquot 
was then increased (10 μL, 0.2 equiv of guest), and the procedure was repeated 
until a total of 4.0 equiv of guest had been added. The final additions were made 
using larger aliquots (20 μL, 0.4 equiv. of guest) until a total of 6.0 equiv. of guest 
had been added. At this point an additional 150 μL aliquot (3.0 equiv.) was added. 
The data was corrected for dilution (~1/3) then plotted as a titration isotherm 
and Jobs plot. 
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DUAL ANION TITRATION 
The general titration procedure was as stated for the single-anion titrations. 
Anion solutions were switched at intervals specific to each titration: in the case 
of host 1a with pimelate 0−1 equiv. and with acetate 1−9 equiv. Pimelate was 
titrated with 10 × 5 μL aliquots (0.1 equiv each) of solution. The anion solution 
was then changed to TBA acetate for the remainder of the titration.  
DIFFUSION NMR 
Stimulated echo (STE) experiments were performed using a diffusion time of 60 
μs, a gradient time of 4 or 5 μs, and a maximum gradient value of 52 G∙cm−1 on a 
500 MHz spectrometer. Each experiment consisted of 16 gradient steps, with 64 
or 32 scans each. Diffusion coefficients were calculated for hosts at both the 
titration concentration (2.5 mM) and a dilute concentration (1.25 mM), and host 
and anion in a 1:1 ratio with the concentration of host at both the titration 
concentration (2.5 mM) and a dilute concentration (1.25 mM). 
MOLECULAR MODELLING 
The equilibrium geometry of hosts and guests were calculated using Spartan ’08 
or Spartan ’10 (Wavefunction Inc.).[227, 228] Initial minimization was conducted 
from the proposed geometry using MMFF at the ground state. The optimized 
structure was further refined by either Semi-Empirical (AM1) or Hartree−Fock 
(HF) calculations. Images were generated using Accelrys[229] and POV-ray.[230]  
TBA DICARBOXYLATE SALT FORMATION 
A literature procedure[102] was employed which involved 1.0 equiv. of the 
required dicarboxylic acid being stirred in 2.0 eq. of TBA–OH/MeOH solution (1.0 
M) for 48 h. Excess MeOH was then removed under reduced pressure, and 
complete dryness obtained by heating (70 °C) the crude solids under vacuum for 
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24 h to provide quantitative yields of the desired bis-anions as white powders. 
The purity of TBA salts was confirmed by 1H NMR analysis. 
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CHAPTER 3 
 
THE [n]POLYNORBORNANE 
SCAFFOLD AND ANION 
RECOGNITION 
 
3.1 PREAMBLE 
As seen in chapter 2 both anionophoric arms of [n]polynorbornane based hosts 
1 and 2 work cooperatively to bind anions (figure 72a). While not expected, two 
anion binding groups in close proximity could be envisioned to bind a single 
anion in cooperation. The cooperativity between arms displayed by hosts 1 and 
2 was not seen in simple norbornane hosts such as norbornane 3a (figure 72b). 
The two ‘arms’ of norbornane 3a bind two acetate molecules independently. An  
 
 
Figure 72: Differences in binding stoichiometry between host 1a and host 3a when binding 
acetate. The structural similarities between hosts are highlighted in red.  
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extended [n]polynorbornane scaffold and/or an additional anion binding arm, 
present in host 1a, are the only differences between hosts 1a and 3a and are 
therefore most likely to affect the change in binding mode (see figure 72a and b, 
for a comparison). The cooperativity between the two arms of 1 and 2 was 
essential to the regioselective binding explored in the chapter 2. Thus the effect 
that the [n]polynorbornane framework itself, has on anion binding and how it 
influences binding stoichiometry was of interest. 
As highlighted in figure 72, the binding regions (red) of hosts 1a and 3a are the 
same, but their interaction with anions (in particular the binding stoichiometry) 
was different. In this chapter, a series of hosts have been synthesised to 
determine if scaffold size or shape influences binding mode, or if the additional 
thiourea anionophore of 1a is responsible for the difference involved. Hosts 4–8 
have been designed with increasing framework size and lack the additional 
thiourea of host 1a (figure 73). Host 4 was the smallest example and 
 
 
Figure 73: Norbornane hosts  1a and 3a–8, designed to assess the effect of increasing framework 
size on anion binding. Previously synthesised hosts encircled.  
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host 8 the largest. The interaction of anion hosts 3a–8 and 1a with anions was 
evaluated by means of 1H NMR titration and diffusion NMR spectroscopy. 
3.2 SYNTHESIS 
3.2.1 RETROSYNTHETIC ANALYS IS 
In order to access hosts 4–8 a divergent synthetic pathway was envisaged 
(schemes 10 and 11). Epoxide 86 can be used in the synthesis of hosts 6–8. 
Precursors to epoxide 86, diamide 84 and Mitsudo adduct 95 can be transformed 
into hosts 4 and 5 respectively. As such epoxide 86 was a key intermediate. The 
proposed pathway provides a succinct route to all five hosts. All reactions 
involved are known reactions (Amide formation, Mitsudo reaction, Weitz-
Scheffer epoxidation, ACE cycloaddition) and thus a general synthetic pathway 
has been outlined in the retrosynthetic analysis (schemes 13 and 14).  
 
 
Scheme 10: retrosynthetic analysis of Hosts 4, 5 and 6 (circled). 
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Scheme 11: Proposed retrosynthetic pathway of hosts 7 and 8 (circled) using key intermediate 86.  
3.2.2 FORWARD SYNTHESIS 
3.2.2.1 BO C-PRO TE CTED  SCAFF OLDS  
The first step in the synthesis of hosts 4–8 was the formation of endo-diamide 84. 
The correct endo-endo stereochemistry can be obtained from a Diels-Alder 
cycloaddition. Due to secondary orbital overlap between cyclopentadiene 89 and 
maleic anhydride 90 the endo product 91 was the favoured kinetic product at the 
low temperatures used (figure 74).[231]  
 
Figure 74: Secondary orbital overlap (Blue) dictates endo-exo selectivity in the formation of 
norbornene anhydride 91.  
It was also hypothesised that the formation of the diamide from an anhydride 
would give higher yields than the literature approach from a diacid due to the 
natural reactivity of anhydrides towards amines. Thus, one amide can be formed 
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without the need for a coupling agent (scheme 12, mechanism A) but will still 
leave one amide to be formed using a amide coupling reagent such as EDCI 
(scheme 12, mechanism B).  
 
Scheme 12: Mechanism of a) acid amide formation with an anhydride and a primary amine [232] and  
b) carbodiimide mediated dehydration of an amine and a carboxylic acid to form an amide .[233] 
Norbornene anhydride 91 was reacted with a single equivalent of Boc-EDA (Boc 
protected ethylene diamine) to form acid amide 99 (46%, scheme 16). The acid 
amide 99 was then reacted with a second equivalent of Boc-EDA in the presence 
of EDCI to afford diamide 84 (29%) in 13% yield over two steps. While the 
isolated yield for the first reaction was low, the conversion as measured by 1H 
NMR spectroscopy of crude reaction mixture prior to work-up was high (>90%). 
As such, a one-pot reaction was investigated and a significantly higher isolated 
yield of the desired product (58%, scheme 13) was obtained. 
 
 
Scheme 13: Synthesis of endo-diamide 84. 
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With diamide 84 in hand, a Mitsudo reaction with 84 and dimethylacetylene 
dicarboxylate (DMAD) to provide diester 85 was attempted. Unfortunately, the 
Mitsudo reaction was unsuccessful using both previously synthesised and freshly 
prepared catalyst.[234] The alkene was also unreactive under microwave-assisted 
Mitsudo conditions.[143] To this end, an alternative route to the Mitsudo adduct 
was explored (scheme 14). 
  
Scheme 14: Synthesis of diester 85.  
Norbornene anhydride 91 was successfully reacted under Mitsudo conditions to 
form anhydride 100 (63%). Anhydride 100 was then subjected to the one-pot 
diamide formation conditions used previously. The one-pot approach was 
ultimately successful and diester 85 was formed in 56% yield (scheme 14).  
The target epoxide 86 could be synthesised through a Weitz-Scheffer epoxidation 
of diamide 85. However, the alkene of diester 85 was unreactive under the usual 
conditions employed to affect epoxidation of alkene diesters[138]  
(tert-butylhydroperoxide [TBHP], t-BuOK, THF; table 1, entry 1). Attempts to 
promote epoxidation of diester 85 with an excess of TBHP (entry 2), 
stoichiometric amounts of base (entry 3), elevated temperature (entries 4 and 6) 
and extended reaction times (entry 5) were trialled. Unfortunately the 
 
   Chapter 3 
75 | 
Table 1: Attempted epoxidation of diamide 85.  
 
Entr
y 
Oxygen 
Source 
(equiv.) 
Base 
(equiv.) Time 
Tem
p 
(°C) 
Solve
nt Result 
1 TBHP 
(2.5) 
t-BuOK 
(0.2) 
24 h 0-25 THF SM 
2 TBHP  
(10) 
t-BuOK 
(0.2) 
24 h 0-25 THF SM 
3 TBHP 
(2.5) 
t-BuOK 
(2.5) 
24 h 0-25 THF SM 
4 TBHP 
(2.0) 
t-BuOK 
(0.2) 
24 h 0-50 THF SM 
5 TBHP 
(2.5) 
t-BuOK 
(0.2) 
48 h 0-25 THF SM 
6 TBHP 
(2.5) 
t-BuOK 
(0.2) 10 min 
  0-
65* 
THF SM 
7 H2O2  
(32) 
NaOH  
(8) 
24 h 0-25 MeOH        SM[235] 
8 NaClO4 
 
Pyridine 24 h 25 H2O Decomposition[235] 
* Carried out under microwave irradiation. 
epoxide was not detected by 1H NMR spectroscopy analysis of the reaction 
mixture in any case.  
Other literature methods[235] using hydrogen peroxide and sodium hypochlorite 
were trialled in order to epoxidise the electron deficient alkene (table 1, entry 7 
and 8). Again, the epoxide was not detected by 1H NMR spectroscopy in either 
case. The unwillingness of the alkene to react in both diester 85 and diamide 84 
was unusual. It may be that the key feature of the scaffolds which influences 
binding mode may also be a key feature that inhibits any reaction at these 
alkenes. The common endo-endo functionality of scaffolds 84 and 85 seem to be 
the molecular feature present in cases where reaction was inhibited at the alkene.  
 Chapter 3 
| 76 
Boc-protected precursors for anion hosts 4 and 5, have been synthesised 
(diamides 84 and 85). Unfortunately due to the inactive nature of the alkene in 
diester 85, epoxide anion host 6 was not synthesised. Without requisite epoxide  
 
Scheme 15: New retrosynthetic pathway for Boc-protected scaffold 87. Old pathway subdued with 
grey.  
86 for synthesis, anion hosts 7 and 8 could not be synthesised using the planned 
route and a different synthetic pathway was required (scheme 15 and 16).  
Reactions of norbornane 106 or ethylimide 103 with alkene diamide 84 were 
pursued to form the remaining Boc-protected scaffolds 87 and 88. 
 
Scheme 16: New retrosynthetic pathway for Boc-protected scaffold 88. Old pathway subdued 
with grey. 
To synthesise norbornane 106, quadricyclane 104 was reacted with DMAD in a 
[2π – 2σ – 2σ] cycloaddition to form Smith’s diene 105. It was found that while 
literature conditions (neat, 100 °C)[138, 236] for the cycloaddition were successful  
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Scheme 17: Synthesis of Boc-protected scaffold 93. 
for small quantities (< 1 mmol), upon scaling up of the reaction, a runaway 
exothermic reaction occurred. The reaction was repeated with DMF (5 mL) as 
solvent and a smooth conversion to the desired product occurred on large scale 
(2 ml, 22 mmol). Smith’s diene 105 was then subjected to modified Weitz-
Scheffer epoxidation conditions to form epoxide 107 (43% yield over two steps) 
which was then hydrogenated (H2, Pd/C) to form norbornane epoxide 106 
quantitatively. Epoxide 106 was then heated with alkene 84 to form Boc-
protected scaffold 87 in 20% yield (scheme 17). 
To form the final Boc-protected scaffold, norbornene anhydride was reacted with 
ethylamine (20% in H2O) to form imide 101 (scheme 18). While heating using 
microwave irradiation has been shown to be successful for imide formation for 
similar scaffolds,[138, 143] complete conversion to the imide could not be obtained 
using the microwave methodology. A conventional reflux method (PhMe, reflux, 
16 h) gave complete conversion to the imide 101.  
 
Scheme 18: Synthesis of ethyl imide 101. 
Ethyl imide 101 was subjected to microwave assisted Mitsudo reaction 
conditions. Conversion to the diester 102 was successful; however, a large 
amount of by-product was detected by 1H NMR spectroscopy. The by-product  
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Scheme 19: Mechanism of imide formation from a primary amine 109 and acid anhydride 108.[232] 
could not be completely removed from the desired diester 102 by column 
chromatography. When the combined fractions were analysed using 1H NMR 
spectroscopy, the impurity was responsible for only one signal at 3.86 ppm, 
which is equivalent to the signal of DMAD in CDCl3 (figure 75), but was clearly not 
DMAD due to different Rf values (DMAD Rf = 0.61; Impurity Rf = 0.19 in 1:2 
EtOAc:petroleum spirits). Using 13C-1H correlation 2D NMR spectroscopy 
(gHMBC, gHMQC), three 13C resonance signals were attributed to the impurity 
(53.5 ppm = Me, 134.0 ppm = alkane/aromatic, 165.2 ppm = carbonyl); the 
signals correlate to a species derived from DMAD. Cyclotrimerisation of DMAD to 
an aromatic system was reported in Mitsudo’s original manuscript.[141] Similar 
 
 
Figure 75: 1H NMR spectra of Mitsudo adduct 102  (all peaks excluding 3.86 ppm) with hexaester 
impurity 113 (3.86 ppm). Inset: 13C NMR spectra of Mitsudo adduct 102 and hexaester 113. 
HCH3 
H12H12
H1,7 
H8,11 H2,6 HCH2CH
HOMeHOMeb 
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Ru(II) catalysts (RuCp*(COD)Cl – also able to catalyse Mitsudo reactions[141]) 
have been shown to cyclotrimerise alkynes.[237] As such the impurity was 
attributed to a product resulting from the trimerisation of DMAD to form 
hexamethyl benzenehexaester 113. Formation of hexaester 113 was confirmed 
by mass spectrometry (MS m/z (+ESI) 444.1 ([C18H18O12 + NH4]+ requires 444.1)). 
Different conditions were trialled in an effort to minimise the formation of 
hexaester 113. Unfortunately none of the attempts were successful (table 2). The 
best product:impurity ratio achieved was 2.4:1 (102:113, 6, table 2, entry 6) as 
measured by 1H NMR. The mass recovered for entry 6 corresponded to 78% yield 
(calculated by 1H NMR spectroscopy). As the next reaction in sequence was a 
Weitz-Scheffer epoxidation and hexaester 113 should be unreactive under such 
conditions the material containing hexaester 113 was used directly in the next 
step. 
Table 2: Conditions trialled to mitigate the production of hexaester 113 in the Mitsudo reaction 
with imide 101  to produce diester 102.  
  
Entry DMAD (eq.) 
Time 
(min) Temp (°C) 
Yield 
(Conversion) 
Ratio 
102:113 
1 2.5 2 100 62% 2.3:1 
2 1.2 20 90 (0%) - 
3 1.2 2 100 (0%) - 
4 2.5 1 100 (70%) - 
5 2.5 2.5 100 (69%) - 
6 2.5 10 100 78% (85%) 2.4:1 
 
The mixture of 102 and 113 was subjected to standard epoxidation conditions 
and the epoxide 103 was formed as evidenced by the disappearance of the alkene 
13C resonance (141.1 ppm) and new resonance corresponding to the cyclobutene  
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Scheme 20: Synthesis of Boc-protected scaffold 87.  
epoxide (63.5 ppm) in the 13C NMR spectrum. The change in the 13C NMR was also 
accompanied by a characteristic downfield shift of the norbornane bridge 
protons (From 1.73 to 2.08 ppm) in the 1H NMR spectrum. Epoxide 103 was again 
isolated as a mixture containing hexaester 113 and as hexaester 113 should 
prove to be unreactive in subsequent ACE cycloaddition the mixture was used 
without further purification. 
The epoxide mixture was reacted in an ACE cycloaddition with endo-diamide 89 
to form the final Boc-protected scaffold 87. Reaction for 15 minutes at 150 °C 
gave the desired product in 62% yield after column chromatography  
 
Figure 76: 1H NMR spectrum and mass spectrum of Boc-protected scaffold 87. 
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(scheme 20). Finally, Hexaester 113 was able to be successfully separated during 
chromatographic purification due to the large difference in Rf from the desired 
Boc-protected scaffold (Rf 87 = 0.14, Rf 113 = 0.78, in EtOAc). 
3.2.2.2  THI O URE A FO RM ATIONS  
With the Boc-protected scaffolds (84, 85, 87 and 88) in hand, the next two steps 
to form anion hosts 4, 5, 7 and 8 required Boc-deprotection followed by reaction 
with isothiocyanates to form the desired thiourea products (scheme 21). In 
similar methodology to literature,[140, 150, 151, 218, 219] the amine was not isolated, 
but used directly after TLC indicated that Boc-deprotection was complete. 
 
Scheme 21: General scheme for generation of the thioureas to form anion hosts 4, 5, 7, and 8.  
Anion Host 4: Boc-deprotection of 84 in 11% TFA:DCM followed by subsequent  
reaction with 4-fluorophenylisothiocyanate provided anion host 4 in 18% yield 
(1H NMR spectra, figure 77, page 82). 
Anion Host 5: Boc-deprotection of 85 in 20% TFA:DCM followed by subsequent 
reaction with 4-fluorophenylisothiocyanate provided anion host 5 in 39% yield 
(1H NMR spectra, figure 78, page 82). 
Anion Host 7: Boc-deprotection of 87 in 15% TFA:DCM followed by subsequent 
reaction with 4-fluorophenylisothiocyanate provided anion host 7 in 37% yield 
(1H NMR spectra, figure 79, page 83).  
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Figure 77: 1H NMR spectra (DMSO-d6) and mass spectra of anion host 4. 
 
 
Figure 78: 1H NMR spectra (DMSO-d6) and mass spectra of anion host 5.  
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Figure 79: 1H NMR spectra (DMSO-d6) and mass spectra of anion host 7.  
 
 
Figure 80: 1H NMR spectra (DMSO-d6) and mass spectra of anion host 8.  
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Anion Host 8: Attempted Boc-deprotection of 88 in 20% TFA:DCM resulted in 
complete decomposition. Such sensitivity of norbornane compounds to excess 
TFA has been observed previously.[138] Thus, scaffold 88 was subjected to milder 
deprotection conditions 13% TFA in DCM, in the presence of PhSH as a 
carbocation scavenger. The milder conditions were successful in providing the 
deprotected scaffold and the diamine was subsequently reacted with  
4-fluorophenylisothiocyanate to afford anion host 8 in a 59% overall yield.  
(1H NMR, figure 80, page 83) 
3.3 EVALUATION 
3.3.1 NMR TITRATION 
To evaluate the mode and strength that hosts 3a–5, 7, 8 and 1a bound anions, 1H 
NMR titrations were employed (table 3). The anions titrated against the suite of 
two-armed hosts are listed below and are accompanied with justification for their 
inclusion in the study. 
Acetate (CH3CO2−): as acetate bound host 3a in a 1:2 H:G ratio and in a 1:1 H:G 
ratio by the ‘two-armed’ end of and host 1a it is the most likely anion to highlight 
the feature of host 1a that facilitates 1:1 binding.  
Phosphate (H2PO4−): phosphate was bound in the same mode as acetate and as 
such will also highlight the feature of host 1a that facilitates 1:1 binding at the 
‘two-armed’ end. 
Pyrophosphate (H2P2O72–): pyrophosphate was bound in a unique 1:1 H:G 
complex which ignored the ‘single-armed’ end of host 1a. Similar binding by the 
current series of hosts will provide further evidence for the 1:1 binding mode 
proposed in chapter 2.  
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Pimelate (−O2C(CH2)5CO2−): pimelate was bound by host 1a in a regioselective 
stepwise manner. All evidence suggested initial binding between the thioureas of 
the ‘two-armed’ end followed by binding at the ‘single-armed’ end. The mode that 
the current series of hosts bind pimelate will provide further evidence for the 
binding mode proposed in chapter 2. 
Terephthalate (−O2C(C4H4)CO2−): terephthalate has been shown to bind host 1a in 
a 1:1 complex where both ends participate (with potential for a weak 1:2 complex 
formed[152]). The rigidity of the terephthalate anion means that it is unlikely to 
bind ‘between the arms’ as per the flexible dicarboxylates. As such, terephthalate 
was expected to be bound weakly.  
 
Table 3: Titration results: maximum observed chemical shift for alkyl urea N–H protons, binding 
stoichiometry, and binding constants (Ka) for hosts 3a, 4,  5, 7, 8 and 1a.  
Error ≤ 15% unless otherwise indicated. 
Anion Param 3a 4 5 7 8 1a 
Acetate Max Δδ 2.6 2.6 2.6 2.6 2.6 2.8 
 H:G 1:2 1:2 A 1:1 1:1  1:1a 
 LogK1 3.4 3.9 - 2.6  2.7 2.9 
 LogK2 2.1 2.1 - - - - 
Phosphate Max Δδ 1.8 1.7 1.9 1.6 1.7 1.9 
 H:G 1:2 1:1  1:2 1:2 1:2   1:1a 
 LogK1 3.0 2.8  3.4 3.4  3.2 3.5 
 LogK2 2.9 -  2.6 2.6  2.6 - 
Pyrophosphate Max Δδ 1.1 1.3 1.3 1.2 1.4 1.4 
 H:G 1:1 1:1 1:1 1:1 1:1   1:1a 
 LogK1 2.8 3.1 3.4 3.1 3.3 3.8 
 LogK2 - - - - - - 
Terephthalate Max Δδ 2.5 2.5 2.4 2.4 2.3 3.1 
 H:G 1:1 1:1 1:1 1:1 1:1   1:2a 
 LogK1 3.2 3.3 3.3 3.2 3.2 5.5 
 LogK2 - - - - - 2.3 
Pimelate Max Δδ 3.6 3.2 3.0 3.1 3.0 3.5 
 H:G 1:1 1:1 1:1 1:1 1:1   1:1a 
 LogK1  4.4b  4.7b  5.0b  4.8b   4.6b  4.8b 
 LogK2 - - - - - - 
a – Stepwise binding (chapter 2), Ka and H:G stoichiometry reported  for the ‘two-armed’ end 
only.[152, 2 18]  
b – Log Ka ≈ 5 are not reliable[58] when calculated from NMR data; error of ≤20% was calculated. 
A – Host self-aggregation prevented accurate determination of H:G stoichiometry or K a 
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Anions were used as their TBA (NBu4+) salts with the exception of pyrophosphate 
which was used as the TBAH (HNBu3+) salt. The titrations were conducted in 
DMSO-d6 using an initial host concentration of 2.5 mM. The H:G stoichiometry 
was assessed by modified Job plot[155] (generated from the titration data[158, 160]) 
and analysis of the binding isotherm[157]. The strength of binding was calculated 
by means of non-linear least squares regression using fittingprogram[58] or 
WinEQNMR2.[156] Where a 1:2 binding was proposed the association constants 
are reported as K1 and K2. Titration isotherms and Job plots for all titrations are 
available in the appendix (Chapter 7). 
ACETATE  
Binding of acetate by host 7 was representative of the series and from the binding 
isotherm of 7 and acetate the H:G stoichiometry was not well defined. The 
extrapolated endpoint did not precisely align on 1 or 2 equivalents of anion 
(dashed line, figure 81, isotherm). The Job plot calculated from the titration data 
was also vague; binding could be 1:1 or 1:2, as the maxima was not clearly at 0.33  
 
 
 
 
Figure 81: Titration isotherm (with endpoint overlay) and Job plot (with 1:1 and 1:2 stoichiometry 
overlays) of host 7 and acetate (DMSO-d6, [H]0 = 2.5mM). 
1:1 1:2 
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or 0.5 molar fraction of host (dashed lines, figure 81, Job plot). The ambiguous 
endpoint and Job plot could indicate that Host 7 bound acetate as a mixture of 1:1 
and 1:2 H:G stoichiometry. Attempts to fit a 1:1 model to the binding of acetate 
by host 7 resulted in a LogKa of 2.6 (with 10% error), while attempts to fit a 1:2 
model provided a LogK1 of 4.1 and LogK2 of 1.6 (with 5% and 3% errors 
respectively). While both models fit with a low asymptotic error, the low 
contribution of K2 to the overall binding model hints at a largely 1:1 interaction.  
Hosts 4, 5 and 8 all bound acetate in a similar manner to host 7. An accurate H:G 
stoichiometry and Ka was unable to be determined for Host 5 due to host self-
aggregation. Nevertheless, the titration curve and maximum chemical shift 
resembled those of host 7 and acetate. In all cases binding stoichiometry was not 
clearly 1:1 or 1:2.  
Host 3a bound acetate in a 1:2 H:G complex and host 1a bound acetate in a 1:1 
ratio at the ‘two-armed’ end as expected from the literature.[138] Binding strength 
was consistent throughout the series of hosts, in respect to a 1:1 binding model 
(average LogKa = 2.7). As the host:guest stoichiometry was not well defined 
throughout the series, this topic is revisited in further detail in section 3.3.3. 
PHOS PHAT E 
Phosphate was bound by all hosts (3a, 4, 5, 7, 8 and 1a). Binding stoichiometry, 
as determined by both analysis of the binding isotherm and Job plot analysis 
(figure 85), was 1:2. For host 7 (typical of the series), both a 1:1 model and a 1:2 
model was fit for calculation of Ka. Both scenarios provided small errors  
(<15%) indicating a good fit. Unlike the acetate example, K2 significantly 
contributed to the overall binding. As K2 ≈ K1/4 it is likely to be a non-cooperative 
form of 1:2 binding;[58] the cooperative element provides extra evidence that a 
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1:2 H:G complex is formed over a 1:1. Both Job plot analysis and fitting model 
agree that a 1:2 complex was formed with a LogK1 of 3.4 and K2 of 2.6.  
Hosts 4 and 8 bound phosphate in the same manner as host 7, whereas host 5 
could not accurately be fit to a 1:2 model due to host self-aggregation interfering 
with a good model fit.  
Host 3a bound phosphate in a clear 1:2 H:G complex and fit to a 1:2 model and 
host 1a bound phosphate in a 1:1 ratio at the ‘two-armed’ end as expected. 
 
 
Figure 82: Titration isotherm (with endpoint overlay) and Job plot (with 1:2 stoichiometry overlay) 
of host 7 and phosphate and proposed binding arrangement (DMSO-d6, [H]0 = 2.5mM). 
PYROP HO SP HAT E 
Pyrophosphate was bound by host 1a in discreet 1:1 complex (as discussed in 
chapter 2, but see also figure 84). The 1a:pyrophosphate complex was unusual in 
the fact that it did not interact with the ‘single-armed’ end of the host. The current 
series of hosts (3a, 4, 5, 7 and 8; excluding 1a), do not include the ‘single-armed’ 
side of host 1a. Thus, using the current theory of how host 1a binds 
pyrophosphate (with little contribution from the ‘single-armed’ end) it was  
 
1:2 
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Figure 83: Titration isotherm (with endpoint overlays) and Job plot (with 1:1 stoichiometry 
overlay) of host 5 and pyrophosphate (DMSO-d6, [H]0 = 2.5mM). 
hypothesised that binding would be equally strong regardless of the absence of 
the ‘single-armed’ end. 
Indeed, all hosts (3a, 4, 5, 7 and 8) clearly bound pyrophosphate in a 1:1 complex 
(Host 5, LogKa = 3.4, figure 83). The 1:1 complexes formed were confirmed by Job 
plot, binding isotherm analysis and a good fit to a 1:1 model (error <15%).  
 
                                
 
Figure 84: Comparison of binding isotherm and proposed binding mode. Left: Host 5 and 
pyrophosphate. Right: Host 1a and pyrophosphate. 
1:1 
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The binding isotherm of all hosts (3a, 4, 5, 7, and 8) resembled the binding 
isotherm of 1a and pyrophosphate; host 5 was typical when binding 
pyrophosphate. The LogKa was similar for both 1a and 5 (LogKa = 3.8 and LogKa 
= 3.3, respectively). The magnitude of change in chemical shift of all protons was 
also similar (figure 84: e.g. ΔδThiourea Ar-NH = 1.4 ppm for 1a; ΔδThiourea Ar-NH = 1.3 
ppm for 5). The binding of pyrophosphate by hosts 3a, 4, 5, 7 and 8 provide 
further evidence to confirm the proposed binding mode of 1a with the anion. The 
binding mode was conserved along the current series of hosts (3a, 4, 5, 7, 8 and 
1a); one pyrophosphate molecule was bound between the arms of the two armed 
end. The binding was independent of any extra framework and or functionality 
at the ‘single-armed’ end. 
PIMELAT E 
Pimelate was bound in a similar manner by all hosts (3a, 4, 5, 7, 8 and 1a). The 
binding of pimelate by host 8 was typical (figure 85), a strong 1:1 H:G complex 
was formed (LogKa = 4.6). Job plot analysis and end-point extrapolation  
 
 
 
Figure 85: Titration isotherm (with endpoint overlays) and Job plot (with 1:1 stoichiometry 
overlay) of host 8 and pimelate (DMSO-d6, [H]0 = 2.5mM). 
1:1 
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confirmed the formation of a 1:1 complex. A strong 1:1 complex was also formed 
between hosts 3a, 4, 5 and 7 and pimelate. Host 1a bound one pimelate dianion 
strongly at the ‘two-armed’ end (LogKa = 4.8) as proposed in chapter 2. The 
binding mode was consistent amongst the entire series of hosts. Again the 
conservation of binding mode throughout the series further confirms the between 
the arms binding mode of pimelate with 1a proposed in chapter 2. 
TEREP HT HA LAT E 
Of the anions chosen in the current study, terephthalate was expected to bind 
weakly to hosts 3a, 4, 5, 7 and 8. Poor binding was expected due to the rigid 
terephthalate being unsuitable to fit in the between the arms arrangement 
proposed for flexible dicarboxylates (section 2.3.1). Contrary to expected, host 7 
bound terephthalate quite well (LogKa = 3.3, figure 86). The binding of 
terephthalate was deemed 1:1 by Job plot, binding isotherm analysis and the 
isotherm was fit to a 1:1 model (<5% error). The same binding as host 7 was 
exhibited by hosts 3a, 4, 5 and 8. 
 
Figure 86: Titration isotherm (with endpoint overlays) and Job plot (with 1:1 stoichiometry 
overlay) of host 7 and terephthalate (DMSO-d6, [H]0 = 2.5mM). 
Given that a 1:1 arrangement was considered geometrically hard to construct, a 
2:2 binding mode was also considered. Molecular modelling was used to 
determine the validity of such a mode (figure 86). Using AM1 both scenarios were 
modelled with host 7 and terephthalate. As both 1:1 and 2:2 complexes were 
1:1 
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plausible, another method was needed to identify the binding mode. Although, it 
is possible to distinguish between binding modes through comparison of the 
quality of fit to a binding model,[238] diffusion measurements can provide an 
experimental route to identify the binding stoichiometry. As such, diffusion NMR 
was employed to verify the binding stoichiometry. 
 
 
  
Figure 87: Modelling of 1:1 and 2:2 host 7 and terephthalate complexes. 
3.3.2 DIFFUSION STUDIES 
Diffusion NMR has been shown to be a powerful technique when applied in the 
field of host-guest chemistry as a way to measure host self-aggregation,[167] 
measure association constants[164, 165, 167] and as a tool to assess binding 
stoichiometry[165, 167] (as discussed in section 1.2.2.6). Using diffusion NMR a 
series of experiments were undertaken to measure diffusion of the anion hosts in  
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Host Diffusion Coefficient  
(D × 10-10 cm2∙s-1) 
2.5 mM 1.3 mM 
3a 1.46 ± 0.02 1.43 ± 0.01 
4 1.34 ± 0.05 1.49 ± 0.02 
5 1.21 ± 0.04 1.35 ± 0.02 
7 1.20 ± 0.01 1.27 ± 0.04 
8 1.21 ± 0.03 1.22 ± 0.02 
1a 1.20 ± 0.01 0.984 ± 0.03 
 
 
Figure 88: Diffusion constants for hosts 3a, 4, 5, 7, 8 and 1a. Error bars represent 1 standard 
deviation (σ) of the diffusion coefficient.  
DMSO-d6 and obtain further evidence for the binding mode encountered with 
terephthalate (i.e. either 1:1 or 2:2 association). 
Diffusion of hosts 3a, 4, 5, 7, 8 and 1a were measured using a Stimulated Echo 
(STE) experiments in DMSO-d6 at a concentration of 2.5 mM (figure 91). Host 3a 
and 4 were found to have a higher diffusion rate than hosts 5, 7, 8 and 1a. The 
similarity in diffusion coefficient between hosts 5, 7, 8, and 1a and their 
difference from 3a and 4 indicates that the molecular feature that influences the 
hydrodynamic radius the most was the inclusion of the methyl esters. At a lower 
host concentration (1.3 mM), the diffusion of hosts 4, 5, and 7 increased. The 
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increase in the rate of diffusion indicates a small degree of host self-aggregation 
in solution. In the titration experiments, aggregation was also noted for host 5. 
The smaller hosts show increased aggregation over the larger indicating that the 
fully formed polynorbornane scaffold retards host aggregation. 
 
Figure 89: Plausible binding modes, 1:1 and 2:2 of host 7 with terephthalate. 
To gain more information about the binding mode (i.e. 1:1 or 2:2, figure 89) of 
hosts 3a, 4, 5, 7, 8 and 1a with terephthalate, host 7 was chosen to be studied in 
further detail by diffusion (table 4). Binding of a small guest (e.g. acetate) to the 
large host 7 should not drastically change the diffusion coefficient. Formation of 
a 1:1 complex (or even a 1:2 complex) with acetate would not significantly add to 
the hydrodynamic radius (i.e. size) of the complex. Upon binding a large guest in 
a 1:1 ratio (e.g. pimelate) a small change in diffusion constant of host 7 would be 
expected. The same would be true of a 1:1 complex with terephthalate. However, 
if host 7 was forming a 2:2 complex mode a large change in diffusion coefficient 
would be expected due to the considerable increase in hydrodynamic radius. 
Table 4: Table of diffusion coefficients (D) for host 7 and anions (error value ±1 SD)  
Host Anion D (1 × 10-10 m2∙s-1) 
7 - 1.20 ± 0.01 
7 Acetate 1.24 ± 0.09 
7 Pimelate 1.15 ± 0.04 
7 Terephthalate 1.14 ± 0.03 
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Using the STE experiment the diffusion coefficient for host 7 was calculated in the 
free state (1.20 × 10-10 m2∙s-1). The host 7 and acetate complex  
(1.24 × 10-10 m2∙s-1) did not have a significantly different diffusion rate than host 
7 alone. The measured diffusion constant of the host 7 and pimelate complex  
(1.15 × 10-10 m2∙s-1) was smaller than what was measured for host 7. The small 
but statistically significant change in diffusion is in line with the formation of a 
1:1 complex rather than a 2:2.  
The measured value for the host 7 and terephthalate complex, again was smaller 
than what was measured for host 7 (1.14 × 10-10 m2∙s-1). The slight decrease in 
diffusion coefficient (−0.6 × 10-10 m2∙s-1) equated to a small increase in 
hydrodynamic radius. The decrease in diffusion coefficient was not sufficient to 
match that of a theoretical diffusion coefficient for the 2:2 complex  
(0.957 × 10-10 m2∙s-1) † . The diffusion coefficient of the 7 and terephthalate 
complex was in closer agreement with the diffusion coefficient of the 1:1 complex 
of 7 and pimelate than the theoretically calculated 2:2 complex. The similarity 
between both diffusion coefficients provides evidence for the formation of the 1:1 
complex over a 2:2 complex, despite the 1:1 initially being considered somewhat 
strained. 
3.3.3 JOB PLOT COMPARISON 
Due to the ambiguous nature of the Job plots obtained using titration data for the 
interaction between hosts 3a, 4, 5, 7, 8 and 1a with acetate, it was deemed 
                                                        
† The shape of the 2:2 complex of 7 and terephthalate was not spherical, but can be approximated 
by a oblate ellipsoid (Appendix 7.5). Therefore, an oblate ellipsoid corrected Stokes-Einstein 
equation was used to calculate the theoretical diffusion coefficient. [164, 170] 
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prudent to repeat the Job plot analysis using Job’s original method[155]. A 5 mM 
total molar concentration was chosen to reflect the same total molar 
concentration of the 1H NMR titration when one equivalent of anion was added. 
Hosts 3a, 4, 5, 7, 8 and 1a were combined in various ratios with TBA acetate 
([H]/[T] = 0.25, 0.33, 0.50, 0.67, 0.75) in DMSO-d6 with the total molar 
concentration equal to 5 mM.  
Using the original method, all cases (except host 5) displayed a clear maxima 
indicating the dominant H:G stoichiometry (figure 90, page 97). A clear H:G 
stoichiometry could not be identified for host 5 with acetate. Analysis of host 5 
by 1H NMR titration and diffusion NMR indicated host self-aggregation. The 
aggregation may have caused the unreliable results of the Job’s analysis. The 
results of the original method were a significant deviation from the values 
obtained from the modified Job plot analysis. 
The H:G stoichiometry determined by Job plot analysis of the interaction of 3a, 4, 
5, 7, 8 and 1a with acetate, indicated that the [3]polynorbornane scaffold itself 
does have an effect on the binding stoichiometry. The single norbornane hosts 3a 
and 4 bound acetate in a 1:2 H:G stoichiometry and the [3]polynorbornane hosts 
7 and 8 bound acetate in a 1:1 H:G stoichiometry (figure 90, page 97). The steric 
bulk of the polynorbornane framework exerts an appreciable effect on the 
binding of anions.  
Job’s original method provided more reliable results than the modified method 
with distinct maxima indicating H:G stoichiometry. The modified method did not 
provide clear information about H:G stoichiometry. The results of this 
comparison indicate that while in many cases the modified methodology can 
 
  
 
 
     
Figure 90: Comparison of Job plots of hosts 4, 5, 7 and 8 with acetate.  
Top Row: Job’s original method (with stoichiometry overlays).  
Centre row: Proposed binding mode with acetate.  
Bottom Row: Modified Job’s method calculated from titration data. 
O
riginal 
M
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M
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M
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1:2 1:1 1:1 ?? 
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correctly confirm H:G stoichiometry, in instances where the H:G stoichiometry is 
not clear the modification does not effectively identify stoichiometry. As has been 
noted in the literature,[58] any method for determination of H:G stoichiometry 
should be used in conjunction with other methods in order to verify results. This 
is especially true when using “shortcut” methods, as such the results obtained 
from the original method for Job plot construction were deemed more reliable. 
Part of the difficulty analysing the H:G interaction of hosts 3a, 4, 5, 7, and 8 when 
using the modified Jobs method may be due to the concentrations at which the 
titrations were conducted. Although, the transformation provides similar ratios 
of host and guest to that of the original method, the total molar concentration 
varies considerably (in our case, from 2.5 mM to >10 mM). As the titration 
method also slightly dilutes the host, using conditions where the host 
concentration is constant may help clarify the dominant H:G species.  
The initial [H] is also fixed at 2.5 mM to allow for comparison to the system where 
regioselective binding was observed, the titration concentration was not optimal 
for the current systems. As the binding was weak to both acetate and phosphate, 
a more suitable concentration for these Ka values would be greater than 2.5mM 
(approximately 20-200 mM for a LogKa of 2.7‡). A higher concentration (but not 
higher than 200 mM) would provide a more suitable titration curve on which to 
fit the required least squares nonlinear regression analysis.[58] Additional benefit 
as a result of the sharper isotherm curvature would be a more identifiable 
titration endpoint. Thus the H:G stoichiometry would be more readily assigned.  
 
                                                        
‡ Appropriate concentrations for binding in the order of LogKa = 2.7 calculated from [H]0/Kd = 10-
100. Dissacociation constant (Kd) = 1/Ka.[58]  
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Figure 91:comparison of titration curves 3a with phosphate at 2.5 mM (left) and 12 mM[150] (right). 
Lowe and Pfeffer’s original titration with host 3a and phosphate was conducted 
at 12 mM§ and a sharper titration curve is observed[150] (curve angle = 137° at 2.5 
mM and 123° at 12 mM, figure 91). 
3.4 SUMMARY AND CONCLUSIONS 
Five [n]polynorbornane hosts (4–8) were designed with (i) increasing 
framework size and (ii) no third thiourea (compared to host 1a). The design 
allowed for examination of what feature of host 1a facilitated regioselective 
binding ([3]polynorbornane or third thiourea). Four out of the five proposed 
hosts were successful synthesised. Due to the inactivity of the alkene of diamide 
84 to Mitsudo reaction and the inactivity of the alkene of diester 85 to 
epoxidation host 6 could not be synthesised.  
The anion binding properties of hosts 4, 5, 7, and 8 as well as host 3a and 1a were 
probed by 1H NMR titration.  
From the Job plot analysis of each host with acetate, it was concluded that for 
acetate the addition of a [3]polynorbornane scaffold affected the ability of the 
thiourea groups to cooperatively bind a single acetate anion. It is the cumulative 
effect of both the extra anionophoric arm and the actual [3]polynorbornane 
scaffold itself in 1a which lead to a stepwise binding interaction. 
                                                        
§ For Lowe and Pfeffer’s original titration [H]0/Kd = 17 
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From the Job plot analysis of each host with phosphate, it was concluded that it 
was the extra anionophoric arm of host 1a that enabled regioselective 
recognition of phosphate. All hosts bound in a 1:2 H:G ratio except for host 1a. 
Using hosts 3a, 4, 5, 7 and 8 the binding mode for 1a with both pimelate and 
pyrophosphate was confirmed. Both the binding mode and strength of binding 
(Ka) for 1a with these anions was unaffected by the loss of the thiourea from the 
‘single-armed’ side of 1a; this confirmed that the ‘single-armed’ end did not play 
a significant role in binding.  
An unusual binding arrangement of hosts 3a, 4, 5, 7 and 8 with terephthalate was 
encountered, and diffusion NMR was used to provide evidence for the 
geometrically unlikely 1:1 H:G complex using host 7 as a model compound. 
In the study performed with acetate and hosts 3a, 4, 5, 7, 8 and 1a herein, the 
modified Jobs method was proven unreliable. With the previous statement in 
mind, the modified Jobs methodology may still be a useful tool for analysis of H:G 
binding stoichiometry when used with care. With the majority of the  
host-anion combinations, the modified method helped confirm the H:G 
stoichiometry of complexes formed.  
3.5 EXPERIMENTAL 
GENERAL EXPERIMENTAL 
All reagents were obtained commercially and used without purification; all 
solvents used were analytical reagent grade. Petroleum spirits refers to the use 
of petroleum spirits fraction boiling between 40 °C and 60 °C. 
NMR spectra were collected on either a JEOL JNM-Ex 270 MHz or an Eclipse JNM-
ECP 400 MHz FT-NMR spectrometer as indicated. Samples were dissolved in 
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CDCl3 or DMSO-d6 (~0.5 mL). 1H NMR spectra are reported as chemical shift 
(ppm) (integral, multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, 
sept = septet, m= multiplet, b = broad), J coupling (Hz), assignment). All titration 
spectra were collected on a 270 MHz FT-NMR spectrometer. Stimulated echo 
diffusion experiments were performed using a Bruker AVANCE III 500 MHz FT-
NMR spectrometer.  
High Resolution mass spectral data was collected on an Agilent Technologies 
LC/MSD TOF mass spectrometer Samples were dissolved in MeCN or MeOH at a 
concentration of less than 1 mg/mL. 
Thin layer chromatography was performed on Merck TLC silica gel 60 F plates, 
and visualised using UV light (λ = 254 nm and 365 nm) and or Bromophenol Blue 
(Bromophenol blue, NaOH, EtOH), or potassium permanganate (KMnO4, H2O, 
K2CO3) as an oxidising dip. Column chromatography was performed with silica 
gel 60 (230-400 mesh). All microwave reactions were performed using a CEM 
Discover S-class microwave reactor.  
Compounds were named according to the IUPAC guidelines with the Von Bayer 
system for polycyclic compounds and the carbohydrate α/β system for ring 
substituents.[239] 
Boc-EDA[138, 150] and RuH2CO(PPh3)3[234] were prepared using literature methods. 
JOB PLOT ANALYSIS 
Job Plots were constructed using 30 mM DMSO-d6 solutions of host and guest. 
Host and guest were added to 5 mm NMR tubes in various ratios (H/G = 0.25, 
0.33, 0.5, 0.67, 0.75) to a total volume of 100 μL. To the mixture was added a 
further 500 μL of DMSO-d6 to afford total concentrations of 5 mM in each tube. 
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The 1H NMR spectrum was collected of each sample. The peak positions were 
recorded and plotted as Δδ*[H]/[T] vs. [H]/[T]. 
OTHER 
For experimental pertaining to single anion titration, diffusion NMR, molecular 
modelling and TBA salt formation see the experimental for chapter 2 (section 
2.5). The association constant of hosts with anions was determined through a 
nonlinear regression analysis using WinEQNMR2[156] or fittingprogram[58]. 
Asymptotic error for regression analysis was less than 15%. In cases where the 
resonances broadened, line broadening was increased to more accurately 
determine the centre of the peak. 
(1α, 2β, 6β, 7α) 4-OXA-TRICYCLO[5.2.1.0 2, 6]DECA-8-ENE-3,5-DIONE 
(91)[ 2 40]  
To a stirred solution of maleic anhydride (5.9 g, 60 mmol) in 
EtOAc:Petroleum spirits (1:1) at 0 °C, freshly cracked cyclopentadiene 
(5 mL, 60 mmol) was slowly added and the reaction stirred for 1 h. During this 
time a precipitate formed. The flask was then heated to dissolve the precipitate 
and upon cooling the desired product crystallised and was collected by vacuum 
filtration to afford the title compound (7.35 g, 74%) as white columnar crystals. 
mp 159–163 °C, lit. 162 °C[240]; δH (270 MHz, CDCl3) 1.55 (1H, d, J 8.9, H10b), 1.77 
(1H, d, J 8.9, H10a) 3.50 (2H, m, H1, H2), 3.56 (2H, m, H2, H6), 6.29 (2H, bm, H8, 
H9); δC (75 MHz, CDCl3) 171.3, 135.5, 52.7, 47.1, 46.1; MS m/z (+ESI) 165.1 
([C9H8O3 + H]+ requires 165.1). 
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(1α, 2β, 6β, 7α) N,N’-DI(TERT-BUTOXYCARBONYLAMINOE THYL) 
BICYCLO[2.2.1]HEPTAN-5-ENE DICARBOXAMIDE  (84) 
To a solution of norbornene anhydride 91 (300 mg, 1.82 mmol) in CHCl3 (50 mL) 
was added Boc-protected EDA (292 mg, 1.82 mmol). The 
resulting solution was stirred at room temperature for 3 h. 
After which time, a solution of EDCI (349 mg, 1.82 mmol) and 
Boc-protected EDA (292 mg, 1.82 mmol) in CHCl3 (50 mL) was slowly added 
using a dropping funnel and the resulting solution was stirred overnight. The 
resulting mixture was transferred to a separatory funnel, diluted with CHCl3 (20 
mL) and washed with H2O (3 × 20 mL), the organic fraction dried (NaSO4), 
filtered, and concentrated in vacuo. The crude solid was then precipitated from 
hot EtOAc/Petroleum spirits upon cooling to afford the title compound (266 mg, 
58%) as a white solid. mp 164.5–166.8 °C; δH (270 MHz, CDCl3) 1.33 (1H, d, J 10.8, 
H1b), 1.43 (18H, s, t-Bu), 1.49 (1H, d, J 8.1, H1a), 3.11 (2H, s, H1,4), 3.17 (2H, s, 
H2,3), 3.22 (8H, bs, ethyl), 5.30 (2H, bs, amide NH), 6.25 (2H, bs, NHBoc), 6.36 
(2H, bs, H5,6); δC (100 MHz, CDCl3) 173.3, 156.7, 135.4, 79.5, 51.6, 50.1, 47.0, 40.3, 
40.1, 28.5; HRMS m/z (+ESI) 467.28681 ([C23H38N4O6 + H]+ requires 467.28641). 
 (1α, 2β, 6β, 7α, 8α, 11α) DIMETHYL 4-OXA-
TETRACYCLO[5.4.1.02, 6 .08, 11]DODECA-9-ENE-3,5-DIONE 
DICARBOXYLATE  (100) 
A microwave vial containing norbornene anhydride 91 (500 mg, 
3.04 mmol), DMAD (751 μL, 6.08 mmol), RuH2CO(PPh3)3 (276 
mg, 0.30 mmol) and DMF (2 mL) was heated using microwave irradiation at 90 
°C for 10 min. The resulting solution was filtered through celite, and the celite 
flushed with EtOAc, the filtrate was collected and concentrated in vacuo. The 
crude solid was purified using flash column chromatography (Rf = 0.5, 
EtOAc:petroleum spirits (1:1)) to afford the title compound (590 mg, 63%) as an 
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off white solid. Mp 155.0–159.4 °C, lit. 161–163 °C[241]; δH (400 MHz, DMSO-d6) 
1.51 (1H, d, J 12.5, H12b), 1.80 (1H, d, J 10.0, H12a), 2.91 (2H, m, H1, 7), 2.98 (2H, 
s, H2,6), 3.53 (2H, dd, J 3.4, 2.0, H8,11), 3.78 (6H, s, OMe); δC (100 MHz, CDCl3) 
170.7, 160.5, 141.1, 52.3, 48.6, 42.3, 37.3, 34.5; MS m/z (+ESI) 307.1 ([C15H14O7 + 
H]+ requires 307.1). 
(1α, 2α, 5α, 6α, 7β, 8β) DIMETHYL 7,8-(N,N’,DI[TERT-
BUTOXYCARBONYLAMINOE THYL]) DICARBOXAMIDE 
TRICYCLO[4.2.1.0 2, 5]NON-3-ENE-7,8-DICARBOXYLATE (85) 
To a solution of anhydride 101 (500 mg, 1.63 mmol) in CHCl3 
(500 mL) was added Boc-protected EDA (261 mg, 1.63 
mmol). The resulting solution was stirred at 23 °C for 2 h. 
After which time a solution of EDCI (312 mg, 1.63 mmol) and 
Boc-protected EDA (261 mg, 1.63 mmol) in DMF (20 mL) was slowly added via 
dropping funnel and the resulting solution was continued to stir overnight. The 
resulting mixture was transferred to a separatory funnel and diluted with CHCl3 
(20 ml), then washed with 1 M HCl (2 × 20 mL) and sat. NaHCO3 (2 × 20 mL). The 
organic fraction  was dried (NaSO4), filtered, and concentrated in vacuo to afford 
the title compound (452 mg, 56%) as a white solid. mp >170 °C (slow 
decomposition); δH (270 MHz, CDCl3) 1.15 (1H, d, J 1.15, H9b), 1.38 (18H, s, t-Bu), 
1.58 (1H, d, J 13.5, H9b), 2.57 (2H, s, H2,5), 2.92 (2H, s, H1,6) 3.22 (8H, bs, ethyl), 
3.44 (2H, s, H7,8), 3.72 (6H, s, OMe), 5.33 (2H, bm, Amide NH), 6.72 (2H, bs, 
NHBoc); δC (100 MHz, CDCl3) 172.0, 162.6, 161.5, 79.5, 52.0, 47.5, 42.4, 40.5, 39.9, 
38.2, 36.6, 32.1, 31.5, 28.5; MS m/z (+ESI) 631.3 [C29H44N4O10 + Na]+. 
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(1α, 2α, 3β, 5β, 6α, 7α) DIMETHYL 4-OXA-
TETRACYCLO[5.2.1.0 2, 4 .03, 5]DEC-8-ENE-3,5-DICARBOXYLATE (107) 
A solution of quadricyclane (1.6 mL, 4 mmol), DMAD (2.0 mL, 4 
mmol) and THF (5 mL) was heated to 100 °C using microwave 
irradiation for 15 min. The crude reaction mixture was concentrated in vacuo and 
formation of the desired diester was confirmed by 1H NMR. δH (270 MHz, CDCl3) 
1.32 (1H, d, J 9.72), 1.40 (1H, d, 9.7), 2.56 (2H, s), 2.70 (2H, s), 3.79 (6H, s), 6.18 
(2H, s). 
The product from above was dissolved in THF (100 mL) and the solution cooled 
to 0 °C. To the solution tert-butyl hydroperoxide (4.4 mL, 1.13 M in PhMe, 4.97 
mmol) was slowly added and stirred for 10 min. In one portion potassium tert-
butoxide (112 mg, 1.00 mmol) was added and the solution allowed to warm to 
room temperature and stir for 16 h. Remaining peroxide was quenched by 
addition of 10 % sodium thiosulfate in H2O (25 mL). The biphasic mixture was 
extracted with CHCl3 (3 × 20 mL), the organic fractions combined, dried (MgSO4), 
filtered and evaporated to dryness in vacuo to afford the title compound (438 mg, 
43%) as an off white solid. mp 99.7–100.6 °C lit. 101.2–102.9 °C[139]; δH (270 MHz, 
CDCl3) 1.33 (1H, d, J 8.1, H10b), 1.40 (1H, d, J 8.1, H10a), 2.56 (2H, s, H1,7), 2.70 
(2H, bm, H2,6), 3.79 (6H, s, OMe), 6.18 (2H, t, J 2.7, H8,9); δC (100 MHz, CDCl3) 
164.9, 137.6, 66.8, 52.8, 49.0, 41.84, 41.75; MS m/z (+ESI) 268.1 ([C13H16O5 + H]+ 
requires 268.1). 
(1α, 2α, 3β, 5β, 6α, 7α) DIMETHYL 4-
OXATETRACYCLO[5.2.1.02, 6.03, 5]DECANE-3,5-DICARBOXYLATE (106) 
A solution of epoxide 107 (50 mg, 0.4 mmol) and Pd/C (5 mg, 
10% wt) in MeOH (10 mL) was stirred under an atmosphere of 
hydrogen for 16 h. The resulting solution was filtered through celite and 
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concentrated in vacuo to afford the title compound (50 mg, quant.) as a white 
power. mp 118.2–121.5 °C; δH (270 MHz, CDCl3) 1.07 (2H, m, H8n,9n), 1.33 (1H, 
d, J 10.8, H10a), 1.57 (2H, m, H8x,9x), 1.75 (1H, d, J 10.8, H10b), 2.29 (2H, s, H1,7), 
2.70 (2H, s, H2,6), 3.78 (6H, s, OMe); δC (100 MHz, CDCl3) 164.9, 64.4, 52.7, 50.1, 
36.3, 33.4, 27.7; MS m/z (+ESI) 253.2 [C13H16O5 + H]+. 
(1α, 2α, 3α, 4β, 5β, 6α, 7α, 8α, 9α, 10α, 11α, 12α, 13α, 14α) 
DIMETHYL 4,5-DI(TERT-
BUTOXYCARBONYLAMINOE THYLCARBOXAMIDE)16-
OXAHEXACYCLO[6.6.1.1 3, 6 .110, 13 .02, 7 .09, 14]HEPTADECANE-1,8-
DICARBOXYLATE (88) 
A solution of epoxide 106 (179 mg, 0.66 mmol), alkene 
84 (307 mg, 0.66 mmol) and DMF (4 ml) were heated to 
140 °C using microwave irradiation for 10 min. The 
resulting solution was concentrated in vacuo and 
recrystallised from EtOAc/Petroleum spirits to afford the title compound (98 mg, 
20%) as a white solid. mp 171.5–175.3 °C; δH (270 MHz, CDCl3); 0.83 (2H, m, 
H11n,12n), 0.96 (1H, d, J 13.7, H17a), 1.06 (1H, d, H15a), 1.34 (2H, m, H11x,12x), 
1.42 (18H, s, t-Bu), 2.01 (2H, s, H3,6), 2.15 (2H, s, H9,14), 2.19 (1H, d, J 8.2, H15b 
or 17b), 2.34 (2H, s, H3,6), 2.67 (2H, s, H10,13), 2.84 (2H, s, H4,5), 3.24 (8H, bm, 
1’ and 2’), 3.81 (6H, s, OMe), 5.50 (2H, br s, Amide NH), 6.13 (2H, br s, BocNH); δC 
(100 MHz, CDCl3) 171.98, 170.17, 156.73, 90.72, 79.35, 55.95, 52.19, 50.17, 48.46, 
42.91, 40.36, 40.12, 38.29, 34.20, 28.52, 22.68, 19.50; HRMS m/z (+ESI) 
719.38612 ([C36H54N4O11 + H]+ requires 719.38612). 
(1α, 2β, 6β, 7α) N-ETHYL 4-AZATRICYCLO[5.2.1.02, 6]DEC-8-EN-3,5 
DIONE (101) 
To a solution of norbornene anhydride 91 (492 mg, 3.0 mmol) in PhMe 
(20 mL) was added ethyl amine (30% in H2O, 1.5 mL, 9.0 mmol) and 
stirred for 1 h at 23 °C, the resulting suspension was then refluxed for 
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24 h. The solution was cooled and decolourising charcoal added and stirred for a 
further 30 min. The solution was then filtered through celite and concentrated in 
vacuo to afford the title compound (504 mg, 87%) as a white solid. mp 77.4–78.0 
°C; δH (270 MHz, CDCl3) 1.01 (3H, t, J 6.8, CH3), 1.51 (1H, d, J 8.3, H10b), 1.70 (1H, 
dt, J 8.3, 1.7, H10a), 3.21 (2H, dd, J 2.9, 1.5, H1,7), 3.35 (4H, m, CH2CH3 and H2,6), 
6.06 (2H, t, J 1.8, H8,9); δC (68 MHz, CDCl3) 177.7, 134.4, 52.2, 45.7, 45.0, 33.3, 
13.25; MS m/z (+ESI) 192.1 ([C11H13NO2 + H]+ requires 192.1). 
(1α, 2β, 6β, 7α, 8α, 11α) DIMETHYL N-ETHYL 4-AZA-
TETRACYCLO[5.4.1.0 2, 6 .08, 11]DODECA-9-ENE-3,5-DIONE-9,10-
DICARBOXYLATE (102) AND HEXAMETHYL BENZENEHEXACARBOXYLAT E 
(113) 
A suspension of imide 101 (191 mg, 1.0 mmol), DMAD (309 μL, 
2.5 mmol), and RuH2CO(PPh3)3 (92 mg, 0.1 mmol) in DMF (3 mL) 
was heated by microwave irradiation at 100 °C for 2 min. The 
resulting solution was filtered through celite (eluent: EtOAc). 
The solution was then concentrated in vacuo and subjected to 
flash column chromatography (Rf = 0.23, EtOAc/Petroleum 
spirits (1:2)) to afford Mitsudo adduct 102 containing 113 (579 mg).  
Mitsudo adduct 102 δH (270 MHz, CDCl3); 1.13 (3H, t, J 7.2, Ethyl CH3), 1.46 (1H, 
d, J 11.4, H10b), 1.74 (1H, d, J 11.4, H10a), 2.77 (2H, s, H1,7), 2.83 (2H, m, H8,11), 
3.19 (2H, dd, J 7.2, 7.2, Hz, H2,6), 3.51 (2H, q, J 7.2, ethyl CH2) 3.76 (6H, s, OMe),; 
δC (100 MHz, CDCl3) 176.7, 160.8, 141.2, 52.1, 47.5, 42.5, 36.2, 34.3, 33.6, 13.3; MS 
m/z (+ESI) 334.0 [C17H19NO6 + H]+ requires 333.1. 
Hexaester 113 δH (270 MHz, CDCl3) 3.86 (H18, s,); δC (100 MHz, CDCl3) 165.2, 
134.0, 53.6; MS m/z (+ESI) 444.1 ([C18H18O12 + NH4]+ requires 444.1). 
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(1α, 2β, 6β, 7α, 8α, 9β, 10β, 11α) DIMETHYL N-ETHYL 4-AZA-10-
OXA-PENTACYCLO[5.5.1.0 2, 6 .03, 5.08, 12]TRIDECANE-3,5-DIONE-9,11-
DICARBOXYLATE (103) AND HEXAMETHYL BENZENEHEXACARBOXYLAT E  
(113) 
A solution of impure Mitsudo adduct 102 and 113 (597 mg, ca. 
1 mmol) in THF (50 mL) was cooled to 0 °C. Slowly via syringe 
tert-butyl hydroperoxide (1.3 mL, 1.5 mmol, 1.14 M in PhMe) 
was added and the resulting mixture stirred for 10 min. In one 
portion, potassium tert-butoxide (17 mg, 0.2 mmol) was added 
and the solution slowly allowed to warm to room temperature 
and stir for a further 24 h. Remaining peroxide was quenched by addition of 10% 
sodium thiosulfate in H2O (30 mL) and volatile organics removed in vacuo. The 
resulting slurry was extracted with CHCl3 (3 × 50 mL), dried (MgSO4), and 
concentrated in vacuo to afford the desired epoxide 103 containing 113 (229 
mg). 
Epoxide 103 δH (270 MHz, DMSO-d6) 1.06 (3H, t, J 7.2, CH3), 1.68 (1H, d, J 11.5, 
H10b), 2.08 (1H, d, J 11.5, H10a), 2.33 (2H, s, H1,7), 3.12 (2H, dd, J 3.5, 2.0, H2,6), 
3.26 (2H, bs, H8,12), 3.42 (2H, q, J 7.2, CH2CH3), 3.75 (6H,s, OMe); δC (100 MHz, 
CDCl3) 176.4, 163.9, 63.5, 53.0, 47.5, 45.7, 38.8, 36.9, 33.6, 13.2; MS m/z (+ESI) 
367.1 ([C17H19NO7 + NH4]+ requires 367.1). 
Hexaester 113 δH (270 MHz, CDCl3) 3.86 (H18, s,); δC (100 MHz, CDCl3) 165.2, 
134.0, 53.6; MS m/z (+ESI) 444.1 ([C18H18O12 + NH4]+ requires 444.1). 
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(1α, 2α, 3α, 4β, 8β, 9α, 10α, 11α, 12α, 13α, 14β, 15β, 16α, 17α) 
DIMETHYL 6-ETHYL-14,  15-
DI(TERTBUTOXYCARBONYLAM INOETHYLCARBOXAMIDE)6-AZA-19-
OXAHEPTACYCLO[9.6.1.13, 9.11 3, 1 602, 1 0.04 , 8.012, 17]ICOSANE-5,7-
DIONE-1,11-DICARBOXYLATE (87) 
A solution of epoxide 103 and 113 (228 mg, 0.39 mmol), 
alkene 84 (182 mg, 0.39 mmol) and DMF (2 mL) was 
heated to 150 °C using microwave irradiation for 15 min. 
The resulting solution was concentrated in vacuo and 
purified by flash column chromatography (Rf = 0.21, EtOAc) to afford the title 
compound (198 mg, 62%) as a pure white solid. mp 116.0–125.2; δH (270 MHz, 
DMSO-d6) 0.92 (1H, d, J 10.29, H20a), 1.16 (3H, t, J 7.1, Ethyl CH3), 1.16 (1H, m, 
H18a), 1.40 (18H, s, t-Bu), 2.10 (2H, s, H14,17), 2.32 (2H, s, H2,11), 2.41 (1H, d, J 
10.2, H18b or 20b), 2.60 (6H, m, H3,10, H13,18 and H15,16), 2.93 (3H, m, H4,9 
and H19b or 21b), 3.07 (2H, br m, H1’ or 2’), 3.23 (4H, br m, H1’ and or 2’), 3.50 
(2H, br m, H1’ or 2’), 3.57 (2H, q, J 7.0, Ethyl CH2), 3.83 (6H, s, OMe), 5.49 (2H, br 
s, Amide NH), 6.29 (2H, br s, BocNH); δC (100 MHz, CDCl3); 176.81, 171.76, 
168.86, 156.86, 90.44, 79.40, 52.48, 50.73, 49.90, 48.33, 48.20, 43.06, 41.32, 
40.44, 40.02, 38.05, 33.77, 29.77, 28.51, 13.09; HRMS m/z (+ESI) 816.40281 
([C40H57N5O13 + H]+ requires 816.40256). 
(1α, 2β, 2β, 3α) N,N’-DI(4-FLUOROPHENYLTHIOURED IOETHYL) 
BICYCLO[2.2.1]HEPTAN-5-ENE DICARBOXAMIDE  (4) 
A solution of Boc-protected scaffold 84 (500 mg, 1.1 mmol) in 11% 
TFA/DCM was stirred at 23 °C for 3.5 h. The solution was 
evaporated to dryness in vacuo and redissolved in DCM (5 mL) and 
again evaporated to dryness. This process was repeated with 
PhMe (5 mL) and CHCl3 (5 mL). The crude diamine was then 
redissolved in DCM (15 mL), added NEt3 (900 μL, 6.42, mmol) and stirred at 23 
 Chapter 3 
| 110 
°C for 10 min. To the resulting solution 4-fluorophenyl isothiocyanate (433 mg, 
3.21 mmol) was added and the reaction stirred at 23 °C for 16 h. The solution was 
then transferred to a separatory funnel then diluted with DCM, washed with 1 M 
HCl (3 × 15 mL), the organic separated, dried with MgSO4 and filtered. The organic 
fraction was evaporated to dryness in vacuo, and purified by flash column 
chromatography (Rf = 0.1, EtOAc) to afford the title compound (90 mg, 18%) as a 
white solid. mp 110.2–120.3 °C; δH (270 MHz, DMSO-d6) 1.23 (2H, s, H7), 2.96 
(2H, s, H2,3) 3.11 (6H, m, H1,4 and H1’ or 2’), 3.46 (4H, bs, H1’ or 2’), 6.09 (2H, s, 
H6,5) 7.13 (4H, dd, J 8.8, 3JF 8.8, H3”), 7.37 (4H, dd, J 8.9, 4JF 5.0, H2”), 7.66 (4H, m, 
Amide NH and Thiourea NH), 9.52 (2H, bs, Ar-NH); δC (100 MHz, CDCl3) 182.25, 
173.85, 160.79 (d, 1JF 246, C4”), 134.8, 133.9, 127.1 (d, 3JF 8, C2”), 116.1 (d, 2JF 23, 
C3”) 51.3, 46.1, 44.0, 39.2, 29.8; HRMS m/z (+ESI) 573.19114 ([C27H30F2N6O2S2 + 
H]+ requires 573.19125).  
(1α, 2α, 5α, 6α, 7β, 8β) DIMETHYL 7,8-DI(4-
FLUOROPHENYLTHIOUREDIOETHYLCARBOXAMIDE) 
TRICYCLO[4.2.1.0 2, 5]NON-3-ENE-3,4-DICARBOXYLATE (5) 
A solution of Boc-protected scaffold 85 (102 mg, 0.2 mmol) 
in 20% TFA/DCM was stirred at 23 °C for 2 h. The solution 
was evaporated to dryness in vacuo and redissolved in DCM 
(5 mL) and again evaporated to dryness. This process was 
repeated with PhMe (5 mL) and CHCl3 (5 mL). The crude 
diamine was then redissolved in CHCl3 (15 mL), added NEt3 (84 μL, 0.61 mmol) 
and stirred at 23 °C for 10 min. To the resulting solution 4-fluorophenyl 
isothiocyanate (100 mg, 0.61 mmol) was added and the reaction stirred at 23 °C 
for 16 h. The solution was transferred to separatory funnel then diluted with 
CHCl3, washed with 1 M HCl (3 × 15 mL), the organic separated, dried with MgSO4 
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and filtered. The organic fraction was evaporated to dryness in vacuo, and 
purified by flash column chromatography (Rf = 0.27, EtOAc) to afford the title 
compound (56 mg, 39%) as a white solid. mp 167.4–169.6 °C; δH (270MHz, D6-
DMSO); 1.14 (1H, d, J 11.8, H9b), 1.37 (1H, d, J 12.0, H9b), 2.37 (2H, s, H7,8), 2.89 
(2H, s, H1,6), 3.18 (8H, m, H1’ and 2’), 3.68 (6H, s, OMe), 7.11 (4H, dd, J 8.8, 3JF 8.8, 
H3”), 7.35 (4H, dd, J 8.7, 4JF 5.0, H2”), 7.74 (2H, bs, Thiourea N-H), 7.80 (2H, bs, 
Amide N-H), 9.55 (2H, s, Ar-NH); δC (100 MHz, CDCl3); 182.2, 172.8, 161.5, 160.9 
(d, 1JF 248, C4”), 141.2, 133.7, 127.1 (d, 3JF 8, C2”), 116.2 (d, 2JF 23, C3”), 52.2, 48.2, 
44.1, 42.5, 39.2, 37.1, 29.8; HRMS m/z (+ESI) 715.21780 ([C40H46F2N6O7S2 + H]+ 
requires 715.21786). 
(1α, 2α, 3α, 4β, 5β, 6α, 7α, 8α, 9α, 10α, 13α, 14α) DIMETHYL 4,5-
DI(4-FLUOROPHENYLTHIOURED IOETHYLCARBOXAMIDE) 16-
OXAHEXACYCLO[6.6.1.1 3, 6 .110, 13 .02, 7 .09, 14]HEPTADECANE-1,8-
DICARBOXYLATE  (7) 
A solution of Boc-protected scaffold 87 (98 mg, 0.16 
mmol) in 15% TFA/DCM was stirred at 23 °C for 2 h. The 
solution was evaporated to dryness in vacuo and 
redissolved in DCM (5 mL) and again evaporated to 
dryness. This process was repeated with PhMe (5 mL) 
and CHCl3 (5 mL). The crude diamine was then redissolved in DCM (15 mL), 
added NEt3 (110 μL, 0.8 mmol) and stirred at 23 °C for 10 min. To the resulting 
solution 4-fluorophenyl isothiocyanate (48 mg, 0.32 mmol) was added and the 
reaction stirred at 23 °C for 16 h. The solution was transferred to separatory 
funnel then diluted with DCM, washed with 1 M HCl (3 × 15 mL), the organic 
separated, dried with MgSO4 and filtered. The organic fraction was evaporated to 
dryness in vacuo, and purified by flash column chromatography (Rf = 0.2, EtOAc) 
to afford the title compound (50 mg, 37%) as a white solid. mp >154 °C 
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(Decomposition, slow evolution of gas); δH (270 MHz, DMSO-d6) 0.69 (1H, d, J 
10.2, H17a), 0.83 (1H, d, J 12.3, H15a), 0.97 (2H, d, J 7.8, H11n,12n), 1.23 (2H, m, 
H11x,12x), 1.88 (2H, s, H14,9), 1.96 (2H, s, H3,4), 2.00 (H1, d, J 8.5, 12b), 2.15 (2H, 
s, H10,13), 2.21 (1H, d, J 9.9, H15b), 2.63 (2H, s, H4,5), 2.83 (2H, s, H2,7), 3.16 (4H, 
m, H1’), 3.47 (4H, m, H2’), 3.74 (6H, s, OMe), 7.13 (4H, dd, J 8.8, 3JF 8.8, H3”), 7.39 
(4H, m, H2”), 7.71 (4H, bs, Amide NH and Thiourea NH), 9.06 (2H, s, Thiourea Ar-
NH); δC (100 MHz, CDCl3) 182.32, 173.04, 170.36, 160.54 (d, 1JF 244, C4”), 134.33, 
126.53 (d, 3JF 8, C2”) 115.95 (d, 2JF 22.5, C3”), 90.67, 56.16, 52.49, 50.41, 49.36, 
44.45, 42.23, 38.73, 38.27, 34.20, 29.77, 28.57; HRMS m/z (+ESI) 825.29135 
([C40H46F2N6O7S2 + H]+ requires 825.29102). 
(1α, 2α, 3α, 4β, 8β, 9α, 10α, 11α, 12α, 13α, 14β, 15β, 16α, 17α)-
DIMETHYL 6-ETHYL-14,  15-DI(4-
FLUOROPHENYLTHIOUREDIOETHYLCARBOXAMIDE)6-AZA-19-
OXAHEPTACYCLO[9.6.1.13, 8.11 3, 1 6.02, 10 .04, 8 .01 2, 1 7]ICOSANE-3,7-
DIONE-1,11-DICARBOXYLATE (8) 
A solution of Boc-protected scaffold 88 (185 mg, 0.22 
mmol) and thiophenol (49 μl, 0.48 mmol) in 13% 
TFA/DCM was stirred at 23 °C for 1 h. The solution was 
evaporated to dryness in vacuo and redissolved in DCM (5 
mL) and again evaporated to dryness. This process was 
repeated with PhMe (5 mL) and CHCl3 (5 mL). The crude diamine was then 
redissolved in DCM (20 ml), basified with NEt3 (173 μL, 1.32 mmol) and stirred 
at 23 °C for 10 min. To the resulting solution 4-fluorophenyl isothiocyanate (166 
mg, 1.5 mmol) was added and the reaction stirred at 23 °C for 16 h. The solution 
was transferred to separatory funnel then diluted with DCM, washed with 1 M 
HCl (3 × 10 mL), sat. NaHCO3 (3 × 10 mL), dried with MgSO4 and filtered. The 
organic fraction was evaporated to dryness in vacuo, the crude solid redissolved 
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in EtOAc and pure product precipitated with cold diethyl ether. The precipitate 
was collected by vacuum filtration and washed with diethyl ether (3 × 1 mL) to 
afford the title compound (120 mg, 59%) as a white solid. mp >176 °C 
(decomposition, slow evolution of gas); δH (270 MHz, DMSO-d6) 0.83 (1H, d, J 8.9, 
H20a), 1.00 (3H, t, J 7.11, CH3), 1.13 (1H, d, J 9.7, H18a), 1.84 (2H, s, H2,10), 2.14 
(2H, s, H13,16), 2.22 (1H, m, H20b), 2.31 (1H, d, J 9.4, H18b), 2.40 (2H, s, H3,9), 
2.61 (2H, s, H14,15), 2.77 (2H, s, H12,17), 3.04 (2H, s, H4,8), 3.14 (4H, m, H1’), 
3.27-3.50 (6H, m, H2’ and CH2CH3), 3.77 (6H, s, OMe), 7.14 (4H, dd, J 8.8, 3JF 8.8, 
H3”), 7.38 (4H, m, H2”), 7.66 (4H, m, Amide NH and thiourea NH), 9.50 (2H, s, 
thiourea Ar-NH); δC (100 MHz, CDCl3) 182.1, 177.6, 172.7, 169.1, 160.7 (d, 1JF 246, 
C4”), 134.1, 127.2 (d, 3JF 9, C2”), 116.1 (d, 2JF 40), 90.5, 52.8, 50.8, 50.1, 48.7, 48.6, 
44.4, 42.4, 41.2, 39.4, 38.0, 35.9, 33.8, 13.1; HRMS m/z (+ESI) 922.3073 
([C44H49F2N7O9S2 + H]+ requires 922.3074). 
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CHAPTER 4 
 
FUSED 
[5]POLYNORBORNANE-
‘SUPER-STAPLED’ PEPTIDES 
 
4.1 PREAMBLE 
Peptide sequences with synthetic modification to join two or more regions along 
the peptide backbone are known as ‘stapled’ peptides.[242] The ‘staples’ have 
attracted interest in recent years, due to their ability to stabilise the secondary 
structure of short peptide sequences.[192, 201, 242] Many short α-helix sections of 
larger peptide sequences are the crucial components that impart biological 
activity.[201] However, if the α-helix component was synthesised without the 
larger peptidic backbone to preorganise the peptide, the α-helix secondary 
structure would be unstable and hence the pharmacological benefit of the active 
conformation is lost. As discussed in the introduction (section 1.2.3.4) several 
protocols have been developed in order to construct stapled peptides. The 
majority of these protocols focus on the use of smaller alkyl[197-199, 201, 203-207, 242] 
or aryl[184, 208, 243, 244] staples. Larger synthetic frameworks, such as 
[n]polynorbornane scaffolds (figure 92), have not been incorporated as peptide 
staples. As these structures are extremely rigid and preorganised (compared to 
alkyl staples) they have the potential to function as ‘super-staples’.  
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Figure 92: Cartoon of [5]polynorbornane peptide staple  
The current chapter primarily investigates the attachment of [5]polynorbornane 
scaffolds onto a short peptide sequence in order to preorganise a peptide. 
However, a short section on the synthesis and evaluation of norbornene 
peptidomimetic scaffolds will be included to highlight the value of a stapled 
peptide approach for incorporation of a [5]polynorbornane into a biochemical 
setting. The peptide staple section will describe the synthesis of the required 
reagents. Then application of these reagents in relevant test reactions will be 
explored to assess their suitability to form a stapled peptide.  
4.2 NORBORNENE RECEPTORS 
As a prelude to the synthesis of stapled peptides; a series of peptidomimetic 
norbornene receptors were designed as simple Vancomycin mimics (figure 93). 
It was envisioned that these small receptors (114–120, figure 97) with suitable 
functionality could bind to the anionic D-alanine-D-alanine portion of the 
 
 
Figure 93: Vancomycin 77   bound and receptor 117 envisioned binding to the terminal D-alanine 
(blue) of the bacterial cell wall.  
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bacterial cell wall (lipid II) as Vancomycin does (discussed in section 1.2.3.3).[180, 
181, 185] 
4.2.1 SYNTHESIS OF NORBORNENE RECEPTORS 
A general four step synthesis including imide formation, amide coupling, 
deprotection and anionophore formation was used to synthesise the norbornene 
receptors 114-120 (figure 94).  
 
Figure 94: Structure of receptors 114–120. 
As a typical example of the series, synthesis of receptor 117 (scheme 22) began 
with imide formation using norbornene anhydride 91 and Boc-protected 
diaminopropanoic acid (Boc-DAP-OH) to generate imide 121 in 95% yield. Imide 
121 was then coupled with glycine methyl ester; using 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDCI) and Hydroxybenzotriazole (HOBt) to 
form amide 122 in 80% yield. Amide 122 was then deprotected (20% 
Trifluoroacetic acid [TFA] in DCM) and treated with 4-fluorophenyl 
isothiocyanate to from thiourea receptor 117 in 67% yield. The synthesis of the 
norbornene receptors 114–120 all followed a similar synthetic route  
(yields, table 5). 
 
Scheme 22: Synthesis of receptor 117.  
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Figure 95:1H NMR spectrum and mass spectrum of receptor 117.  
4.2.2 EVALUATION OF NORBORNENE RECEPTORS 
Norbornene receptors 114–120 were evaluated for their ability to bind both 
acetate and a model anion representing the bacterial cell wall precursor using  
 
Table 5: General receptor structure bound to acetyl D-alanine (Blue) and table of yields, 
functionality and binding strength (K a) of receptors in DMSO-d6 at [H]0 = 2.5 mM (error ≤ 15%). 
  
Receptor Isolated 
yield 
X Y R n 
Log Ka 
AcO− 
Ac-D-
Ala− 
114 63% O F i-Pr 1 2.5 1.9 
115 19% O F H 1 2.5 1.7 
116 75% S H H 1 2.6 1.9 
117 67% S F H 1 2.6 1.9 
118 86% S H i-Pr 1 2.9 1.8 
119 78% S H CH3 1 2.7 2.0 
120 91% S H H 4 2.6 1.8 
H10b H10a 
H1,2,7,6 
H1’,8’ 
H5’ H2’ H8,9 
HthioureaNH 
H3” 
H2” 
Hamide 
Hthiourea Ar-NH 
[117 + H]+ 
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1H NMR titration (table 5). To simulate binding of the terminal D-alanine-D-
alanine component of the bacterial cell wall precursor (lipid II), N-acetyl D-
alanine was chosen as a model substrate. Both anions were used as their TBA 
salts. The titrations were conducted in DMSO-d6 using an initial host 
concentration of 2.5 mM. The strength of binding (LogKa) was calculated using 
WinEQNMR2.[156] All titration isotherms and modified Job Plots are available in 
the appendix. 
All receptors (114–120) bound to both acetate and acetyl D-alanine in a 1:1 
Host:Guest (H:G) complex. Unfortunately only modest binding to acetyl-D-alanine 
was observed (Average LogKa = 1.9). Vancomycin on the other hand binds to D-
alanine-D-alanine very strongly in a more competitive solvent (LogKa = 5.6 in 
H2O[182]). 
4.2.3 CONCLUSIONS DRAWN FRO M NORBORNENE RECEPTORS 
Due to the weak binding of the norbornene receptors to D-alanine, they certainly 
cannot function as antimicrobial compounds using the anticipated mode of action 
akin to vancomycin. These norbornene receptors both lack the amount of H–bond 
donors that Vancomycin possesses, and more importantly lack the 
preorganisation induced by the aryl rings included in Vancomycin’s structure. To 
increase the affinity of this class of norbornene receptors towards D-alanine two 
things are required, firstly, more H–Bond donors akin to Vancomycin, and 
secondly, increased preorganisation of these hydrogen bond donors.  
More hydrogen bond donors can be accessed in a relatively easy way, by 
including a short peptide sequences (n = 4–7) into the structure. Vancomycin 
itself is a heptapeptide. Extra preorganisation can be induced using a fused 
[n]polynorbornane to rigidify the peptide chain. Such a rigidified peptide would 
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be classed as a stapled peptide. Thus investigation into the use of a fused 
[n]polynorbornane scaffold as a peptide super-staple was initiated as an efficient 
method to produce highly preorganised peptides. 
4.3 PEPTIDE STAPLES: STRATEGIES AND SYNTHESIS 
There are many well researched methods to staple peptides:[245] Lactamisation, 
[211-214] Alkene Metathesis, [197-199, 201, 204, 206, 207] and copper catalysed 1,3-dipolar 
Huisgen azide-alkene cycloaddition (CuAAC)[184, 207, 208, 243, 246-248] are three such 
methods. These methods lend themselves well to the synthesis of a stapled 
peptide using an appropriately functionalised [5]polynorbornane scaffold and 
peptide partner. 
 
Figure 96: Comparison of the different staple to peptide linker groups. Disulfide with alkene/ane 
and amide with 1,4 substituted 1,2,3-triazole to highlight the similar geometry and polarity ( Red 
H-bond donor, Blue H-bond acceptor). 
The advantages of these linker groups are that they are all biologically relevant.  
Amide bonds (figure 97, 123) are already an integral part of peptide primary 
structure and 1,4 substituted 1,2,3-triazoles (the result of the click reaction, 
figure 97, 124), are regarded as isosteres of the amide functional group.[249] The 
alkene (figure 97, 125) or hydrogenated alkane from metathesis is a mimic of 
 
 
Figure 97: Results of the three stapling methods. New bonds formed highlighted in red. From left: 
lactamisation 123, CuAAC 124 and alkene metathesis 125. 
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disulphide bonds, and have been shown to be able to replace such bonds in 
synthetic peptide mimics.[250-252]  
Although each of the stapled peptide formation methods have been shown to 
work for smaller scaffolds, there are disadvantages to each approach. Amide 
bonds can be cleaved by proteases in vivo, and the reactions to form them are 
generally lower yielding than CuAAC and alkene metathesis. CuAAC is considered 
a ‘click’ reaction due to its high yields and benign conditions.[253] The 
disadvantage of the triazole and alkene linkers is that they both require boutique 
amino acids or post-synthetic modification of the peptide component before 
reaction to form the stapled peptide.   
Regardless, all three protocols (lactamisation, alkene metathesis, and CuAAC) 
were investigated for the stapling reaction of a [5]polynorbornane to a peptide 
partner. A series of [5]polynorbornane staples 9–11 were identified, each with 
suitable functionalisation for the respective stapling reactions (Lactamisation, 
alkene metathesis, CuAAC, figure 101) and hence became synthetic targets. 
 
Figure 98: The three peptide staple candidates, hosts 9–11. 
[5]Polynorbornane diacid 9 has suitable functionalisation for amide bond 
formation; the carboxylic acids can be attached to short peptides through lysine 
side chains (primary amine) from the peptide partner under standard peptide 
coupling conditions. Diene 10 with two allyl amides has terminal alkenes suitable 
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for metathesis. Diazide 11 is functionalised with two azide groups that can be 
cyclised with a dialkyne functionalised peptide partner using CuAAC. 
It has been shown that two azides preorganised in close proximity can enhance 
the yield of ditriazole formation through ligand cooperation (scheme 23).[249, 254] 
In light of prior work by Finn et al., the azide functionalised preorganised scaffold 
was deemed as the more valuable choice over an alkyne functionalised 
[5]polynorbornane. 
 
Scheme 23: Cooperation of organo-copper intermediates during the formation of ditriazoles.[254] 
In order to form a stapled peptide with diene 10 and diazide 11, specialised 
amino acids are required with suitable functionalisation for reaction with 10 and 
11. Diene 10 requires the inclusion of allyl glycine or another allylated amino acid 
and diazide 11 requires propargylated residues.  
4.3.1 STEPWISE SYNTHESIS 
For the synthesis of symmetrical [5]polynorbornanes bis-epoxide 58 has proven 
an valuable reagent. Bis-epoxide 58 was synthesised in two step one-pot reaction. 
Firstly, reaction of quadricyclane 104 with DMAD to form Smith’s diester 105 
followed by Mitsudo reaction to form tetraester 130 in 86% yield. The tetraester 
130 was subsequentially transformed by Weitz-Scheffer epoxidation to give bis-
epoxide 58 in a 34% yield. 
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Scheme 24: Synthesis of diacid staple  9.  
With bis-epoxide 58 in hand, the synthesis of diacid 9 began; firstly with the 
formation of imide 131 (scheme 24). Using microwave irradiation imide 131 was 
isolated in a 42% yield. Imide 131 was then reacted under ACE cycloaddition 
conditions with bis-epoxide 58 to form diacid staple 9 (63%, figure 102).  
 
Figure 99:1H NMR spectrum and mass spectrum of diacid 9. 
Diacid staple 9 was converted to the diene 10 through amide coupling (scheme 
25). The amide coupling process was efficient, providing diene 10 in 62% yield. 
The conversion to the amide was confirmed by new signals in the 1H NMR 
spectrum corresponding to the amide N–H (6.23 ppm) and two resonances  
  
[9 + NH4]+ 
H29a 
H1, 
H31 
H31 
H4,5,18,19 
H2’ 
H6,20 
H1’ 
H3’ 
HOMe 
HCOOH 
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Scheme 25: Synthesis of diene staple 10. 
typical of an ABMX2 system for the alkene CH and CH2 (5.20 + 5.87 ppm). The 
success of this reaction provided initial proof that the carboxylic acids are 
available for conversion to amides and hint at a successful peptide stapling 
candidate. 
 
Figure 100: 1H NMR spectrum and mass spectrum of diene 10. 
With two potential staples successfully synthesised (diacid 9, diene 10) attention 
turned to diazide 11. As azide functional groups are not compatible with the high 
temperatures required for ACE cycloaddition, the azides must be installed after 
framework construction. Azides can be installed through several methods. 
Azidation methods include, SN2 displacement of a leaving group by the azide 
anion, direct azidation of a diol and azidation of an 
 
H29a 
H6, 
H31 
H4,5,18,19 
H2’ H6,20 H3’ H7’ 
HOMe 
HamideNH H8’ H1’ 
[10 + H]+ 
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Scheme 26: Retrosynthesis of Diazide 11. Multiple pathways utilising differ ent azidation 
strategies shown. 
amine by diazotransfer (scheme 26). These three methods were each trialled in 
order to identify the most efficient route to diazide 11. To investigate these 
methods, two differently functionalised scaffolds were required: diol precursor 
132 and diamine precursor 133 (figure 101). 
  
Figure 101: Azide precursor frameworks diol  132 and diamine 133.  
To synthesise diol 132, norbornene anhydride 91 was heated with 
enthanolamine (pathway A, scheme 27). Unlike previously successful reactions 
for imide formation, the isolated yield of alcohol 135 was extremely low (< 5%). 
In addition, no starting material was detected by 1H NMR in the crude reaction 
mixture. Further examination of fractions separated during work-up indicated 
that the product was lost during aqueous work-up, which was required to remove 
excess ethanolamine. As such, a second route was devised. Pathway B (scheme 
27), involved the reaction of norbornene anhydride 91 with 
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Scheme 27: Pathway A and B for the synthesis of diol 132. 
bis-epoxide 58 to form anhydride 136, before imide formation. Using the 
alternative two-step method, diol 132 was isolated in a 37% overall yield. 
4.3.2 ONE-POT METHODOLOGIES 
A one-pot, multicomponent reaction was hypothesised to be an efficient method 
for synthesis of these symmetric scaffolds. Solvent free one-pot multicomponent 
reactions have recently been reported for the synthesis of polynorbornane 
scaffolds.[255] However, as the required materials would evaporate at the 
reported temperatures (ca. 200 °C), a new methodology was developed to allow 
for lower temperature (scheme 28).  
Acid amide 137 was formed by combining norbornene anhydride 91 and 
ethanolamine in solution at room temp in an unsealed pressure vessel for 5 
minutes. Bis-epoxide 58 was added and pressure vessel sealed. The pressure 
vessel was then heated to 140 °C for 48 hours to affect the formation of both imide 
and [5]polynorbornane scaffold. The one-pot methodology was successful and 
diol 132 was isolated in 88% yield with no requirement for purification as the 
product was directly precipitated using H2O. The 88% yield was a significant 
improvement than that obtained using the stepwise methodology (37%). The 
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Scheme 28: One-pot pathway for diol  132. 
one-pot methodology also neatly circumvented the problematic isolation of imide 
135. 
Diol 132 was insoluble in CDCl3, so characterisation was carried out in DMSO-d6. 
Three key framework resonances were unfortunately obscured by the solvent 
signal in the 13C spectrum. Their chemical shift was elucidated by 2D gHMQC 
experiments (40.7 ppm, 40.5 ppm, 40.0 ppm). 
 
Figure 102: 1H NMR spectra (DMSO-d6) and mass spectra of diol 132.  
HOH 
HOMe 
Hethyl 
Hethyl 
H6 
H5 
H29b 
H4 
H2 H31 
H1 H29a 
[132 + NH4]+ 
 Chapter 4 
| 128 
The literature preparation for diamine 133, required a four step synthesis 
including two protection/deprotection steps and purification by column 
chromatography (41% yield overall).[138] A protecting group free synthesis of 
diamine precursor 133, was undertaken using the one-pot protocol (scheme 29).  
Ethylene diamine (EDA) and norbornene anhydride 91 were combined in an 
unsealed pressure vessel to pre-form acid amide 138 (5 min, room temperature). 
Tosic acid (TsOH) was then added to form an ammonium salt (5 min, room 
temperature). Bis-epoxide 58 was added, the pressure vessel sealed and heated 
to 140 °C for 48 hours to affect the formation of both imide and 
[5]polynorbornane scaffold. Diammonium 133a was isolated in 78% yield as a 
precipitate from the reaction mixture, requiring no further purification. While 
diammonium 133a was conveniently isolated as a salt, simple basification (e.g. 
NEt3 or DIPEA) before reaction would liberate the desired amine 133. 
  
Scheme 29: One-pot reaction pathway for ammonium 133a.  
Due to the success of the one-pot methodology in forming diammonium 133a and 
diol 132, it was also applied to the synthesis of diacid 9. Using the same 
conditions as for diol 132, diacid 9 was formed in a 50% yield after  
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Figure 103: 1H NMR spectrum (DMSO-d6) of diammonium 133a. 
recrystallization from methanol. The one-pot method improved the overall yield 
of diacid 9 from 26% to 50%. 
4.3.3 AZIDE SYNTHESIS 
With fused [5]polynorbornanes diol 132 and amine 133a in hand, three general 
pathways that could be used to generate diazide 11 were investigated: direct 
azidation, SN2 displacement and diazotransfer.  
4.3.3.1 DI RE CT AZID ATION  
Direct azidation has been demonstrated in the literature using both a Mitsunobu 
type strategy[256-258] and through reaction of a hydroxyl group with 
diphenylphosphoryl azide (DPPA).[259] 
Direct reaction of diol 132 with DPPA provided no conversion to the azide. Only 
starting material was noted in the 1H NMR spectra. A Mitsunobu literature 
preparation[258] of an azide from a hydroxyl group using DEAD, PPh3 and DPPA 
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as the azide source was followed. Again no conversion to the desired product was 
detected using 1H NMR spectroscopic analysis of the reaction product.  
The bulk of literature examples for the conversion of hydroxyl groups to azides 
via Mitsunobu strategies,[257] use hydrazoic acid as the azide source. Due to the 
unstable nature of hydrazoic acid, this approach was not pursued. 
4.3.3.2 SN2 DIS PL ACEMEN T  
Before use in an SN2 displacement reaction, diol 132 must first be activated. The 
hydroxyl groups must first be converted into a leaving group (e.g. Cl, Br, I, OTs, 
OMs, ONs). 
The hydroxyl groups of diol 132 were converted to mesylate (OMs) groups using 
mesyl chloride to form dimesylate 140 in quantitative yield (scheme 30). 
Unfortunately, displacement of OMs by sodium azide was unsuccessful and only 
diol 132 was isolated after precipitation by addition of H2O to the reaction 
mixture. 
 
Scheme 30: Activation of the hydroxyl groups and attempted displacem ent of mesylate groups by 
sodium azide. 
As displacement of OMs did not provide the desired diazide, the diol was next 
converted to the dibromide (scheme 32). PBr3 has been shown to be capable of 
transforming a hydroxyl group to a bromide.[260] The addition of DMF to PBr3 
(141) facilitates the formation of a Vilsmeier-type intermediate  
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Scheme 31: The reaction of PBr3 and an alcohol in the presence of DMF. [260-262] 
 
(146, scheme 31).[261] The Vilsmeier intermediate is a more reactive species and 
conversion of diol 132 to dibromide 144 was efficient (93% isolated yield). 
Dibromide 144 was then treated with sodium azide in DMSO to afford diazide 11 
in a modest 37% yield (scheme 32). 
 
Scheme 32: Synthesis of diazide 11 via SN2 displacement of bromine.  
4.3.3.3 DI AZO  TRANS FER 
Transformation of an amine to an azide requires a diazo transfer agent and many 
reagents exist for this purpose.[263-266] Unfortunately, many diazo transfer agents 
are explosive and unpredictable.[267] Due to safety concerns, some of these 
reagents are synthesised immediately before use. 2-Azido-1,3-
dimethylimidazolinium hexafluorophosphate (ADMP 145) is an efficient diazo 
transfer agent with a good safety profile.[264, 265] Due to the benign nature of the 
reagent, and literature precedence for the amine to azide transformation,[264] 
ADMP was chosen for the current study. 
 
Scheme 33: Synthesis of ADMP 145. 
To synthesise ADMP literature methods were followed (scheme 33).[264, 268]  
1,3-dimethylimidazolidinone 146 was treated with oxalyl chloride to afford the 
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chloride salt 147 in very good yield (90%).[268] The chloride salt was extremely 
hygroscopic, and would deliquesce from atmospheric H2O nearly 
instantaneously. As such salt 147 was handled under a stream of N2 at all times. 
Anion exchange of the chloride from salt 147 provided hexafluorophosphate salt 
148 in a good yield (80%). The hexafluorophosphate salt 148 was not as 
hygroscopic as the chloride salt 147 and could be handled without an inert 
atmosphere. Hexafluorophosphate salt 148 was treated with sodium azide and 
the desired ADMP was isolated in 88% yield. As mentioned previously, 
diazotransfer agents are notoriously unstable; therefore, ADMP was stored at 4 
°C. In this project ADMP was stored under N2 at 4 °C for 6+ months with no sign 
of degradation.  
The diazo transfer reaction between ADMP and an amine has been shown to be 
an efficient method of azide formation.[264] As such, ADMP was reacted with 
diamine 133 (liberated from diammonium 133a) under basic conditions for 16 
hours (table 6 entry 1). Upon analysis of the crude reaction mixture by 1H NMR 
spectroscopy, an unknown impurity was detected. As can be seen in scheme 34, 
there are possible guandino side and by-products (149 and 150 respectively).  
 
 
Scheme 34: Diazo transfer mechanism using ADMP 145 (Blue) with possible formation of 
guanidine side/by-products (red).[264, 265]  
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Water solubility of the guanidine by-products usually ensures they are easily 
removed though acidic work-up; in this instance acidic work up was not able to 
remove the impurity. 
The diazide was also not able to be purified by chromatography due to similar Rf 
values of both azide 11 and impurity (Rf = 0.18 EtOAc). All attempts (table 6) to 
minimise production of the impurity were unsuccessful. Entries 2 and 3 varied 
base (both shown to be successful in the literature[264]); and entry 3 shortened 
reaction time (to mitigate the production of impurity if formation of the impurity 
was controlled by slow kinetics). Diazide 11 was finally isolated in low 29% yield 
through precipitation from DMSO (table 6, entry 4).  
Table 6: Optimisation of the transformation of amines to azides by ADMP .  
 
 
Entry ADMP (equiv.) 
Base 
(equiv.) Additive Time 
Temp 
(°C) Pure 
Yield  
(Mass 
Recovery) 
1 6 NEt3 (16) - 16 h 0–22 N (60%) 
2 4 DMAP (8) - 48 h 22 N (2%) 
3 2.4 NEt3 (12) - 15 min 22 N (16%) 
4 3 NEt3 (12) - 16 h 0–22 Y 29% 
5 2.4 NEt3 (15) CuSO4 16 h 0–22 Y 42% 
 
CuSO4 has been shown to catalyse azide formation using other diazo transfer 
reagents.[263] Literature reports by Kitamura et al. indicated that addition of 
CuSO4 to reactions containing ADMP provided little benefit.[264] Contrary to  
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Figure 104: 1H NMR spectra and mass spectra of diazide 11 in CDCl3. 
Kitamura’s report, a higher yield of diazide was isolated (42%) when ADMP and 
diamine 133 were reacted in the presence of CuSO4 and base (table 6, entry 5) 
In summary, two viable reaction pathways (SN2 displacement of bromine and  
 
 
Scheme 35: Overview of the two viable reaction pathways for diazide 11 formation.  
H29a 
H2 
H1 
H4 
H3
H5,29
H6 
HEthyl 
HOMe 
[11 + H]+ 
   Chapter 4 
135 | 
diazotransfer, scheme 35) were identified to provide diazide 11 in similar overall 
yield (27% for SN2, 33% for diazotransfer). Both methods afforded the desired 
diazide in high purity. With the diazide in hand, all three staples 9, 10 and 11 had 
been synthesised. 
4.3.4 STAPLING REACTIONS: PROOF OF CONCEPT  
Three unique methods of macrocyclisation to peptide chains were trialled. To test 
the effectiveness of each method test reactions were performed. The test 
reactions would validate each method and, depending on efficiency, ultimately 
dictate which reaction would be used to introduce the [5]polynorbornane staple 
to a peptide sequence. 
4.3.4.1 LACTAMIS ATI ON 
The carboxylic acid functionality of diacid 9 was already proven to be reactive 
under amide coupling conditions due to the successful synthesis of diene staple 
9 (section 4.2.1). To further test the reactivity of this framework, diacid 9 was 
reacted with diaminobutane and EDCI in an attempt to form macrocycle 157. 
Unfortunately even at dilute concentration (1 mM), oligomer formation occurred 
(scheme 36). Oligomer formation was evidenced by a flocculation of an insoluble 
material, which when analysed by 1H NMR spectroscopy provided a broad 
spectra characteristic of a polymeric material. Due to the oligomer formation on 
a test substrate (diaminobutane), lactamisation is unlikely to produce the desired 
stapled peptide. 
 
Scheme 36: Unsuccessful synthesis of macrocycle 157.  
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Amine side chain functionalities (e.g. lysine) are common in peptides (both 
synthetic and natural). As amine’s are reactive during solid phase peptide 
synthesis (SPPS), auxiliary protecting groups are needed which further 
complicates the synthesis of peptides. For resin bound stapling, the use of 
auxiliary protecting groups can be especially complicated as they must be 
orthogonal from FMOC deprotection (High pH) and peptide cleavage (Low pH). 
From the outset, using carboxylic acids to attach a [5]polynorbornane to a 
peptide sequence has extra complications during SPPS.  
4.3.4.2 ALKE NE ME TATHESIS  
The selectivity of an alkene metathesis reaction posed an interesting problem. 
Much success in stapling peptides has been achieved using alkene metathesis, 
however, peptides are commonly stapled intramolecularly. Intermolecular 
reaction is required to form the desired stapled peptide with diene 10. The 
[5]polynorbornane scaffold of diene 10 provides preorganisation of the alkene 
groups suitable for cyclisation onto a peptide. Unfortunately, the preorganisation 
also provides spatial arrangement for the undesirable intramolecular 
macrocyclisation. To test if intermolecular reaction was favoured over 
intramolecular, diene 10 was reacted without a peptide partner (scheme 37).  
When Diene 10 was reacted with Grubbs catalyst (Gen I) at room temperature no 
reaction occurred. At elevated temperature (40 °C) the reaction gave full 
conversion to macrocycle 158 while dimer 159 was not detected by 1H NMR 
spectroscopy. Macrocycle 158 was isolated in a 96% yield. Macrocycle 158 was  
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Scheme 37: Macrocyclisation of diene amide 10 by alkene metathesis. 
further hydrogenated (H2, Pd/C) to form the alkane 157 in quantitative yield 
(scheme 40). The successful synthesis of macrocycle 157 via the alkene 
metathesis methodology, provided more evidence that it was not formed using 
the lactamisation methodology (section 4.3.4.1). 
Due to the favourability of the intramolecular reaction, the alkene metathesis 
method was deemed unsuitable for intermolecular peptide stapling reactions. 
While not suitable for the current project, the high yield of RCM from diene 10 
lends itself to use in other peptide-polynorbornane hybrids (suggested in the 
concluding remarks 5.3). 
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Figure 105: 1H NMR spectra (CDCl3) and mass spectra of alkane macrocycle 157. 
4.3.4.3 CO PPER  CATALYSED 1,3-DI POL AR AZIDE-AL KENE  CYCL O AD DITIO N  
To test if the azide functional groups of staple 11 were reactive towards alkynes 
in a CuAAC, a test reaction was carried out, in which, phenylacetylene was reacted 
with diazide 11 in the presence of Cu(I). Two different copper sources were 
trialled (CuSO4 and CuI). The use of copper iodide gave desired ditriazole 160 in 
excellent yield (85%, scheme 38). The use of copper sulphate in the presence of 
sodium ascorbate provided no reaction. The occurrence of a singlet at 7.57 ppm 
in the 1H NMR spectra was indicative of the formation of the ditriazole (figure 
106). 
Scheme 38: CuAAC reaction of Diazide  11  and phenylacetylene. 
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Suitable peptides for attachment of the diazide peptide staple 11 must include 
alkyne functionality. An advantage of this approach is that the alkyne functional 
group does not require protection during SPPS. As such, the CuAAC provides an 
advantage over the amide coupling method as the SPPS does not require 
orthogonal protecting groups. 
Figure 106: 1H NMR spectra (CDCl3) and mass spectra of ditriazole 160. 
Due to both the high yield of the CuAAC test reaction (85%), a likely compatibility 
with SPPS, and no chance for intramolecular cyclisation, CuAAC was chosen as 
the method of choice for peptide stapling.  
4.4 DITRIAZOLE ‘SUPER-STAPLED’ PEPTIDE 
The aim of this chapter was to include a fused [n]polynorbornane in a 
biochemical setting by formation of a stapled peptide and to study the effects of 
the preorganised scaffold on the peptide secondary structure. Peptide 13 (figure 
107), with two alkyne functional groups, was chosen as the peptide substrate to 
cyclise with azide 11. Hexapeptide 13 is similar in structure to poly-alanine 
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sequences which are known to have β-sheet character.[269, 270] Substituting amino 
acids 2` and 5` with propargyl glycine (Pgl) provides two alkynes groups for 
reaction with diazide 11. To minimise chance of reaction at the N and C termini, 
peptide 13 was designed with a carboxamide at the C-terminus and an acetamide 
at the N-terminus. After the synthesis of peptide 13, two methods of 
macrocyclisation were investigated: 1) on-resin (before cleavage of the peptide 
from the resin) and; 2) solution-state (after cleavage of the peptide from the 
resin). Following macrocyclisation, circular dichroism (CD) spectroscopy and 
infrared (IR) spectroscopy would clarify the effect that a polynorbornane 
framework has on the secondary structure of peptide 13  
(α-helix, β-Sheet, random coil). 
 
Figure 107: Peptide 13. 
4.4.1 SOLID PHASE PEPTIDE SYNTHESIS (SPPS) 
The hexapeptide 13 was synthesised using standard 
fluorenylmethyloxycarbamate (Fmoc) chemistry SPPS (scheme 42).[271] Rink 
resin was used to afford terminal amide functionality and the peptide was 
‘capped’ using acetic anhydride. The coupling agent used was O-(Benzotriazol-1-
yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU) in conjunction 
with HOBt and Diisopropylethylamine (DIPEA). Fmoc deprotection was achieved 
using 20% piperidine in DMF. It should be noted that while a Kaiser (ninhydrin) 
test was used to monitor Fmoc deprotection (a blue colour indicates a free 
amine), when Fmoc was removed from propargyl glycine residues, a red colour 
was seen.  
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Scheme 39: Solid phase peptide synthesis of resin bound peptide 12. Each step (i-vii) was also 
contained a coupling solution (HBTU, HOBt, DIPEA and DMF) and was followed by a deprotection 
step (20% piperidine in DMF). 
After peptide bound resin 12 was capped with acetic anhydride the resin was 
dried and divided into two portions. One part was subjected to cleavage 
conditions to isolate peptide 13 and one part subjected to on-resin cyclisation 
with diazide 11 before cleavage. 
Peptide 13 was cleaved from the resin using a solution of 95% TFA, 2.5% H2O 
and 2.5% Triethyl silane. After cleavage the peptide was isolated in 90% yield. A 
signal corresponding to the desired peptide 13 was observed in the mass 
spectrum (534.26704 [C24H35N7O7 + H]+) confirming successful synthesis (figure 
108). Unfortunately a small amount of FMOC protected peptide was also detected 
(m/z = 736 corresponding to NH2CO-Ala-Pgl-Ala-Ala-Pgl-Ala-Fmoc). The highly 
UV active Fmoc group was also detected in the HPLC 
 
 
Figure 108: HPLC trace (UV detection at 214 nm) and mass spectrum of peptide 13.
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(retention time = 16 min). The UV spectra of the Fmoc-peptide (imparted by the 
highly UV active fluorenyl moiety) had a characteristic absorbance at 254 nm 
(figure 112). As the desired peptide 13 was not particularly active in the UV and 
the Fmoc-peptide was highly active in the UV, quantification was impossible. The 
secondary structure of peptide 13 was analysed by CD spectroscopy. Due to a 
minimum at ca. 200 nm in the CD spectrum of peptide 13 indicated that the 
peptide had no stable secondary structure (i.e. random coil) in MeOH.[272]  
With both resin bound peptide 12 and free peptide 13 in hand, both a solution 
state coupling and a resin bound coupling were trialled.  
  
Figure 109: UV Spectra of Peptide 13 and Fmoc Peptide. 
4.4.2 SOLUTION STATE STAPLING 
The solution state coupling (CuAAC) of diazide 11 and free peptide 13 was 
conducted under dilute conditions (2 mM) to suppress oligomer formation 
(scheme 40). After 48 hours the reaction was filtered through celite to remove 
the catalyst and the product purified by preparative TLC (Rf = 0.37 – 1:3 
MeOH:DCM) to afford a new material in 16% yield (the characterisation of the 
new material is discussed in section 4.4.4). 
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Scheme 40: Solution state coupling of azide 11 and peptide 13. 
4.4.3 RESIN BOUND STAPLING 
A resin bound approach to stapled peptide 14 posed a unique problem. 
Conventional magnetic stirring of the resin bound peptide would be detrimental 
to the resin. Conventional mixing of resin bound peptide as used in SPPS did not 
allow for effective heating. To mitigate resin break down, and both effectively  
 
 
 
Figure 110: Custom apparatus for agitation of the reaction vessel . 
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heat and mix the ‘slurry’ a custom apparatus was assembled. The custom 
apparatus (outlined in figure 110) agitated the slurry by spinning the reaction 
vessel while the vessel was immersed in a paraffin oil bath for effective heating. 
Using the custom apparatus (figure 110) the resin bound peptide was reacted 
with azide 11 under similar CuAAC conditions used in the solution state coupling. 
Post-reaction, the resin was washed with DMF then DCM. The resin was dried and 
the peptide cleaved from the resin using a solution of 95% TFA, 2.5% H2O and 
2.5% triethyl silane. The crude product was then purified by preparative TLC to 
afford a new material in 12% yield (the characterisation of the new material is 
again discussed in section 4.4.4). 
 
Scheme 41: Resin bound coupling of azide 11 with peptide 12. 
4.4.4 STAPLED PEPTIDE CHARACTERISATION 
To characterise the new material produced by both on resin and solution state 
CuAAC, three techniques: HRMS, HPLC and IR were employed. Unfortunately, the 
new material was not sufficiently soluble in solvents compatible with CD 
spectroscopy (e.g. H2O, MeOH); therefore, in order to gain characteristic chemical 
information. IR spectroscopy was instead used to assess the secondary structure 
of the protein in the solid state.  
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HRMS confirmed formation of the stapled peptide. The molecular ion was 
observed as the proton adduct — [14+H]+ ( m/z = 1406.56806  
[C65H80N15O21 + H]+ requires 1406.56477, figure 111). Using chromatographic 
separation (HPLC-MS), a single peak (Rf = 5.83 min) was attributed to the desired 
stapled peptide 14. While other materials were also detected (peptide Rf = 3.88 
min, Fmoc-peptide Rf = 7.24 min) the presence of a single peak attributed to the 
mass of stapled peptide 14 confirms that CuAAC was successful in conjugating 
polynorbornane 11 to peptide 13.  
As mass spectrometry is both a non-quantitative and non-selective detection 
method for HPLC, it is not an effective means to measure purity. Only trace 
amounts of both the Fmoc-peptide and peptide 13 were detected by UV-HPLC 
(figure 112) and as the extra components detected by HPLC-MS were not 
detected by UV-HPLC, they were assigned as trace impurities which indicate that 
peptide 14 was in fact isolated in high purity. 
 
 
Figure 111: HPLC-MS trace of stapled peptide  14 (black) with blank (red). Arrow highlighting the 
peak corresponding to stapled peptide  14 and extracted MS spectra.  
*highlights peaks not present in the blank.  
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Figure 112: UV-HPLC traces for stapled peptide 14 and peptide 13 (detection at 214 nm). 
The UV absorbance profile of the stapled peptide 14 was relatively unchanged 
from peptide 13 (figure 113), further supporting the peptidic nature of the 
isolated compound. The evidence provided by both HRMS and HPLC confirm the 
successful synthesis of a stapled peptide, in a 16% yield. 
 
Figure 113: UV Spectra of the stapled peptide  15 and peptide 14 for comparison.  
FT-IR was used to assign absorbance peaks in the amide region  
(1600-1700 cm−1, figure 114). The IR absorbance peaks in the amide region 
overlap significantly. The use of a second derivative analysis and Gaussian 
function (OPUS program) fitting to model peak position and peak contribution 
can deconvolute the IR absorbances.[273-275] The deconvoluted peaks can then be 
assigned to a secondary structure. Assessing secondary structure from 
deconvoluted IR spectra has been questioned in the literature and as such the 
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technique is regarded as an auxiliary method of characterisation.[274, 275] 
Unfortunately, as CD spectroscopy was ruled out due to low compound solubility, 
it was necessary for FT-IR to become the primary method of secondary structure 
characterisation. 
 
Figure 114: FT-IR Spectra of free peptide 13 and stapled peptide 14 amide region highlighted 
(1550-1700cm-1). 
Table 7: Deconvoluted peak positions of the amide region (1600 -1700 cm−1). 
 Peak (cm −1) Integral Percentage (%) Assignment 
Peptide 
1610 0.080 1.4% β-Aggregation 
1627 0.166 2.9% β-Strand 
1671 5.463 95.7% Random Coil 
Stapled 
Peptide 
1612 5.657 22.3% β-Aggregation 
1637 1.546 6.1% β-Strand 
1678 18.127 71.6% β-Strand 
 
Using the data from the FT-IR spectra, absorbance peak assignments were made 
to both the stapled peptide and free peptide based on the work of Byler and 
Susi[273] (table 7). Peaks in the amide region of free peptide 13 indicate that in the 
solid state the peptide was in a predominantly random coil structure  
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(1671 cm−1). Random coil secondary structure assigned by FT-IR is in agreement 
with secondary structure assigned to free peptide 13 by CD spectroscopy.  
In contrast to the random coil structure, the FT-IR spectrum of stapled peptide 
14 contains amide region peaks that correlate to a β-strand secondary structure 
(1637 cm−1, 1678−1). It appeared that the [5]polynorbornane scaffold did indeed 
effect the secondary structure of the peptide as free peptide 13 was 
predominately random coil and stapled peptide 14 was preorganised into 
predominantly β-strand secondary structure. 
4.5 SUMMARY AND CONCLUSIONS 
A series of three [5]polynorbornane staples (9–11) were successfully 
synthesised. All three staples were used in test reactions to assess their ability to 
be attached to a short peptide sequence. It was deemed that diazide staple 12 
would be the most suitable candidate for attachment to a peptide using a copper 
catalysed 1,3-dipolar azide-alkyne cycloaddition strategy. 
A hexapeptide sequence was synthesised using solid phase peptide synthesis and 
reacted with diazide 11 both on resin and in solution to form stapled peptide 14. 
Both methodologies proved equally successful in low yields of 16% and 12% 
respectively. 
The polynorbornane staple stabilised a β-strand secondary structure. The ability 
for a [5]polynorbornane structure to stabilise any secondary structure prospects 
the use of polynorbornane frameworks to stabilise short β-sheet peptides of 
interest. 
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In addition to the conclusions drawn herein, an overall summary and conclusions 
section is included in chapter 5, where a global view of the use of the 
[n]polynorbornane scaffold in this thesis is included.  
4.6 EXPERIMENTAL 
GENERAL EXPERIMENTAL 
All reagents were obtained commercially and used without purification; all 
solvents used were analytical reagent grade. Petroleum spirits refers to the 
fraction boiling between 40 °C and 60 °C. 
NMR spectra were collected on either a JEOL JNM-Ex 270 MHz, a Varian Unity 
Plus 300 MHz, an Eclipse JNM-ECP 400 MHz FT-NMR or a Bruker AVANCE III 500 
MHz FT-NMR spectrometer as indicated. Samples were dissolved in CDCl3, DMSO-
d6 or CD3CN (~0.5 mL) and reported relative to TMS = 0.00 ppm. 1H NMR spectra 
are reported as chemical shift (ppm) (integral, multiplicity (s = singlet, bs = broad 
singlet, d = doublet, t = triplet, sept = septet, m= multiplet), J coupling (Hz), 
assignment). 
High Resolution Mass Spectral data was collected on either an Agilent 
Technologies LC/MSD TOF Mass Spectrometer or a LC Agilent 1200 MS 6520 
QTOF with dual electrospray ionisation source. Samples were dissolved in 
acetonitrile or MeOH at a concentration of less than 0.1 mg/mL. Low resolution 
mass spectra were collected on a Micromass ZMD electrospray quadrapole 
spectrometer.   
Thin layer chromatography was performed on Merck TLC silica gel 60 F plates, 
and visualised using UV light (λ = 254 nm and 365 nm) and or Bromophenol Blue 
(Bromophenol blue, NaOH, EtOH), or potassium permanganate (KMnO4, H2O, 
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K2CO3) as an oxidising dip. Column chromatography was performed with silica 
gel 60 (230-400 mesh). Preparative TLC was conducted on Merck PSC-
Fertigplatten Kieselgel 60 F254 200 mm × 200 mm × 2 mm plates. All microwave 
reactions were performed using a CEM Discover S-class microwave reactor.  
UV-HPLC was performed on Agilent 1260 infinity using a Zorbax 300SB C8 
column (2.1 mm × 150 mm) with a flow rate of 0.5 mL/min at 25 °C with UV 
detection at 214 nm. Gradient elution was performed with H20, 0.01% TFA 
(Solvent A) and MeCN, 0.01% TFA (Solvent B) as follows: 0 min: 97% A, 3% B; 5 
min: 97% A, 3% B; 25 min 30% A, 70% B. HPLC-MS was performed on a LC 
Agilent 1200 MS 6520 QTOF with dual electrospray ionisation source using an 
Agilent Eclipse plus C18 RRHD 1.8 μm column (2.1 mm × 100 mm) with a flow 
rate of 0.35 mL/min at 30 °C. Gradient elution was performed with H20, 0.1 % 
Formic Acid (Solvent A) and MeCN, 0.1 % Formic Acid (Solvent B) as follows: 0 
min: 95% A, 5% B; 10 min: 0% A, 100% B; 12 min: 0% A, 100% B; 12.1 min: 95% 
A, 5% B; 16 min, 95% A, 5% B. IR spectra were collected on a Bruker AlphaP ATR-
FTIR spectrometer. CD spectra were collected on a JASCO J-815 CD Spectrometer. 
Compounds were named according to the IUPAC guidelines with the Von Bayer 
system for polycyclic compounds and the carbohydrate α/β system for ring 
substituents.[239] 
OTHER 
For experimental pertaining to single anion NMR titration see the experimental 
for Chapter 2 (section 2.5) 
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 (2’S) (1α, 2β, 6β, 7α)-N-[2'-
(TERTBUTOXYCARBONYLAM INO)CARBOXYETHYL] 4-
AZATRICYCLO[5.2.1.02, 6]DEC-8-EN-3,6 DIONE (121) 
A microwave vessel was charged with norbornene anhydride 91 (82 
mg, 0.5 mmol) and N'(tertbutoxycarbonyl) di-1,2-aminopropinoic 
acid (Boc-Dap-OH) (102 mg, 0.5 mmol) and EtOAc (0.5 mL). The 
resulting mixture was heated to 120 °C under microwave irradiation 
for 45 min. The solution was cooled, diluted with EtOAc (20 mL), washed with 1 
M HCl (3 × 15 mL), dried with MgSO4, filtered and concentrated in vacuo to afford 
the title compound (146 mg, 83%) as a white solid Mp 165-170 °C; δH (270 MHz, 
CDCl3) 1.43 (9H, s, t-Bu), 1.54 (1H, d, J 8.6, H10b), 1.73 (1H, d, J 8.9, H10a), 3.31 
(2H, m, H1, H7), 3.38(2H, bs, H2, H6), 3.77 (2H, m, H1’), 4.39 (1H, m, H2’), 5.26 
(1H, d, J 5.8, NH), 6.12 (2H, m, H8, H9); δC (75 MHz, CDCl3) 178.2, 177.6, 172.8, 
155.7, 134.8, 134.2, 80.7, 77.2, 52.2, 52.0, 45.9, 45.0, 44.9, 38.8, 28.3; HRMS m/z 
(-ESI) 349.1442 ([C17H22N2O6 – H+]- requires 349.1400) 
GENERAL PROCEDURES 
In this thesis the synthesis of compounds (114–120) were not specifically 
discussed. Only a general synthetic outline was provided, with the synthesis of 
121 discussed in more detail. As such multiple step syntheses for single 
compounds have been combined into one experimental for compounds 114–
120. Where intermediates were isolated and characterised, the characterisation 
data is provided. 
(A) – GENERAL PROCEDURE AMINO ACID AMIDE COU PLING  
To a suspension of norbornene carboxylic acid, C-protected amino acid salt (1.2–
1.3 equiv.), EDCI (1.2–1.3 equiv) and HOBt (0.5–0.1 equiv.) in dry CHCl3 was 
added NEt3 (3 equiv.). The resulting solution was stirred at room temperature for 
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24 h. The reaction mixture was then transferred to a separatory funnel, diluted 
with CHCl3 (20 mL), washed with 1M HCl (3 × 20 mL), sat. sodium bicarbonate (3 
× 20 mL). The organic fraction was separated, dried with MgSO4 filtered and 
concentrated in vacuo to afford the norbornene amide. 
(B) – GENERAL PROCEDURE FOR BOC DEPROTECTION AND (THIO)UREA 
FORMATION  
A solution of Boc protected norbornene peptide in 20% TFA in DCM (5 mL) was 
stirred at room temperature until complete Boc deprotection by TLC analysis. 
The resultant mixture was concentrated in vacuo, added ca. 2 mL of DCM, 
concentrated in vacuo, added ca. 2 mL PhMe and concentrated in vacuo. The 
resultant TFA salt was used directly in the next step. 
To the trifluoroacetic acid salt, 15 mL solvent was added. The solution was 
basified using NEt3 (3 eq.), and stirred at room temperature for 10 min. To the 
resultant amine, an iso(thio)cyanate (2 eq.) was added, and stirred for at room 
temperature for 16 h. The resultant mixture was concentrated in vacuo and 
purified by flash column chromatography.  
(2’S) (1α, 2β, 6β, 7α)-N-[2’-(TERT-BUTOXYCARBONYLAMINO) N’-(5’-
METHOXYCARBONYL)METHYL PROPYLAMIDE] 4-
AZATRICYCLO[5.2.1.02, 6]DEC-8-EN-3,6 DIONE (122) 
Following general procedure A, a solution of acid 121 (150 mg, 0.38 mmol), 
glycine methyl ester hydrochloride (62 mg, 0.49 mmol), EDCI 
(94mg, 0.49 mmol), HOBt (10 mg, 0.08 mmol) and NEt3 (157 μL, 
1.14 mmol) were reacted to afford the title compound (85 mg, 
48%) as a pale brown oil. δH (270 MHz, CDCl3) 1.34 (9H, s, t-Bu), 
1.46 (1H, d, J 7.7,  H10b), 1.63 (1H, d, J 7.7, H10a), 3.18 (2H, m, H2, H6), 3.28 (2H, 
bs, H1, H7), 3.61 (2H, m, H1’), 3.65 (3H, s, H8’), 3.95 (2H, m, H5’),4.26 (1H, m, H2’), 
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5.34 (1H, d, J 8.0, NHBoc), 6.00 (2H, m, H8, H9), 7.10 (1H, bs, H4’); δC (75 MHz, 
CDCl3) 178.3, 177.4, 169.8, 155.6, 134.7, 134.0, 80.3, 77.3, 56.8, 52.2, 52.1, 45.8, 
45.8, 45.4, 44.7, 41.1, 39.0, 29.2, 28.1, 16.6; HRMS m/z (+ESI) 464.2356 
([C20H23N3O7 + H]+ requires 464.2391). 
 (2’S ,  5’S)-(1α, 2β, 6β, 7α)-N-[2’-(P-FLURORPHENYLUREIDO)-N’-
(1”-METHOXYCARBONYL-2”-METHYLPROPYL)PROPANAMIDE]-4-AZA-
TRICYCLO[5.2.1.0 2, 6]DECA-8-ENE-3,5-DIONE (114) 
Following general procedure A, a solution of acid 121 (593 mg, 
1.7 mmol), valine methyl ester hydrochloride (341 mg, 2.0 mmol), 
EDCI (504 mg, 2.0 mmol), HOBt (115 mg, 0.85 mmol) and NEt3 
(0.5 mL, 3.4 mmol) were reacted and washed with sat. NaCl (3 × 
15 mL) to afford amide 114a (595 mg, 75%) as a pale brown solid. 
mp 151.1-152.8 °C; δH (270 MHz, CDCl3) 0.86 (3H, d, J 6.9, H7'), 0.89 (3H, d, J 6.9, 
H7'), 1.42 (9H, s, t-Bu), 1.53 (1H, d, J 8.4, H10b), 1.72 (1H, d, J 8.9, H10a), 2.15 (1H, 
m, H1"), 3.27 (2H, m, H1, H7), 3.38 (2H, bs, H2, H6), 3.61 (2H, bs, H1'), 3.71 (3H, 
s, OMe), 4.25 (1H, m, H2'), 4.47 (1H, dd, J 4.5, 8.9, H5'), 5.17 (H1, d, J 7.9, NHBoc), 
6.09 (2H, m, H8, H9), 6.93 (1H, d, J 7.4, NH4'); δC (75 MHz, CDCl3) 178.45, 177.33, 
171.74, 169.54, 155.85, 134.85, 133.90, 80.49, 77.29, 57.02, 52.42, 52.08, 45.91, 
45.70, 45.24, 44.96, 44.75, 38.29, 31.01, 28.18, 18.87, 17.43; HRMS m/z (+ESI) 
464.2356 ([C23H23N3O7 + H]+ requires 464.2391). 
Following general procedure for B, N-Boc norbornene 114a (185 mg, 1.04 mmol) 
was deprotected then reacted with 4-fluorophenylisocyanate (128 μL, 1.14 
mmol) and NEt3 (122 μL, 0.42 mmol) in DCM. The reaction mixture was diluted 
with DCM, washed with 0.1 M HCl (3 × 15 mL) and sat. NaCl (3 × 15 mL), 
concentrated in vacuo and subjected to flash column chromatography (16:3:1 
Petroleum spirits /EtOAc/EtOH, Rf = 0.19) to afford the title compound (328 mg, 
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63%) as an off-white solid. mp 94.4-98.7 °C; [α]25D = - 43.15 ° (c 1.11 in CHCl3); 
νmax/cm-1 1744 s, 1702 vs, 1649 s and 1620 (C=O), 1566s and 1509 (NH), 835 
(CF); δH (400 MHz, D6-DMSO) 0.86 (6H, dd, J 7.0, 5.4, H7'), 1.51 (2H, bs, H10), 2.51 
(1H, dsept, J 6.7, 6.7, H2''), 3.20 (2H, bs, H1, H7), 3.29 (2H, m, H2, H6), 3.44 (2H, 
d, J 7.0, H1'), 3.65 (3H, s, H7''), 4.17 (1H, dd, J 7.7, 6.6, H1''), 4.57 (1H, td, J 8.8, 7.0, 
H2'), 5.99 (2H, m, H8, H9), 6.10 (1H, d, J 8.8, H1''), 7.06 (2H, dd, J 9, 3JF 8.8, H2’), 
7.36 (2H, dd, J 9, 4JF 4.8, H1'), 8.51 (1H, d, J 8.1, H4''), 8.84 (1H, s, H3'''); δC (100 
MHz, DMSO-d6) 177.24, 177.16, 171.6, 170.1, 157.0 (1C, d, 3JF 235), 154.4, 136.6, 
134.4, 134.0, 119.2 (1C, d, 3JF 6.8), 115.2 (1C, d, 2JF 22), 57.6, 51.8, 51.6, 50.4, 45.4, 
45.3, 44.2, 44.1, 39.5, 29.9, 18.9,18.3; HRMS m/z (+ESI) 501.2125 ([C25H29N4O6F 
+ H]+ requires 501.2143). 
(2’S)-(1α, 2β, 6β, 7α)-N-[2’-(P-FLURORPHENYLUREIDO)-N’-(1”-
METHOXYCARBONYL-2”-METHYL)PROPANAMIDE]-4-AZA-
TRICYCLO[5.2.1.0 2, 6]DECA-8-ENE-3,5-DIONE (115) 
Following general procedure for B, N-Boc norbornene 122 (154 
mg, 0.31 mmol) was deprotected then reacted with 4-
fluorophenylisocyanate (76 μL, 0.40 mmol) and triethylamine (87 
μL, 0.62 mmol) in DCM. The reaction mixture was diluted with 
DCM, washed with 3 × 0.1 M HCl (15 mL) and 3 × sat. NaCl (15 mL), 
concentrated in vacuo and subjected to flash column chromatography (100% 
EtOAc, Rf = 0.32) to afford the title compound (63.4 mg, 19%) as a pale brown 
solid. mp 75.6-83.5 °C; [α]26D = - 30.99 ° (c 1.14 in CHCl3); νmax/cm-1 1752, 1700 
and 1656 (C=O), 1557 and 1508 (NH), 899 (CF); δH (400 MHz, D6-DMSO) 1.51 
(2H, bs, H10), 3.20 (2H, s, H1, H7), 3.28 (2H, dd, J 11.3 6.9, H2, H6), 3.47 (2H, m, 
H1’), 3.63 (3H,s, H8’), 3.82 (2H, d, J 6.0, H5’) 4.52 (1H, td, J 9.2, 5.3, H2’) 5.98 (2H, 
m, H8, H9), 6.07 (1H, d, J 9.0, H1”), 7.06 (2H, dd, J 9.0, 2JF 9.0, H5”), 7.37 (H2, dd, J 
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9.0, 3JF 4.9, H5’’) 8.60 (1H, t, J 5.8, H4’), 8.83 (1H, s, H3”); δC (100 MHz, DMSO-d6) 
177.3, 177.2, 170.2, 170.0, 158.2, 157.0 (d, 1JF 237.5), 136.5 (d, 4JF 2.1), 134.3, 
134.0, 119.1 (d, 3JF 7.8), 115.2 (d, 2JF 22.1), 79.2, 51.7, 51.6, 50.4, 45.4, 45.2, 44.2, 
44.0, 40.7; HRMS m/z (+ESI) 459.1679 ([C22H23N4O6F + H]+ requires 459.1674)  
(2’S) (1α, 2β, 6β, 7α)-N-[2’-(4’’-PHENYLTHIOUREDO) N’-
(5’METHOXYCARBONYL)METHYL PROPYLAMIDE] 4-
AZATRICYCLO[5.2.1.02, 6]DEC-8-EN-5,6 DIONE (116) 
Following general procedure B, N-Boc norbornene 122 (185 mg, 
0.44 mmol) was deprotected then reacted with 
phenylisothiocyanate (92 μL, 0.0.48 mmol) and NEt3 (122 μL, 0.42 
mmol) in DCM. The reaction mixture was diluted with DCM, 
washed with 0.1 M HCl (3 × 10 mL) and H2O (10 mL), concentrated 
in vacuo and subjected to flash column chromatography (50:49:1 Petroleum 
spirits/EtOAc/EtOH) to afford the title compound (150 mg, 75%) as an off-white 
solid. mp 92.9-103.6 °C; δH (270 MHz, CDCl3) 1.47 (1H, d, J 8.7, H10a), 1.66 (1H, d, 
J 8.5, H10b), 3.24 (2H, s, H1,7), 3.29 (2H, m, H2,6), 3.69 (3H, s, OMe), 3.73 (2H, m, 
H1’), 3.97 (2H, d, J 5.5, H5’), 5.32 (1H, m, H2’), 6.04 (2H, m, H8,9), 6.92 (1H, d, 
thiourea NH), 7.27 (3H, m, H1” and H3”), 7.40 (3H, m, H2” and Amide NH), 8.41 
(1H, s, Thiourea Ar-NH); δC (100 MHz, CDCl3) 180.7, 178.6, 177.8, 170.0, 169.5, 
136.6, 134.7, 134.6, 129.9, 127.1, 125.0, 56.3, 52.5, 52.3, 46.2, 46.1, 44.9, 44.8, 
41.3, 39.6, 29.7; HRMS m/z (+ESI) 479.13594 ([C22H24N4O5S + Na]+ requires 
479.13596). 
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(2’S) (1α, 2β, 6β, 7α)-N-[2’-(4’’-FLUOROPHENYLTHIOUREDO) N’-
(5’METHOXYCARBONYL)METHYL PROPYLAMIDE] 4-
AZATRICYCLO[5.2.1.02, 6]DEC-8-EN-3,6 DIONE (117) 
Following general procedure for B, N-Boc norbornene 122 (102 
mg, 0.24 mmol) was deprotected then reacted with 4-
fluorophenylisothiocyanate (47 mg, 0.31 mmol) and NEt3 (0.1 mL, 
0.72 mmol) in THF. The mixture was subjected to flash column 
chromatography (15% petroleum spirits in EtOAc) to afford the 
title compound (79 mg, 67%) as an off-white solid. mp 84.7-97.0 °C; δH (270 MHz, 
DMSO-d6) 1.51 (1H, d, J 8.8, H10a) 1.69 (1H, d, J 8.8, H10b), 3.27 (2H, m, H1,7), 
3.32 (2H, m, H2,6), 3.71 (5H, m, OMe and H1’), 3.98 (2H, d, J 5.5, H5’), 5.29 (1H, 
td, J 8.4, 4.5, H2’), 6.06 (2H, m, H8,9), 6.82 (1H, d, J 8.0, Thiourea NH), 7.10 (2H, 
dd, J 8.5, 3JF 8.5, H2”), 7.26 (3H, m, H1” and amide NH), 8.12 (1H, s, Thiourea Ar-
NH); δC (100 MHz, CDCl3) 181.2, 178.6, 177.8, 169.9, 169.5, 161.36 (d, 1JF 248, 
C4”), 134.6 (3JF 19.5, C3”), 132.4, 127.6 (4JF 8.5, C2”), 116.7 (2JF 22.7, C4”), 56.4, 
52.5, 52.3, 46.2, 46.1, 44.9, 44.8, 41.3, 39.6, 29.8; HRMS m/z (+ESI) 475.14460 
([C22H23FN4O5S + H]+ requires 475.14560). 
(2’S ,  5’S)-(1α, 2β, 6β, 7α)-N-[2'-(PHENYLTHIOUREIDO)-N’-(1”-
METHOXYCARBONYL-2”-METHYLPROPYL)PROPANAMIDE]-4-AZA-
TRICYCLO[5.2.1.0 2, 6]DECA-8-ENE-3,5-DIONE (118) 
Following general procedure B, N-Boc norbornene 114a (154 mg, 
0.31 mmol) was deprotected then reacted with 
fluorophenylisocyanate (76 μL, 0.40 mmol) and NEt3 (87 μL, 0.62 
mmol) in DCM. The reaction mixture was diluted with DCM, 
washed with 0.1 M HCl (3 × 15 mL) and sat. NaCl (3 × 15 mL), 
concentrated in vacuo and subjected to flash column chromatography (16:3:1 
Petroleum spirits/EtOAc/EtOH, Rf = 0.19) to afford the title compound (115 mg, 
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86%) as an pale brown solid. mp 86.9-91.2 °C; [α]26D = - 29.55 ° (c 1.14 in CHCl3); 
νmax/cm-1 1743 s, 1628 vs and 1598 (C=O), 1634 (NH), 1152 (C=S), 723 and 689 
(Aryl CH); δH (400 MHz, DMSO-d6) 0.86 (3H, d, J 6.5, H2” or H3”) 0.88 (3H, d, J 6.5, 
H2” or H3”) 1.54 (2H, bs, H10), 2.04 (1H, qqd, J 6.2, 6.2, 6.2, H1”), 3.22 (2H, bs, H1, 
H7), 3.31 (2H, m, H2, H6), 3.57 (2H, d, J 5.8, H1’), 3.66 (3H, s, H8’), 4.17 (1H, dd, J 
7.7, 7.7, H5’), 5.25 (1H, m, H2’) 6.02 (2H, m, H8, H9), 7.14 (1H, dd, J 7.0, 7.0, H7’”), 
7.34 (2H, dd, J 7.3, 7.3, H6’”, H7’”), 7.44 (2H, d, J 7.7, H5”’, H9”’), 7.54 (H1, d, J 8.4, 
H1’”), 8.50 (1H, d, J 6.9, H4’), 9.93 (1H, s, H3’”); δC (100 MHz, DMSO-d6) 180.2, 
177.3, 177.2, 171.5, 169.2, 138.9, 134.5, 134.2, 128.7, 124.5, 123.2, 57.6, 54.0, 
51.8, 51.8, 45.4, 45.3, 44.2, 44.1, 39.5, 29.9, 18.9, 18.3; HRMS m/z (+ESI) 499.2002 
([C25H30N4O5S + H]+ requires 499.2010).  
(2’S,  5’S) (1α, 2β, 6β, 7α)-N-[2’-(PHENYLTHIOUREIDO) N’-(5’-
METHOXYCARBONYL)ETHYL ETHYLAMIDE] 4-
AZATRICYCLO[5.2.1.02, 6]DEC-8-EN-3,6 DIONE (119) 
Following general procedure A, a solution of norbornene 
carboxylic acid 121 (398 mg, 1.0 mmol), alanine methyl ester 
hydrochloride (167 mg, 1.2 mmol), EDCI (230 mg, 1.2 mmol), 
HOBt (40 mg, 0.3 mmol) and NEt3 (415 μL, 3.0 mmol) were 
reacted to afford amide 119a (319 mg, 73%) as a brown solid. δH 
(270MHz, CDCl3) 1.36 (3H, d, J 7.2, H6’), 1.41 (9H, s, t-Bu), 1.52 (1H, d, J 8.8, H10a), 
1.71 (1H, d, J 8.8, H10b), 3.26 (2H, m, H1,7), 3.37 (2H, bs, H2,6), 3.67 (2H, m, H1’), 
3.72 (3H, s, OMe), 4.25 (1H, m, H2’), 4.50 (1H, t, J 7.3, H5’), 5.18 (1H, bd, J 9.2, 
NHBoc), 6.07 (2H, m, H8,9), 6.90 (1H, m, AmideNH); δC (68 MHz, CDCl3) 178.5, 
177.6, 172.9, 169.1, 155.8, 134.9, 134.1, 52.7, 52.6, 52.2, 48.1, 46.0, 45.9, 45.9, 
45.1, 44.9, 39.0, 28.3, 18.3. 
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Following general procedure B, amide 119a (102 mg, 0.24 mmol) was 
deprotected then reacted with phenyl isothiocyanate (57 μL, 0.30 mmol) and 
NEt3 (0.1 mL, 0.69 mmol) in THF. The mixture was subjected to flash column 
chromatography (20% Petroleum spirits/EtOAc, Rf = 0.59) to afford the title 
compound (85 mg, 78%) as an off-white solid. mp 92-99 °C; δH (270MHz, CDCl3) 
1.40 (3H, d, J 7.2, H6’), 1.52 (1H, d, J 8.7, H10a), 1.70 (1H, d, J 10.0, H10b), 3.29 
(2H, m, H1,7), 3.33 (2H, m, H2,6), 3.71 (2H, m, H1’), 3.72 (3H, s, OMe), 4.46 (1H, 
m, H2’), 5.26 (1H, m, H5’), 6.06 (2H, m, H8.9), 6.82 (1H, d, J 8.4, Thiourea NH), 7.04 
(1H, d, J 7.5, Amide NH), 7.24 (2H, d, J 5.8, H1”), 7.30 (1H, dd, J 7.4, 7.4, H3”), 7.44 
(2H, dd, J 7.7, 7.7, H2”), 7.84 (1H, s, Thiourea Ar-NH); δC (100 MHz, CDCl3); 180.6, 
178.6, 177.8, 172.8, 168.6, 136.3, 134.7, 134.6, 130.0, 127.2, 125.0, 56.4, 52.6, 
52.3, 48.5, 46.2, 44.9, 44.8, 40.0, 29.7, 17.8; HRMS m/z (+ESI) 475.16967 
([C23H26N4O5S + H]+ requires 471.16951). 
(2’S) (1α, 2β, 6β, 7α)-N-[2’-(PHENYLTHIOUREIDO) N’-
(5’METHOXYCARBONYL)METHYL ETHYLAMIDE] 4-
AZATRICYCLO[5.2.1.02, 6]DEC-8-EN-3,6 DIONE (120) 
A microwave vessel was charged with norbornene 
anhydride 91 (82 mg, 0.5 mmol) and α-Boc-Lys-OH (123 
mg, 0.5 mmol) and EtOAc (0.25 mL). The resulting mixture 
was heated to 120 °C under microwave irradiation for 45 
min. The solution was cooled, diluted with  EtOAc (20 mL), 
washed with 1 M HCl (3 × 15 mL), dried with MgSO4, filtered and concentrated in 
vacuo to afford imide 120a (146 mg, 77%) as a pale yellow viscous oil. δH (270 
MHz, CDCl3) 1.16–1.91 (6H, m, H2’,3’,4’), 1.43 (9H, s, t-Bu), 1.52 (1H, d, J 8.7, 
H10a), 1.71 (1H, d, J 10.2, H10b), 3.24 (2H, m, H1,7), 3.36 (4H, m, H2,6 and H1’), 
4.23 (1H, m, H5’), 5.10 (1H, bd, J 7.9, NH Boc), 6.08 (2H, s, H8,9); δC (100 MHz, 
   Chapter 4 
159 | 
CDCl3) 178.06, 176.44, 155.70, 134.52, 80.14, 53.23, 52.34, 45.80, 44.97, 37.98, 
31.71, 28.38, 27.32, 22.50. 
Following general procedure A, a solution of imide 120a (175 mg, 0.44 mmol), 
glycine methyl ester hydrochloride (72 mg, 0.57 mmol), EDCI (109 mg, 0.57 
mmol), HOBt (2 mg, 0.01 mmol) and NEt3 (184 μL, 1.32 mmol) were reacted to 
afford amide 120b (143 mg, 77%) as a brown viscous oil. δH (270MHz, CDCl3) 
1.16-1.86 (6H, m, H2’,3’,4’), 1.41 (9H, s, t-Bu), 1.50 (1H, d, J 8.8, H10a), 1.69 (1H, 
d, J 8.8, H10b), 3.12 (2H, m, H1,7), 3.29 (4H, m, H2,6 and H1’), 3.71 (3H, s, OMe), 
4.00 (1H, d, J 8.8, H8’), 5.12 (1H, bd, J 7.9, NHBoc), 6.06 (2H, s, H8,9), 6.76 (1H, bt, 
J 5.3, Amide NH); δC (100 MHz, CDCl3) 177.98, 177.85, 177.79, 177.77, 170.16, 
134.54, 134.51, 52.35, 52.35, 52.32, 45.82, 45.80, 45.78, 44.95, 44.92, 41.17, 
37.69, 28.38, 27.35, 27.26, 22.5. 
Following general procedure for B, amide 120b (65 mg, 0.14 mmol) was 
deprotected then reacted with phenylisothiocyanate (34 μL, 0.18 mmol) and NEt3 
(58 μL, 0.42 mmol) in THF. The mixture was subjected to flash column 
chromatography (gradient elution: 20% petroleum spirits in EtOAc to 15% 
petroleum spirits in EtOAc) to afford the title compound (64 mg, 91%) as an off-
white solid. mp 70-81.8 °C; δH (270 MHz, CDCl3) 1.27 (4H, m, alkyl), 1.44 (2H, m, 
alkyl), 1.50 (1H, d, J 8.8, H10a), 1.70 (1H, d, J 8.05, H10b), 1.94 (2H, m, Alkyl), 3.21 
(2H, m, H1,7), 3.29 (4H, m, H1’ and H2,6), 3.71 (3H, s, OMe), 4.01 (2H, m, H8’), 
5.06 (1H, m, H5’), 6.06 (2H, m, H8,9), 6.77 (1H, d, J 8.1, Thiourea NH), 6.92 (1H, t, 
J 6.92, Amide NH), 7.27 (3H, m, H1” and H3”) 7.41 (2H, m, H2”), 8.01 (1H, s, 
Thiourea Ar-NH); δC (100 MHz, CDCl3) 180.3, 178.1, 172.0, 170.0, 136.5, 134.6, 
134.5, 130.0, 127.0, 124.9, 57.9, 52.5, 52.3, 45.8, 45.0, 41.3, 37.8, 31.6, 29.8, 27.3, 
22.3; HRMS m/z (+ESI) 499.20013 ([C25H30N4O5S + H]+ requires  499.20097). 
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TETRABUTYLAMMONIUM ACETYL D-ALANINATE 
To a solution of acetyl D-alaninate methyl ester (55 mg, 0.30 
mmol) in MeOH (5 mL) was added TBA OH (288 μL, 1.034 M 
in MeOH) and allowed to stir at room temperature overnight. The resulting 
solution was concentrated in vacuo to afford the title compound (112 mg, 
quantitative). δH (270 MHz, CDCl3) 0.98 (12H, m, Bu), 1.40 (12H, m, Bu and CH3), 
1.63 (8H, m, Bu), 1.92 (3H, s, AcCH3), 3.31 (8H, m, Bu), 4.06 (1H, m, CH), 7.07 (1H, 
bs, AcNH); δc (100 MHz, CDCl3) 176.29, 168.92, 58.82, 51.17, 24.03, 23.75, 19.78, 
13.69. 
(1α, 2α, 5α, 6α,  7α, 10α) TETRAMETHYL 
TETRACYCLO[4.4.1.0 2, 5 .07, 10]UNDECA-3,  8-DIENE-3,4,8,9-
TETRACARBOXYLATE (130) [ 1 38 ]  
A solution of quadricyclane (1 ml, 11 mmol), DMAD (1.5 ml, 12 
mmol) and 2.5 mL DMF was heated in a sealed pressure vessel 
for 2 h at 90 °C. NB: Exothermic reaction. The solution was cooled to  
~50 °C, where upon DMAD (3 mL, 22 mmol) and RuH2CO(PPh3)3 (100 mg, 0.11 
mmol) was added. The pressure vessel was capped and heated to 100 °C for a 
further 96 h.  The solution was cooled and the resulting precipitate collected and 
washed with EtOAc (3 × 3 mL) to afford the title compound (3.6 g, 86%) as a light 
tan solid. mp 134.5–137.7 °C lit. 141.1–142.8 °C[138]; δH (270 MHz, CDCl3) 1.36 
(2H, s, H11), 2.40 (2H, s, H1,6), 2.74 (4H, s, H2,5,7,10), 3.76 (12H, s, OMe); δC (100 
MHz, CDCl3) 161.3, 142.5, 52.0, 46.1, 31.8, 23.6; MS m/z (+ESI) 377.1 ([C19H20O8 
+ H]+ requires 377.1). 
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(1α, 2α, 3β, 5β, 6α, 7α, 8α, 9β, 11β, 12α) TETRAMETHYL 4,10-
DIOXAHEXACYCLO[5.5.1.0 2, 6 .03, 5.08, 12 .09 , 11]TRIDECANE-3,5,9,11-
TETRACARBOXYLATE (58) [ 13 8 ]  
To oven dried three necked round bottom flask, tetraester 130 
(3 g, 7.9 mmol) and 500 mL of THF was cooled to 0 °C under a 
nitrogen atmosphere. Slowly via syringe tert-butyl hydroperoxide (21 ml, 1.13 
mM in PhMe, 23.7 mmol) was added and the resulting mixture stirred for 10 min. 
In one portion, potassium tert-butoxide (269 mg, 2.4 mmol) was added and the 
solution slowly allowed to warm to room temperature over 24 hours. Remaining 
peroxide was quenched with 10% Sodium thiosulfate in H2O (50 mL), excess THF 
removed in vacuo. The resulting slurry was extracted with CHCl3 (3 x 50 mL), 
dried (NaSO4), and concentrated in vacuo to dryness. The resulting solid was 
triturated with hot MeOH to afford the title compound (1.19 g, 36 %) as a white 
solid. mp 185.7 °C (decomposition) lit. 191.2–194.9 °C[138]; δH (270 MHz, CDCl3) 
1.90 (2H, s, H13), 2.55 (4H, s, H2,6,7,12), 3.27 (2H, s, H1,7), 3.81 (12H, s, OMe); δC 
(100 MHz, CDCl3) 164.3, 64.4, 53.0, 48.9, 36.5, 28.6; MS m/z (+ESI) 426.1 
([C19H20O10 + NH4]+ requires 426.1). 
(1α, 2 β, 6 β, 7α)-N-(3’-CARBOXYPROPYL)-4-AZA-
TRICYCLO[5.2.1.0 2, 6]DECA-8-ENE-3,5-DIONE  (131) 
A solution of norbornene anhydride 91 (200 mg, 1.23 mmol) and 4-
amino butyric acid (126 mg, 1.23 mmol) in PhMe (5 mL) was added to 
a microwave vial. The solution was then heated using microwave 
irradiation at 110 °C for 30 min. The resulting solution was diluted with 
EtOAc (5 mL) and washed with 1 M HCl (3 × 15 mL). The organic layer was 
collected, dried (MgSO4), filtered and solvent removed in vacuo. The crude 
product was recrystallised in 1:1 EtOAc/Petroleum spirits  to afford the desired 
compound (131 mg, 42%) a white solid. mp 116.6-118.0 °C; δH (270 MHz, CDCl3) 
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1.51 (1H, d, J 8.6, H10b), 1.70 (1H, d, J 8.6, H10a), 1.74 (2H, m, H2’), 2.27 (2H, t, J 
7.51, H3’), 3.23 (2H, m, H2, H6), 3.37 (4H, m, 3.37, H1, H1’, H7), 6.08 (2H, dd, J 
1.81, 1.81, H8, H9), δC (100 MHz, CDCl3) 22.9, 31.3, 37.5, 45.0, 45.8, 52.3, 134.6, 
178.0, 178.1; HRMS m/z (-ESI) 248.09202 ([C13H14NO4]- requires 248.09228). 
(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) - TETRAMETHYL 8, 22-
DI(CARBOXYPROPYL)-8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27-TETRACARBOXYLATE (9) 
Method A: A microwave vial containing bis-epoxide 58 
(50 mg, 0.12 mmol), norbornene imide 131 (67 mg, 
2.2 mmol) and DMF (2 mL) was heated at 150 °C for 
10 min. The resulting solution was concentrated in 
vacuo and the crude product recrystallised from MeOH to afford the title 
compound (59 mg, 63%) as a white solid. 
Method B: A screw cap pressure vessel was charged with norbornene anhydride 
91 (328 mg, 2.0 mmol), 4-amino butyric acid (204 mg, 2.0 mmol) and MeCN (10 
mL) and stirred for 5 min at room temperature. To the resulting slurry, bis-
epoxide 58 (408 mg, 1 mmol) was added; the pressure vessel was sealed, and 
heated with stirring at 140 °C for 48 h. The resulting solution was concentrated 
in vacuo and recrystallised by slow evaporation of methanol to afford the title 
compound (456 mg, 50%) as a while solid. mp >215 (decomposition); δH (270 
MHz, CDCl3) 1.15 (2H, d, J 10.3, H29a,33a), 1.81 (2H, s, H1,15), 1.90 (2H, s, H31), 
2.00 (8H, s, H4,5,11,12,18,19,25,26), 2.36 (4H, t, J 7.7, H2’), 2.93 (4H, s, 
H6,10,20,24), 3.49 (4H, t, J 8.3, H1’), 3.80 (16H, s, OMe and H3’); δC (100 MHz, 
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CDCl3) 177.3, 177.0, 168.6, 90.2, 63.9, 54.3, 52.5, 50.8, 48.3, 41.2, 40.8, 38.3, 38.0, 
32.0, 23.5; HRMS m/z (+ESI) 924.33788 ([C45H50N2O18 + H]+ requires 924.33969). 
(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) - TETRAMETHYL 8, 22-
DI(N-ALLYLPROPYLAMIDE)-8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27TETRACARBOXYLATE (10) 
A round bottom flask containing dicarboxylic acid 9 
(287 mg, 0.31 mmol), EDCI (166 mg, 0.86 mmol) and 
CHCl3 (15 mL) was stirred for 10 min at room 
temperature. To the resulting mixture, allyl amine 
(120 μL, 1.56 mmol) and stirred for 3 days at room 
temperature. The resulting mixture was diluted with CHCl3 (20 mL) and washed 
with 1 M HCl (3 × 15 mL) and sat. NaCO3 (3 × 15 mL), dried (NaSO4), filtered, and 
concentrated in vacuo. The crude product was purified by column 
chromatography (5% EtOH in EtOAc, Rf = 0.25) to afford the title compound (190 
mg, 62%) as a white solid. mp 192.6–197.0 °C; δH (270MHz, CDCl3) 1.15 (2H, d, J 
10.3, H29a,33a), 1.70 (4H, s, H6’), 1.80 (2H, s, H1,15), 1.88 (4H, s, H2,14,16,28), 
1.93 (2H, s, H31), 1.95 (4H, s, H4,12,18,26), 2.19 (4H, t, J 7.0, H2’), 2.54 (4H, m, 
H5,11,19,25), 2.94 (4H, m, H6,10,20,24), 3.54 (4H, t, J 6.6, H1’), 3.8 (12H, s, OMe), 
3.88 (4H, t, J 5.6, H3’), 5.20 (4H, m, H8’), 5.87 (2H, m, H7’), 6.23 (2H, t, J 5.5, amide 
NH); δC (68 MHz, CDCl3) 177.1, 171.6, 168.3, 134.3, 116.4, 90.0, 54.6, 52.4, 51.0, 
48.2, 42.0, 41.1, 40.7, 38.0, 37.9, 34.1, 28.9, 24.6; HRMS m/z (+ESI) 985.40712 
([C51H60N4O16 + H]+ requires 985.40771. 
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(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) – TETRAMETHYL 8, 22,  
30,  32-
TETRAOXADODECACYCLO[13.13.1.1 3, 1 2.14, 1 0.11 7, 2 7.11 9, 25 .02, 1 4.04, 1 2 .0
6, 1 0.01 6, 2 8.01 8, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27-TETRACARBOXYLATE  (136) 
A microwave vial containing bis-epoxide 58 (204 mg, 
0.5 mmol), norbornene anhydride 91 (164 mg, 1.0 
mmol) and MeCN (2 mL) was heated at 150 °C for 10 
min. The resulting solution was concentrated in vacuo and the crude product 
recrystallised from MeOH to afford the title compound (184 mg, 50%) as a white 
solid. mp >274 °C (slow decomposition); δH (270 MHz, CDCl3) 1.19 (2H, d, J 10.8, 
H29a,33a),1.84 (2H, s, H1,4), 2.03 (4H, s, H2,14,16,28), 2.17 (4H, s, H4,12,18,26), 
2.63 (6H, m, H5,11,19,25 and H29b,33b), 3.28 (4H, m, H6,10,20,24); δC (68 MHz, 
CDCl3) 170.6, 168.0, 90.0, 54.6, 52.6, 51.0, 49.3 (HSQC), 42.1(HSQC), 40.7, 38.1, 
33.4; MS m/z (+ESI) 737.3 [C37H36O16 + H]+. 
(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) - TETRAMETHYL N,N’-
DI(HYDROXYLETHYL)-8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27TETRACARBOXYLATE  (132) 
A screw cap pressure vessel was charged with 
norbornene anhydride 91 (328 mg, 2 mmol), 
ethanolamine (119 μL, 2 mmol) and MeCN (10 mL) 
and stirred for 5 min at room temperature. To the resulting slurry, bis-epoxide 
58 (408 mg, 1 mmol) was added; the pressure vessel was sealed, and heated with 
stirring at 140 °C for 48 h.  The reaction vessel was cooled and H2O added (10 
mL) to the resulting solution. The resulting precipitate was collected by vacuum 
filtration and washed with H2O/MeCN (1:1, 2 × 1 mL), H2O (2 × 1 mL), Et2O (2 × 
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1 mL) to afford the title compound (624 mg, 76%) as a white solid. mp >322 (slow 
decomposition); δH (270 MHz, DMSO-d6) 1.10 (2H, d, J 10.9, H29a,33a), 1.59 (H2, 
s, H1,15), 1.72 (2H, s, H31), 1.94 (4H, s, H2,14,16,28), 2.00 (4H, s, H4,12,18,26), 
2.24 (2H, d, J 9.7, H29b,33b), 2.32 (4H, s, H5,11,19,25), 2.99 (4H, s, H6,10,20,24), 
3.44 (4H, m, Ethyl), 3.54 (4H, m, ethyl), 3.76 (12H, s, OMe), 4.62 (2H, t, J 5.4, OH); 
δc (100 MHz, DMSO-d6) 177.62, 168.88, 89.95, 57.5, 54.2, 52.8, 51.0, 48.2, 40.7 
(confirmed by gHMQC), 40.5 (confirmed by gHMQC), 40.0 (confirmed by 
gHMQC), 37.6, 28.71; HRMS m/z (+ESI) 840.31850 ([C41H46N2O16 + NH4]+ 
requires 840.31850). 
(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) -  TETRAMETHYL 8,22-
DI(2-BROMOETHYL)-8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25.02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27-TETRACARBOXYLATE (144) 
To a two-necked round bottom flask fitted with an air 
condenser was added DMF (2 mL). To the stirred 
solvent was added PBr3 (ca. 33 μL, 0.36 mmol) and 
stirred for 15 min at 23 °C. To the resulting slurry was added diol 132 (100 mg, 
0.12 mmol) and the reaction mixture stirred for a further 2 h at 60 °C. After which 
time ca. 5 mL of sat. NaHCO3 was added slowly till gas evolution ceased. The 
resulting precipitate was collected by vacuum filtration, and washed with H2O (3 
× 1 mL), Et2O (3 × 1 mL) to afford the title compound (106 mg, 93%) as a pale 
yellow solid. mp >333.8 (decomposition); δH (500 MHz, DMSO-d6) 1.16 (2H, d, J 
9.7, H29a,33a), 1.65 (2H, s, H31), 1.78 (2H, s, H1,15), 1.88 (4H, s, H2,14,16,28), 
2.09 (4H, s, H4,12,18,26) 2.29 (2H, d, J 10.0, H29b,33b), 2.38 (4H, s, H5,11,19,25), 
3.04 (4H, s, H6,10,20,24), 3.79 (20H, s, OMe and Ethyl); δC (100 MHz, CDCl3) 
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176.6, 168.5, 90.2, 54.7, 52.4, 51.1, 48.4, 41.2, 40.7, 40.6, 38.4, 29.2, 29.0; HRMS 
m/z (+ESI) 966.14824 ([C41H4479Br81BrN2O14 + NH4]+ requires 966.1482). 
(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) -  TETRAMETHYL N,N`-
DI(AMMINOETHYL)-8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27TETRACARBOXYLATE DITOSYLATE (133a) 
An unsealed screw cap pressure vessel was charged 
with norbornene anhydride 91 (328 mg, 1.22 mmol), 
ethylenediamine (83 μL, 1.22 mmol) and MeCN (8 
mL) and stirred for 5 min at room temperature, then 
TsOH.H2O (231 mg, 1.22 mmol) was added and 
stirred for a further 5 min. To the resulting slurry, bis-epoxide 58 (250 mg, 0.61 
mmol) was added, the pressure vessel sealed, and heated with stirring at 140 °C 
for 72 h. The reaction vessel was cooled and the resulting precipitate was 
collected by vacuum filtration and washed with MeCN (2 × 1 mL) to afford the 
title compound (782 mg, 78%) as a tan solid. mp > 226 (decomposition); δH 
(270MHz, DMSO-d6) 1.14 (2H, d, J 8.6, H29a,33a), 1.58 (2H, s, H1,15), 1.68 (2H, s, 
H31), 1.90 (4H, s, H2,14,16,28), 1.98 (4H, s, H4,12,18,26), 2.24 (2H, s, H29b,33b), 
2.30 (H6, s, Ar-CH3), 2.32 (4H, s, H5,11,19,25), 2.95 (4H, bm, H2’), 3.02 (4H, s, 
H6,10,20,24), 3.63 (4H, bm, H1’), 3.76 (12H, s, OMe), 7.13 (4H, d, J 8.4, Ar-H), 7.84 
(4H, d, J 8.1, Ar-H), 7.77 (6H, bs, NH3); δC (68 MHz,) 177.6, 168.9, 145.9, 138.4, 
128.7, 126.1, 118.7, 90.0, 54.1, 52.8, 50.7, 48.4, 40.8, 37.6, 37.3, 36.2, 21.4, 1.7; 
HRMS m/z (+ESI) 821.32322 ([C41H30N4O14 + H]+ requires 821.32398). 
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2-CHLORO-1,3-DIMETHYL-4,5-DIHYDRO-1H-IMIDAZOL-3-IUM 
HEXAFLUOROPHOSPHATE  (148)[ 26 4 ,  26 5 ,  2 68 ]  
Following a literature method,[268] A solution of 
dimethylimidazolidinone (3 mL, 18 mmol) in dry THF (15 mL) was 
cooled to 0 °C and oxalyl chloride (2.5 mL, 18 mmol) was slowly added. The 
resulting mixture was then refluxed at 70 °C for 16 h. The resulting hygroscopic 
precipitate was filtered under a stream of N2 and washed with diethyl ether (3 × 
5 mL) to afford 2-chloro-1,3-dimethyl-4,5-dihydro-1H-imidazol-3-ium chloride 
147 (2.7 g, 90%) as a white hygroscopic solid which was used directly in the next 
step.  
Following another literature method,[264] under a N2 atmosphere, to a solution of 
chloride salt 147 (2.7 g, 16 mmol) in MeCN (4 mL) was added a solution of KPF6 
(3.0 g, 16 mmol) in MeCN (12 mL). The mixture was stirred for 20 min and filtered 
through a celite pad under N2. The filtrate was concentrated in vacuo. The 
minimum amount of MeCN was used to redissolve the solids. The solution was 
added to cold Et2O and the resulting precipitate was collected and washed with 
Et2O (3 × 2 mL) under a stream of N2 to afford the title compound (3.63 g, 80%) 
as a white solid. δH (500 MHz, CD3CN) 3.15 (8H, s, H4,5), 3.95 (4H, s, CH3); δC (126 
MHz, CD3CN) 117.3, 49.8, 34.2; MS m/z (+ESI): 133.0 [C5H10ClN2]+. 
2-AZIDO-1,3-DIMETHYL-4,5-DIHYDRO-1H-IMIDAZOL-3-IUM 
HEXAFLUOROPHOSPHATE  (145)[ 26 4 ]  
Following a literature preparation,[264] a solution of PF6 salt 148 
(1.7 g, 6.0 mmol) in MeCN (6 mL) was cooled to 0 °C under a N2 
atmosphere. To this solution was added sodium azide (1.2 g 18 mmol),  the 
mixture was stirred for 1 h at room temperature and filtered through a celite pad 
under N2. The liquor was concentrated in vacuo. The minimum amount of MeCN 
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was used to redissolve the solids. The solution was then added to cold Et2O and 
the resulting precipitate was collected and washed with Et2O (3 × 2 mL) under a 
stream of N2 to afford the title compound (1.5 g, 88%) as a white solid. δH (270 
MHz, CD3CN) 3.04 (6H, s, CH3), 3.78 (4H, s, H4,5); δC (68 MHz, CD3CN) 117.4, 49.0, 
32.9; MS m/z (+ESI) 140.1 ([C5H10N5]+ requires 140.1). 
 (1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) -  TETRAMETHYL 8,22-
DI(2-AZIDOLETHYL)-8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27-TETRACARBOXYLATE  (11) 
Method1: A solution of dibromide 144 (92 mg, 0.097 
mmol), sodium azide (63 mg, 0.97 mmol) and DMSO 
(2 mL) was stirred at 60 °C for 20 h. After which time 
the solution was cooled, and H2O (3 mL) was added. The resulting precipitate was 
collected by vacuum filtration, washed with H2O (3 × 1 mL), Et2O (3 × 1 mL) to 
afford the title compound (31 mg, 37%) as a white solid 
Method 2: To a solution of diammonium salt 133a (448 mg, 0.39 mmol), NEt3 
(829 μL, 5.91 mmol), CuSO4 (20 mg, 0.08 mmol) and DCM (10 mL) was added 
ADMP (271 mg, 0.95 mmol). The resulting solution was stirred for 20 h at 23 °C. 
After which after which time the reaction was quenched using sat. NaHCO3 (ca. 
10 mL). The biphasic mixture was transferred into a separatory funnel, diluted 
with DCM (30 mL), organic fraction separated and washed with 1 M HCl (3 × 10 
mL) and sat. NaHCO3 (10 mL). The organic fraction was collected, dried with 
MgSO4 and concentrated in vacuo. The crude product was then redissolved in 
DMSO (20 mL) and precipitated with H2O (30 mL). The precipitate was collected 
by vacuum filtration and washed with H2O (3 × 1 mL) and Et2O (3 × 1 mL) to 
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afford the title compound (146 mg, 42%) as a white solid. δH (270 MHz, DMSO-
d6) 1.16 (2H, d, J 14.1), 1.64 (4H, s, H2,14,16,28), 1.82 (2H, s, H1,15), 1.91 (4H, s, 
H4,12,18,26), 1.95 (2H, s, H31), 2.25 (6H, bs, H5,11,19,25 and H29b,33b), 2.95 
(4H, m, H6,10,20,24), 3.61 (8H, m, ethyl), 3.82 (12H, s, OMe);  δC (68MHz, DMSO-
d6) 176.6, 168.4, 90.0, 54.9, 52.5, 51.2, 48.2, 41.2, 40.7, 37.9, 37.3, 28.9, 28.3; HRMS 
m/z (+ESI) 890.33082 ([C41H44N8O14 + NH4]+ requires 890.33152). 
CYCLO{[(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 
16α, 17α, 18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) TETRAMETHYL 
8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27-TETRACARBOXYLATE][4-(PROPYLAMIDE)BUT-2-ENE 
PROPYLAMIDE]} (158)  
A 1 mM solution containing diene 10 (50 mg, 0.05 
mmol) and Grubbs generation I catalyst (8.2 mg, 0.001 
mmol) in DCM (50 mL) was refluxed for 48 h. The 
resulting solution was concentrated to dryness in 
vacuo and the crude product purified by column chromatography (Rf = 0.11, 25% 
EtOAc in acetone) to afford the title compound (47 mg, 96%) as a white powder. 
δH (270MHz, CDCl3) 1.16 (2H, d, J 10.9), 1.68 (4H, s, H2,14,16,28), 1.77 (2H, s, 
H1,15), 1.88 (4H, m, 6’), 1.93 (2H, s, H31), 1.97 (4H, s, H4,12, 18,26), 2.22 (4H, t, J 
6.8, H1’) 2.51 (2H, m, H29b,33b), 2.55 (4H, s, H5,11,19,25), 2.95 (4H, m, 
H6,10,20,24), 3.53 (4H, t, J 6.7, H1’), 3.83 (12H, s, OMe), 3.88 (4H, m, H3’), 5.74 
(2H, s, H7’), 6.23 (2h, bm, amide NH); δC (68MHz, CDCl3) 177.2, 171.3, 168.4, 
128.3, 90.0, 54.7, 52.4, 51.0, 48.2, 41.2, 40.6, 40.4, 37.9, 37.7, 33.9, 29.1, 24.4; 
HRMS m/z (+ESI) 957.37628 ([C49H56N4O16 + H]+ requires 957.37641). 
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CYCLO{[(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 
16α, 17α, 18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) TETRAMETHYL 
8,22-DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10.
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27TETRACARBOXYLATE][4-(PROPYLAMIDE) BUTANE 
PROPYLAMIDE]} (157) 
A solution of macrocycle 158 (42 mg, 0.4 mmol), Pd/C 
(4 mg, 10% wt.) and MeOH (10 mL) was stirred under 
a hydrogen atmosphere for 16 h. The resulting 
solution was filtered through celite and concentrated 
in vacuo to afford the title compound (42 mg, quant.) as a white power. mp >282 
(decomposition); δH (270 MHz, CDCl3) 1.16 (2H, d, J 11.5 1.64 (4H, s, H2,14,16,28), 
1.72 (2H, s, H7’), 1.78 (2H, s, H1,15), 1.87 (4H, m, 6’), 1.92 (2H, s, H31), 1.97 (4H, 
s, H4,12, 18,26), 2.20 (4H, t, J 6.8, H1’) 2.51 (2H, m, H29b,33b), 2.55 (4H, s, 
H5,11,19,25), 2.93 (4H, m, H6,10,20,24), 3.31 (4H, m, H3’), 3.53 (4H, t, J 6.7, H1’), 
3.83 (12H, s, OMe), 6.29 (2H, bm, amide NH); δC (68 MHz, CDCl3) 177.2, 171.9, 
168.4, 90.0, 54.7, 52.4, 51.0, 48.2, 47.3, 43.4, 41.2, 40.7, 39.4, 37.9, 34.2, 26.8, 24.5; 
HRMS m/z (+ESI) 997.34762 ([C49H58N4O16 + K]+ requires 997.34762). 
(1α, 2α, 3α, 4α, 5α, 6β, 10 β, 11α, 12α, 13α, 14α, 15α, 16α, 17α, 
18α, 19α, 20 β, 24 β, 25α, 26α, 27α, 28α) -  TETRAMETHYL 8,22-
DI[2’-(4’’-PHENYL 1’’H-1’’ ,2’’ ,3’ ’-TRIAZOLE-1’’’-YL)ETHYL]-8,22-
DIAZA-30,32-
DIOXADODECACYCLO[13.13.1.13, 12 .14, 1 0.117, 27 .119, 25 .02, 1 4.04 , 12 .06, 10 .
016, 28 .018, 26 .020, 24]TRITRIACONTANE-7,9,21,23-TETRAONE-
3,13,17,27-TETRACARBOXYLATE  (160) 
To a solution of phenyl acetylene (8 μL, 0.071 
mmol) in MeCN (2 mL) was added copper 
iodide (8 mg, 0.043 mmol) and DIPEA (61 μL, 
0.35 mmol). To the resulting mixture was 
added diazide 11 (31 mg, 0.035 mmol), an air 
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condenser fitted, and the solution heated for 20 h at 60 °C. After which time the 
solution was cooled and 1 M HCl (5 mL) added. The resulting solution was 
extracted with CHCl3 (3 × 5 mL), organics combined, dried with MgSO4 and 
concentrated in vacuo to afford the title compound (32 mg, 85%) as a tan solid. 
mp >261 (decomposition); δH (500MHz, CDCl3) 1.17 (2H, d, J 11.0, H29a,33a), 
1.77 (2H, s, H31), 1.91 (6H, s, H2,14,16,28 and H1,15), 2.31 (4H, s, H4,12,18,26), 
2.57 (6H, m, H5,11,19,25 and H29b,33b), 2.98 (4H, dd, J 3.2, 1.8, H6,10,20,24), 
3.80 (12H, s, OMe), 3.85 (4H, t, J 6.5, H1’), 4.41 (4H, t, J 6.41, H2’), 7.45 (2H, dd, J 
7.4, 7.4, H4’’’), 7.53 (4H, dd, J 7.6, 7.6, H3’’’), 7.57 (2H, s, H5”), 7.73 (4H, d, J 7.1, 
H2’’’); δC (100 MHz, CDCl3) 176.5, 168.5, 132.6, 130.9, 129.3, 128.6, 125.6, 119.5, 
89.9, 54.7, 52.3, 51.1, 48.3, 47.0, 41.1, 40.6, 37.9, 29.8, 29.7; HRMS m/z (+ESI) 
1077.39860 ([C57H56N8O14 + H]+ requires 1077.39888). 
SYNTHESIS OF RESIN BO UND PEPTIDES. (12) 
The synthesis of resin bound peptide 12 was completed through SPPS using 
standard Fmoc chemistry.[271] Rink resin (294 mg, 0.2 mmol loading) was 
deprotected in a solution of 20% piperidine in DMF; amino acids were coupled 
using HBTU (360 mg 0.96 mmol), HOBt (136 mg, 1.0 mmol) and DIPEA (400 μL, 
2.3 mmol) for 1 h; then capped using acetic anhydride (1 mL, 11.0 mmol), DIPEA 
(400 μL, 2.3 mmol). DMF (3 × 4 mL) and DCM (3 × 4 mL) were used to wash the 
resin between coupling/deprotection steps. Reactions were monitored by the 
Kaiser test and assumed to be quantitative. The resin was collected and dried 
overnight under vacuum. 
PEPTIDE CLEAVAGE (13) 
Resin bound peptide (0.1 mmol) was suspended in 95% TFA, 2.5% H2O and 2.5% 
triethysilane (4 mL). The resin was allowed to sit with occasional stirring for 4 h. 
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The solution was then filtered, and concentrated by a stream of N2. The solution 
was then added to cold Et2O (40 mL, −80 °C), centrifuged and the supernatant 
decanted off. The solid was then subjected to two washes with Et2O, 
centrifugation and decanting cycles. The excess Et2O was allowed to evaporate at 
room temperature to afford peptide 13 (90%, 48 mg) as a white solid. UV-HPLC 
Rf = 1.33 min, 3% MeCN/H2O; νmax/cm-1 1685 amide C=O, 2360 and 2344 C≡C, 
3279 N–H; HRMS m/z (+ESI) 534.26704 ([C24H35N7O7 + H]+ requires 534.26707)  
SOLUTION PHASE COPPER CAT ALYSED 1,3-DIPOLAR CYCLOADDITIO N (14) 
To a solution of linear peptide 13 (33 mg, 0.061 mmol) in DMF (61 mL, 2 mM), 
CuI (24 mg, 0.13 mmol) and DIPEA (43 μL, 0.24 mmol) were added and the 
resulting solution stirred for 10 min at room temperature. After this time, diazide 
11 (53 mg, 0.061 mmol) was added and the solution stirred at 60 °C for 2 days. 
The resulting solution was filtered through celite and concentrated to dryness in 
vacuo. The crude solid was then purified by preparative TLC (Rf= 0.37, 20% MeOH 
in CHCl3) to afford stapled peptide 14 (23 mg, 16%) as a light brown hygroscopic 
solid. 
SOLID PHASE COPPER CA TALYSED 1,3-DIPOLAR CYCLOADDITIO N (14) 
To a suspension of resin bound peptide 12 (160 mg, 0.1 mmol) in DMF (60 mL, 1 
mM), CuI (42 mg, 0.22 mmol) and DIPEA (100 μl, 0.75 mmol) were added and the 
resulting suspension was sit for 10 min at room temperature. After this time, 
diazide 11 (87 mg, 0.1 mmol) was added and the solution mixed at 60 °C for 4 
days. The resulting suspension was washed with DMF (3 × 4 mL) and DCM (3 × 4 
mL) and dried overnight under vacuum. The resin bound stapled peptide was 
suspended in 95% TFA, 2.5% H2O and 2.5% triethysilane (4 mL). The resin was 
allowed to sit with occasional stirring for 4 h. The solution was then filtered, and 
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concentrated under a stream of N2. The solution was then added to cold Et2O (40 
mL, −80 °C), centrifuged and the supernatant decanted off. The solid was then 
subjected to two washes with Et2O, centrifugation and decanting cycles. Thereby 
the excess Et2O was allowed to evaporate at room temperature to afford the 
crude stapled peptide. The crude solid was then purified by preparative TLC (Rf 
= 0.38, 20% MeOH in CHCl3) to afford stapled peptide 14 (17 mg, 12%) as a light 
brown hygroscopic solid. UV-HPLC Rf = 0.81 min, 3% MeCN/H2O; νmax/cm-1 857, 
1043 N=N, 1164 O–Me and N=N, 1525 ester C=O, 1682 Amide C=O, 3345 N–H; 
HRMS m/z (+ESI) 1406.56149 ([C65H79N15O21 + H]+ requires 1406.56477). 
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CHAPTER 5 
 
CONCLUDING REMARKS 
 
5.1 PREAMBLE 
While specific conclusions about each individual chapter have been provided at 
the end of each chapter, this short section will draw some general conclusions 
about the use of fused [n]polynorbornanes in anion recognition and as 
frameworks for peptide rigidification.  
5.2 GENERAL CONCLUSIONS 
5.2.1 ANION RECOGNITION 
The anion recognition study focused on understanding exactly how three-armed 
polynorbornane hosts 1 and 2 bound anions (chapter 2). The stepwise 
regioselective recognition of dicarboxylates was shown to be facilitated through 
a between the arms binding mode (figure 115). The preference for dicarboxylates 
to bind between the arms of the ‘two-armed’ end of the scaffold over binding at 
the ‘single-armed’ end gave rise to binding in which the  
 
 
Figure 115: Between the arms  binding mode of host 1a with a dicarboxylate. 
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stepwise process allowed for the assembly of a dicarboxylate (pimelate or 
malonate) between the ‘two-armed’ end and acetate at the single armed end.  
The binding interaction of host 1 and 2 with pyrophosphate occurred differently 
than that of the dicarboxylates (chapter 2). Pyrophosphate was bound exclusively 
at the ‘two-armed’ end with no interaction at the single armed end, regardless of 
the amount of pyrophosphate or other anions (such as acetate) added. Both 
diffusion NMR and molecular modelling suggested a 1:1 H:G binding mode where 
the bulky TBAH counter-cation sterically blocked access to the ‘single-armed’ end 
(figure 116). 
 
Figure 116: Cartoon of molecular modelling (MMFF) of host 1a (Black) with TBAH (green) 
pyrophosphate (blue) highlighting the possible H-Bond between countercation and guest and the 
close association of another countercation with the host -guest complex.  
A series of five hosts were identified as synthetic targets (4–8) to both confirm 
binding modes seen in chapter 2 and study the cooperation of the arms. Four of 
the five hosts were successfully synthesised. The remaining hosts (4, 5, 7, and 8) 
along with host 3a and 1a were analysed by NMR titration, Job plot analysis and 
diffusion NMR. 
 
Figure 117: Host 8 and host 1a  bound to pimelate.  
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The between the arms binding mode of the dicarboxylates was conserved 
amongst the series along with the 1:1 binding modes with pyrophosphate. The 
conservation of binding mode across the series provided extra evidence for the 
binding modes proposed in chapter 2 (figure 117).  
 
Figure 118: Host 3a bound in a 1:2 H:G ratio and host 7 bound in a 1:1 H:G ratio.  
In the case of polynorbornane hosts binding acetate it was shown that the scaffold 
itself had an effect on the stoichiometry of the host:acetate complex (figure 118). 
5.2.2 PREORGANISATION OF PEPTIDES 
To incorporate an [n]polynorbornane scaffold into a biochemical setting, a 
[n]polynorbornane was attached to a peptide sequence as a peptide super-staple. 
Three candidates for peptide stapling (9–11, figure 119) were synthesised using 
a one-pot methodology for the polynorbornane construction. The one-pot 
methodology gave increased yields over the stepwise methods (polynorbornane 
133, one pot 78%, stepwise 41%). 
 
Figure 119: Three staple candidates developed, all of which used the one-pot methodology for 
[5]polynorbornane construction.  
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Each staple was assessed for its ability to be attached to a peptide using a test 
reaction. Diazide 11 proved to be the most suitable. A hexapeptide incorporating 
two propargyl glycine residues was synthesised, and reacted with diazide 11 
under both solution state and solid phase methodologies to form the desired 
target (scheme 42). Both reactions were confirmed successful by  
HPLC-MS and the ‘super-stapled’ peptide was characterised by IR, UV, HPLC and 
MS. 
 
Scheme 42: Solution state coupling of azide  11 and peptide 13 to form stapled peptide 14. 
The preorganisation induced by the [5]polynorbornane scaffold was successful 
in stabilising peptide secondary structure. Using IR deconvolution methods, the 
free peptide was confirmed as predominantly random coil while the stapled 
peptide was tentatively assigned β-sheet secondary structure. 
5.3 FUTURE WORK 
The use of TBAH (HNBu3+) pyrophosphate in place of TBA (NBu4+)  
pyrophosphate lead to an unusual H:G complex where the ‘single-armed’ side of 
1 and 2 did not participate (chapter 1). From molecular modelling it was 
hypothesised that the TBAH participated in the H:G complex. One method to test 
the hypothesis was to repeat titrations with TBA pyrophosphate. But as no 
suitable source of TBA pyrophosphate was available (section 2.6), the titrations 
   Chapter 5 
179 | 
could not be conducted. Upon securing of a pure source of TBA pyrophosphate it 
would be prudent to again test the interaction of 1 and 2 to confirm if binding of 
pyrophosphate was truly akin to the dicarboxylates. 
As the interactions of hosts with anions were inferred from the movement of 
hydrogen bonding protons, the exact nature of many H:G complexes is not known. 
The structure of the complex was proposed though careful examination of 1H 
NMR titrations and molecular modelling. While attempts to crystallise the H:G 
complexes have been unsuccessful, there are many advanced methodologies for 
gaining crystallographic information which were outside the scope of the current 
investigation. The use of organo/hydrogels to facilitate crystal growth has been 
well documented[276-280] and recently Fujita has reported X-ray crystallographic 
data that was obtained for non-crystalline materials trapped in metal-organic 
frameworks.[281] 
 
Figure 120: Initial steps towards and proposed future synthesis of host 165  
In addition to further crystallographic studies to confirm the between the arms 
binding mode observed for hosts 1–2 with dicarboxylates it is possible that a host 
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with different electron withdrawing groups at each end would provide an 
example, where the urea protons of each end would be fully resolved (host 165) 
during titration. A host such as host 165 could contain  
4-fluorophenylthiouredio ethyl arms at the ‘two-armed’ end and a 
phenylthioureido ethyl arm at the ‘single-armed’ end (figure 120). A titration 
experiment including a host such as 165 and pimelate could, in turn, provide 
more evidence for the between the arms binding mode. 
 
Figure 121: Example of a possible Michael reaction mediated by 2a. 
The stepwise regioselective recognition of anions displayed by hosts 1 and 2, 
lends itself well to design of novel organocatalysts/synthetic enzymes.[282] 
Enolates are intermediates used in aldol, Mannich, and Michael additions, thus a 
suitably functionalised polynorbornane could be used to bind enolised 1,3 
dicarbonyls and direct reaction partners in a Michael addition (figure 121).[283] 
Potential problems may arise in this research avenue from product inhibition; i.e. 
if the resulting difunctional species binds to the catalyst stronger than the initial 
reactants. Depending on the binding strength of the reactants vs the product this 
may or may not be an issue. Alternatively, the replacement of the calixarene 
scaffold by an [n]polynorbornane to mimic the phosphoesterase enzymes 
discussed in the introduction (section 1.2.4.1) is also a readily achievable possible 
organocatalyst (figure 122).  
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Figure 122: Use of a [3]polynorbornane to catalyse phosphoester cleavage, akin to calixarene 70. 
The ability of the [5]polynorbornane scaffold to stabilise β-Sheet secondary 
structure paves the way for the use of the scaffold to preorganise a clinically 
relevant β-sheet, such as those that comprise amyloid fibres[284] or  
θ-defensins.[215] As α-helix conformation was not stabilised by the 
[5]polynorbornane, the [5]polynorbornane may have been simply too large. 
Stapling a peptide at the i and i+7 or using a [3]polynorbornane and stapling at 
the i and i+4 positions may stabilise α-helix formation. 
 
Scheme 43: RCM to introduce a peptide staple. 
Due to the high yield obtained of macrocycle 158 from the RCM of diene 10, the 
similar [5]polynorbornanes can be used to join and staple two peptide sequences. 
The [n]polynorbornane scaffold would possibly rigidify the peptide, facilitate 
conjugation of two peptides and or mimic β-turn secondary structure.  
 Chapter 5 
| 182 
The difficulty in characterising the [5]polynorbornane stapled peptide 14 was 
that the resulting peptide was insoluble in most solvents (and all solvents that 
are compatible with CD spectroscopy). To solubilise a second generation of the 
[n]polynorbornane peptides anionic and or cationic groups could be included in 
the peptide sequence to increase aqueous solubility. The interaction of these β-
sheet rigidified peptides with themselves and other species in solution would 
help our understanding of the supramolecular interactions of β-sheet peptides. 
 
 183 | 
CHAPTER 6 
 
REFERENCES 
 
[1] F. P. Schmidtchen and M. Berger, Artificial Organic Host Molecules for 
Anions, Chem. Rev., 1997, 97, 1609-1646. 
[2] J.-M. Lehn, Supramolecular Chemistry—Scope and Perspectives 
Molecules, Supermolecules, and Molecular Devices (Nobel Lecture), 
Angew. Chem., Int. Ed., 1988, 27 (1), 89-112. 
[3] J. B. Wittenberg and L. Isaacs, in Supramolecular Chemistry from Molecules 
to Nanomaterials, eds. P. Gale and J. Steed, John Wiley and Sons Ltd, West 
Sussex, 2012, vol. 1. 
[4] Y. Hua and A. H. Flood, Click chemistry generates privileged CH hydrogen-
bonding triazoles: the latest addition to anion supramolecular chemistry, 
Chem. Soc. Rev., 2010, 39 (4), 1262. 
[5] F. Zapata, A. Caballero, N. G. White, T. D. W. Claridge, P. J. Costa, V. t. Félix 
and P. D. Beer, Fluorescent Charge-Assisted Halogen-Bonding Macrocyclic 
Halo-Imidazolium Receptors for Anion Recognition and Sensing in 
Aqueous Media, J. Am. Chem. Soc., 2012, 134 (28), 11533-11541. 
[6] G. Cavallo, P. Metrangolo, T. Pilati, G. Resnati, M. Sansotera and G. 
Terraneo, Halogen bonding: a general route in anion recognition and 
coordination, Chem. Soc. Rev., 2010, 39 (10), 3772-3783. 
[7] A. Caballero, F. Zapata, N. G. White, P. J. Costa, V. Félix and P. D. Beer, A 
Halogen-Bonding Catenane for Anion Recognition and Sensing, Angew. 
Chem., Int. Ed., 2012, 51 (8), 1876-1880. 
[8] E. Webber, in Encyclopedia of Supramolecular chemistry, eds. J. Atwood 
and J. Steed, Marcel Drekker Inc, New York, 2004, vol. 1. 
[9] N. Campbell and J. Reece, Biology, 6th edn., Benjamin Cummings, 2002. 
Chapter 6 
| 184 
[10] S. Baskin, A. Horowitz and E. Nealley, The antidotal action of sodium nitrite 
and sodium thiosulfate against cyanide poisoning, J. Clin. Pharmacol., 
1992, 32 (4), 368-375. 
[11] D. Nelson and M. Cox, Principles of Biochemistry, 4th edn., WH Freeman 
and Company, New Your, 2005. 
[12] B. Dietrich and M. W. Hosseini, in Supramolecular chemistry of anions, eds. 
A. Bianchi, K. Bowman-James and E. Garcia-Espana, John Wiley and Sons 
Inc, New York, 1997. 
[13] P. D. Beer and P. A. Gale, Anion Recognition and Sensing: The State of the 
Art and Future Perspectives, Angew. Chem., Int. Ed., 2001, 40 (3), 486-516. 
[14] J. Sessler, P. Gale and W. Cho, Anion Receptor chemistry, RSC Publishing, 
Cambridge, 2006. 
[15] A. D. Bond, in Pharmaceutical Salts and Co-crystals, The Royal Society of 
Chemistry, 2012, pp. 9-28. 
[16] E. Fischer, Einfluss der Configuration auf die Wirkung der Enzyme, Ber. 
Dtsch. Chem. Ges., 1894, 27 (3), 2985. 
[17] E. Fischer, Ueber die optischen Isomeren des Traubenzuckers, der 
Gluconsäure und der Zuckersäure, Ber. Dtsch. Chem. Ges., 1890, 23 (2), 
2611. 
[18] D. E. Koshland, The Key–Lock Theory and the Induced Fit Theory, Angew. 
Chem., Int. Ed., 1995, 33 (23-24), 2375-2378. 
[19] D. E. Koshland, Application of a Theory of Enzyme Specificity to Protein 
Synthesis, Proc. Natl. Acad. Sci. U. S. A., 1958, 44 (2), 98-104. 
[20] Brown, LeMay and Bursten, Chemistry: The Central Science, 7th edn., 
Prentice-Hall Inc, Upper Saddle River, 1997. 
[21] G. Desiraju, in Encyclopedia of Supramolecular Chemistry, eds. J. Atwood 
and J. Steed, Marcel Dekker, New York, 2004, vol. 1, pp. 658-665. 
[22] Horton, Moran, Scrimgeour, Perry and Rawn, Principles of biochemistry, 
4th edn., Pearson Prentice Hall, Upper Saddle River, 2006. 
[23] M. D. Best, S. L. Tobey and E. V. Anslyn, Abiotic guanidinium containing 
receptors for anionic species, Coord. Chem. Rev., 2003, 240 (1–2), 3-15. 
[24] P. Blondeau, M. Segura, R. Perez-Fernandez and J. de Mendoza, Molecular 
recognition of oxoanions based on guanidinium receptors, Chem. Soc. Rev., 
2007, 36 (2), 198-210. 
   Chapter 6 
185 | 
[25] L. Nie, Z. Li, J. Han, X. Zhang, R. Yang, W.-X. Liu, F.-Y. Wu, J.-W. Xie, Y.-F. Zhao 
and Y.-B. Jiang, Development of N-Benzamidothioureas as a New 
Generation of Thiourea-Based Receptors for Anion Recognition and 
Sensing, J. Org. Chem., 2004, 69 (19), 6449-6454. 
[26] S. Nishizawa, P. Bühlmann, M. Iwao and Y. Umezawa, Anion recognition by 
urea and thiourea groups: Remarkably simple neutral receptors for 
dihydrogenphosphate, Tetrahedron Lett., 1995, 36 (36), 6483-6486. 
[27] J. N. Babu, V. Bhalla, M. Kumar, R. K. Puri and R. K. Mahajan, Chloride ion 
recognition using thiourea/urea based receptors incorporated into 1,3-
disubstituted calix[4]arenes, New J. Chem., 2009, 33 (3), 675. 
[28] M. A. Hossain, R. A. Begum, V. W. Day and K. Bowman-James, in 
Supramolecular Chemistry, John Wiley & Sons, Ltd, 2012. 
[29] P. A. Gale, From Anion Receptors to Transporters, Acc. Chem. Res., 2011, 
44 (3), 216-226. 
[30] J. Yoo, M.-S. Kim, S.-J. Hong, J. L. Sessler and C.-H. Lee, Selective Sensing of 
Anions with Calix[4]pyrroles Strapped with Chromogenic 
Dipyrrolylquinoxalines, J. Org. Chem., 2008, 74 (3), 1065-1069. 
[31] H. Miyaji, D. An and J. L. Sessler, Mono Halogen Substituted 
Calix[4]pyrroles: Fine-tuning the Anion Binding Properties of 
Calix[4]pyrrole, Supramol. Chem., 2001, 13 (6), 661-669. 
[32] H. Miyaji, S.-J. Hong, S.-D. Jeong, D.-W. Yoon, H.-K. Na, J. Hong, S. Ham, J. L. 
Sessler and C.-H. Lee, A Binol-Strapped Calix[4]pyrrole as a Model 
Chirogenic Receptor for the Enantioselective Recognition of Carboxylate 
Anions, Angew. Chem., Int. Ed., 2007, 46 (14), 2508-2511. 
[33] M. G. Fisher, P. A. Gale, J. R. Hiscock, M. B. Hursthouse, M. E. Light, F. P. 
Schmidtchen and C. C. Tong, 1,2,3-Triazole-strapped calix[4]pyrrole: a 
new membrane transporter for chloride, Chem. Commun., 2009(21), 
3017-3019. 
[34] L. S. Evans, P. A. Gale, M. E. Light and R. Quesada, Anion binding vs. 
deprotonation in colorimetric pyrrolylamidothiourea based anion 
sensors, Chem. Commun., 2006(9), 965-967. 
[35] Y. Li and A. H. Flood, Pure C-H hydrogen bonding to chloride ions: a 
preorganized and rigid macrocyclic receptor, Angew. Chem., Int. Ed., 2008, 
47 (14), 2649-2652. 
Chapter 6 
| 186 
[36] S. Lee, Y. Hua, H. Park and A. H. Flood, Intramolecular Hydrogen Bonds 
Preorganize an Aryl-triazole Receptor into a Crescent for Chloride 
Binding, Org. Lett., 2010, 12 (9), 2100-2102. 
[37] E. M. Zahran, Y. Hua, S. Lee, A. H. Flood and L. G. Bachas, Ion-Selective 
Electrodes Based on a Pyridyl-Containing Triazolophane: Altering Halide 
Selectivity by Combining Dipole-Promoted Cooperativity with Hydrogen 
Bonding, Anal. Chem., 2011, 83 (9), 3455-3461. 
[38] Y. Hua, R. O. Ramabhadran, J. A. Karty, K. Raghavachari and A. H. Flood, 
Two levels of conformational pre-organization consolidate strong CH 
hydrogen bonds in chloride-triazolophane complexes, Chem. Commun., 
2011, 47 (21), 5979-5981. 
[39] K. P. McDonald, R. O. Ramabhadran, S. Lee, K. Raghavachari and A. H. Flood, 
Polarized Naphthalimide CH Donors Enhance Cl– Binding within an Aryl-
Triazole Receptor, Org. Lett., 2011, 13 (23), 6260-6263. 
[40] P. B. Cranwell, J. R. Hiscock, C. J. Haynes, M. E. Light, N. J. Wells and P. A. 
Gale, Anion recognition and transport properties of sulfamide-, 
phosphoric triamide- and thiophosphoric triamide-based receptors, 
Chem. Commun., 2013, 49 (9), 874-876. 
[41] V. Ramalingam, M. E. Domaradzki, S. Jang and R. S. Muthyala, Carbonyl 
Groups as Molecular Valves to Regulate Chloride Binding to Squaramides, 
Org. Lett., 2008, 10 (15), 3315-3318. 
[42] A. Rostami, C. J. Wei, G. Guérin and M. S. Taylor, Anion Detection by a 
Fluorescent Poly(squaramide): Self-Assembly of Anion-Binding Sites by 
Polymer Aggregation, Angew. Chem., Int. Ed., 2011, 50 (9), 2059-2062. 
[43] V. Amendola, G. Bergamaschi, M. Boiocchi, L. Fabbrizzi and M. Milani, The 
Squaramide versus Urea Contest for Anion Recognition, Chem. Eur. J., 
2010, 16 (14), 4368-4380. 
[44] M. Neus Piña, M. Carmen Rotger, A. Costa, P. Ballester and P. M. Deyà, 
Evaluation of anion selectivity in protic media by squaramide–Cresol Red 
ensembles, Tetrahedron Lett., 2004, 45 (19), 3749-3752. 
[45] N. Busschaert, I. L. Kirby, S. Young, S. J. Coles, P. N. Horton, M. E. Light and 
P. A. Gale, Squaramides as Potent Transmembrane Anion Transporters, 
Angew. Chem., Int. Ed., 2012, 51 (18), 4426-4430. 
   Chapter 6 
187 | 
[46] D. J. Cram, The Design of Molecular Hosts, Guests, and Their Complexes 
(Nobel Lecture), Angew. Chem., Int. Ed., 1988, 27 (8), 1009-1020. 
[47] D. J. Cram, Preorganization—From Solvents to Spherands, Angew. Chem., 
Int. Ed., 1986, 25 (12), 1039-1057. 
[48] J. Steed and J. Atwood, Supramolecular chemistry, John Wiley & Sons, Ltd., 
2009. 
[49] P. J. Cragg, R. Vahora, A. Bianchi, E. Garcıa-Espa˜na, W. Levason, G. Reid, L. 
F. Lindoy, K.-M. Park, S. S. Lee, B. Sreenivasulu, L. Baldini, F. Sansone, A. 
Casnati, R. Ungaro, M. J. Hardie, R. Warmuth, S. F. Lincoln, D.-T. Pham, A. I. 
Day, J. G. Collins, A. N. Swinburne, J. W. Steed, J. L. Sessler, E. Karnas, E. 
Sedenberg, C. G. Claessens, M. V. Martınez-Dıaz, T. Torres, M. P. Conley, J. 
Valero, J. d. Mendoza, P. A. Gale, C. J. E. Haynes, M. A. Hossain, R. A. Begum, 
V. W. Day, K. Bowman-James, S. Kubik, C. Godoy-Alc´antar, A. K. 
Yatsimirsky, E. Garc´ıa-Espana, R. Belda, J. Gonzalez, J. Pitarch, A. Bianchi, 
S. V. Luis, I. Alfonso, F. Galindo, A. D. Cort, S. J. Loeb, A. J. Wilson, J. S. Fossey 
and T. D. James, Molecular Recognition, P. Gale and J. Steed, John Wiley and 
Sons. Ltd, West Sussex, 2012. 
[50] D. R. Turner, M. J. Paterson and J. W. Steed, Conformational control by 
'zipping-up' an anion-binding unimolecular capsule, Chem. Commun., 
2008, (12), 1395-1397. 
[51] I. Martí, J. Rubio, M. Bolte, M. I. Burguete, C. Vicent, R. Quesada, I. Alfonso 
and S. V. Luis, Tuning Chloride Binding, Encapsulation, and Transport by 
Peripheral Substitution of Pseudopeptidic Tripodal Small Cages, Chem. 
Eur. J., 2012, 18 (52), 16728-16741. 
[52] M. Alajarin, R.-A. Orenes, J. W. Steed and A. Pastor, Self-assembly of 
tris(ureidobenzyl)amines: flexible bricks for robust architectures, Chem. 
Commun., 2010, 46 (9), 1394-1403. 
[53] A. Barnard, S. J. Dickson, M. J. Paterson, A. M. Todd and J. W. Steed, 
Enantioselective lactate binding by chiral tripodal anion hosts derived 
from amino acids, Org. Biomol. Chem., 2009, 7 (8), 1554-1561. 
[54] J. V. Gavette, A. L. Sargent and W. E. Allen, Hydrogen Bonding vs Steric 
Gearing in a Hexasubstituted Benzene, J. Org. Chem., 2008, 73 (9), 3582-
3584. 
Chapter 6 
| 188 
[55] G. Hennrich and E. V. Anslyn, 1,3,5-2,4,6-Functionalized, Facially 
Segregated Benzenes—Exploitation of Sterically Predisposed Systems in 
Supramolecular Chemistry, Chem. Eur. J., 2002, 8 (10), 2218-2224. 
[56] A. Metzger, V. M. Lynch and E. V. Anslyn, A Synthetic Receptor Selective for 
Citrate, Angew. Chem., Int. Ed., 1997, 36 (8), 862-865. 
[57] S. O. Kang, J. M. Llinares, D. Powell, D. VanderVelde and K. Bowman-James, 
New Polyamide Cryptand for Anion Binding, J. Am. Chem. Soc., 2003, 125 
(34), 10152-10153. 
[58] P. Thordarson, Determining association constants from titration 
experiments in supramolecular chemistry, Chem. Soc. Rev., 2011, 40 (3), 
1305-1323. 
[59] S. O. Kang, D. VanderVelde, D. Powell and K. Bowman-James, Fluoride-
Facilitated Deuterium Exchange from DMSO-d6 to Polyamide-Based 
Cryptands, J. Am. Chem. Soc., 2004, 126 (39), 12272-12273. 
[60] R. M. Duke, E. B. Veale, F. M. Pfeffer, P. E. Kruger and T. Gunnlaugsson, 
Colorimetric and fluorescent anion sensors: an overview of recent 
developments in the use of 1,8-naphthalimide-based chemosensors, 
Chem. Soc. Rev., 2010, 39 (10), 3936-3953. 
[61] T. Gunnlaugsson, M. Glynn, G. M. Tocci, P. E. Kruger and F. M. Pfeffer, Anion 
recognition and sensing in organic and aqueous media using luminescent 
and colorimetric sensors, Coord. Chem. Rev., 2006, 250 (23–24), 3094-
3117. 
[62] T. Gunnlaugsson, P. E. Kruger, P. Jensen, J. Tierney, H. D. P. Ali and G. M. 
Hussey, Colorimetric “Naked Eye” Sensing of Anions in Aqueous Solution, 
J. Org. Chem., 2005, 70 (26), 10875-10878. 
[63] T. Gunnlaugsson, H. Ali, M. Glynn, P. Kruger, G. Hussey, F. Pfeffer, C. G. 
Santos and J. Tierney, Fluorescent Photoinduced Electron Transfer (PET) 
Sensors for Anions; From Design to Potential Application, J. Fluoresc., 
2005, 15 (3), 287-299. 
[64] T. Gunnlaugsson, P. E. Kruger, P. Jensen, F. M. Pfeffer and G. M. Hussey, 
Simple naphthalimide based anion sensors: deprotonation induced colour 
changes and CO2 fixation, Tetrahedron Lett., 2003, 44 (49), 8909-8913. 
[65] P. A. Gale, Structural and Molecular Recognition Studies with Acyclic Anion 
Receptors†, Acc. Chem. Res., 2006, 39 (7), 465-475. 
   Chapter 6 
189 | 
[66] E. B. Veale and T. Gunnlaugsson, Bidirectional Photoinduced Electron-
Transfer Quenching Is Observed in 4-Amino-1,8-naphthalimide-Based 
Fluorescent Anion Sensors, J. Org. Chem., 2008, 73 (20), 8073-8076. 
[67] T. Gunnlaugsson, P. E. Kruger, T. C. Lee, R. Parkesh, F. M. Pfeffer and G. M. 
Hussey, Dual responsive chemosensors for anions: the combination of 
fluorescent PET (Photoinduced Electron Transfer) and colorimetric 
chemosensors in a single molecule, Tetrahedron Lett., 2003, 44 (35), 
6575-6578. 
[68] S. V. Bhosale, S. V. Bhosale, M. B. Kalyankar and S. J. Langford, A Core-
Substituted Naphthalene Diimide Fluoride Sensor, Org. Lett., 2009, 11 
(23), 5418-5421. 
[69] W. Huang, H. Lin, Z. Cai and H. Lin, An efficient novel anion sensor for the 
recognition of acetate, J. Inclusion Phenom. Macrocyclic Chem., 2011, 69 (1-
2), 63-68. 
[70] K. K. Y. Yuen and K. A. Jolliffe, Bis[zinc(II)dipicolylamino]-functionalised 
peptides as high affinity receptors for pyrophosphate ions in water, Chem. 
Commun., 2013, 49 (42), 4824-4826. 
[71] V. J. Dungan, H. T. Ngo, P. G. Young and K. A. Jolliffe, High affinity sulfate 
binding in aqueous media by cyclic peptides with thiourea arms, Chem. 
Commun., 2013, 49 (3), 264-266. 
[72] P. G. Young and K. A. Jolliffe, Selective recognition of sulfate ions by 
tripodal cyclic peptides functionalised with (thio)urea binding sites, Org. 
Biomol. Chem., 2012, 10 (13), 2664-2672. 
[73] P. G. Young, J. K. Clegg and K. A. Jolliffe, Neutral cryptand-like cyclic 
peptide–thiourea receptors for selective recognition of sulphate anions in 
aqueous solvents, Supramol. Chem., 2011, 24 (2), 77-87. 
[74] L. Frish, F. Sansone, A. Casnati, R. Ungaro and Y. Cohen, Complexation of a 
Peptidocalix[4]arene, a Vancomycin Mimic, with Alanine-Containing 
Guests by NMR Diffusion Measurements, J. Org. Chem., 2000, 65, 5026-
5030. 
[75] C. Capici, Y. Cohen, A. D'Urso, G. Gattuso, A. Notti, A. Pappalardo, S. 
Pappalardo, M. F. Parisi, R. Purrello, S. Slovak and V. Villari, Anion-Assisted 
Supramolecular Polymerization: From Achiral AB-Type Monomers to 
Chiral Assemblies, Angew. Chem., Int. Ed., 2011, 123 (50), 12162-12167. 
Chapter 6 
| 190 
[76] A. J. McConnell, C. J. Serpell, A. L. Thompson, D. R. Allan and P. D. Beer, 
Calix[4]arene-based rotaxane host systems for anion recognition, Chem. 
Eur. J., 2010, 16 (4), 1256-1264. 
[77] M. H. Filby, S. J. Dickson, N. Zaccheroni, L. Prodi, S. Bonacchi, M. Montalti, 
M. J. Paterson, T. D. Humphries, C. Chiorboli and J. W. Steed, Induced fit 
interanion discrimination by binding-induced excimer formation, J. Am. 
Chem. Soc., 2008, 130 (12), 4105-4113. 
[78] J. M. Kim, S. J. Min, S. W. Lee, J. H. Bok and J. S. Kim, An excimer emission 
approach for patterned fluorescent imaging, Chem. Commun., 2005 (27), 
3427-3429. 
[79] N. Basilio, V. Francisco and L. Garcia-Rio, Independent pathway formation 
of guest-host in host ternary complexes made of ammonium salt, 
calixarene, and cyclodextrin, J. Org. Chem., 2012, 77 (23), 10764-10772. 
[80] V. K. Gupta, R. Ludwig and S. Agarwal, Anion recognition through modified 
calixarenes: a highly selective sensor for monohydrogen phosphate, Anal. 
Chim. Acta, 2005, 538 (1–2), 213-218. 
[81] P. A. Gale, J. L. Sessler, V. Král and V. Lynch, Calix[4]pyrroles:  Old Yet New 
Anion-Binding Agents, J. Am. Chem. Soc., 1996, 118 (21), 5140-5141. 
[82] P. Lo and M. Wong, Extended Calix[4]arene-Based Receptors for Molecular 
Recognition and Sensing, Sensors, 2008, 8 (9), 5313-5335. 
[83] S. E. Matthews and P. D. Beer, Calixarene-based Anion Receptors, 
Supramol. Chem., 2005, 17 (6), 411-435. 
[84] A. Casnati, F. Sansone and R. Ungaro, Peptido- and glycocalixarenes: 
playing with hydrogen bonds around hydrophobic cavities, Acc. Chem. 
Res., 2003, 36 (4), 246-254. 
[85] M. l. Hamon, M. l. Ménand, S. p. Le Gac, M. Luhmer, V. Dalla and I. Jabin, 
Calix[6]tris(thio)ureas: Heteroditopic Receptors for the Cooperative 
Binding of Organic Ion Pairs, J. Org. Chem., 2008, 73 (18), 7067-7071. 
[86] E. Masson, X. Ling, R. Joseph, L. Kyeremeh-Mensah and X. Lu, Cucurbituril 
chemistry: a tale of supramolecular success, RSC Advances, 2012, 2 (4), 
1213-1247. 
[87] M. Xue, Y. Yang, X. Chi, Z. Zhang and F. Huang, Pillararenes, A New Class of 
Macrocycles for Supramolecular Chemistry, Acc. Chem. Res., 2012, 45 (8), 
1294-1308. 
   Chapter 6 
191 | 
[88] T. Ogoshi and T.-a. Yamagishi, Pillararenes: Versatile Synthetic Receptors 
for Supramolecular Chemistry, Eur. J. Org. Chem., 2013, 2013 (15), 2961-
2975. 
[89] G. Yu, Z. Zhang, C. Han, M. Xue, Q. Zhou and F. Huang, A non-symmetric 
pillar[5]arene-based selective anion receptor for fluoride, Chem. 
Commun., 2012, 48 (24), 2958-2960. 
[90] Y.-Q. Zhang, Q.-J. Zhu, S.-F. Xue and Z. Tao, Chlorine Anion Encapsulation 
by Molecular Capsules Based on Cucurbit[5]uril and 
Decamethylcucurbit[5]uril, Molecules, 2007, 12 (7), 1325-1333. 
[91] J.-X. Liu, L.-S. Long, R.-B. Huang and L.-S. Zheng, Molecular Capsules Based 
on Cucurbit[5]uril Encapsulating “Naked” Anion Chlorine, Cryst. Growth 
Des., 2006, 6 (11), 2611-2614. 
[92] W. Chen, Y. Zhang, J. Li, X. Lou, Y. Yu, X. Jia and C. Li, Synthesis of a cationic 
water-soluble pillar[6]arene and its effective complexation towards 
naphthalenesulfonate guests, Chem. Commun., 2013. 
[93] S. D. Whitmarsh, A. P. Redmond, V. Sgarlata and A. P. Davis, Cationic 
cyclocholamides; toroidal facial amphiphiles with potential for anion 
transport, Chem. Commun., 2008, (31), 3669-3671. 
[94] A. P. Davis and J.-B. Joos, Steroids as organising elements in anion 
receptors, Coord. Chem. Rev., 2003, 240 (1–2), 143-156. 
[95] S. Ghosh, A. R. Choudhury, T. N. Guru Row and U. Maitra, Selective and 
Unusual Fluoride Ion Complexation by A Steroidal Receptor Using OH...F- 
and CH...F- Interactions:  A New Motif for Anion Coordination?, Org. Lett., 
2005, 7 (8), 1441-1444. 
[96] L. Fang, W.-H. Chan, Y.-B. He, D. W. J. Kwong and A. W. M. Lee, Fluorescent 
Anion Sensor Derived from Cholic Acid: The Use of Flexible Side Chain, J. 
Org. Chem., 2005, 70 (19), 7640-7646. 
[97] A. P. Davis, Anion binding and transport by steroid-based receptors, Coord. 
Chem. Rev., 2006, 250 (23–24), 2939-2951. 
[98] A. Davis, Bile Acid Scaffolds in Supramolecular Chemistry: The Interplay 
of Design and Synthesis, Molecules, 2007, 12 (9), 2106-2122. 
[99] A. Kumar and P. S. Pandey, Anion Recognition by 1,2,3-Triazolium 
Receptors: Application of Click Chemistry in Anion Recognition, Org. Lett., 
2007, 10 (2), 165-168. 
Chapter 6 
| 192 
[100] B. A. McNally, A. V. Koulov, T. N. Lambert, B. D. Smith, J.-B. Joos, A. L. Sisson, 
J. P. Clare, V. Sgarlata, L. W. Judd, G. Magro and A. P. Davis, Structure–
Activity Relationships in Cholapod Anion Carriers: Enhanced 
Transmembrane Chloride Transport through Substituent Tuning, Chem. 
Eur. J., 2008, 14 (31), 9599-9606. 
[101] A. J. Ayling, M. N. Pérez-Payán and A. P. Davis, New “Cholapod” 
Anionophores; High-Affinity Halide Receptors Derived from Cholic Acid, J. 
Am. Chem. Soc., 2001, 123 (50), 12716-12717. 
[102] S.-Y. Liu, Y.-B. He, W. H. Chan and A. W. M. Lee, Cholic acid-based high 
sensitivity fluorescent sensor for α,ω-dicarboxylate: an intramolecular 
excimer emission quenched by complexation, Tetrahedron, 2006, 62 (50), 
11687-11696. 
[103] F. M. Pfeffer and R. A. Russell, Strategies and methods for the attachment 
of amino acids and peptides to chiral [n]polynorbornane templates, Org. 
Biomol. Chem., 2003, 1 (11), 1845-1851. 
[104] R. N. Warrener, D. Margetic, G. Sun, A. S. Amarasekara, P. Foley, D. N. Butler 
and R. A. Russell, Molecular topology: The synthesis of a new class of rigid 
arc-shaped spacer molecules based on syn-facially fused norbornanes and 
7-heteronorbornanes in which heterobridges are used to govern 
backbone curvature, Tetrahedron Lett., 1999, 40 (21), 4111-4114. 
[105] P. K. Eggers, N. Darwish, M. N. Paddon-Row and J. J. Gooding, Surface-
Bound Molecular Rulers for Probing the Electrical Double Layer, J. Am. 
Chem. Soc., 2012, 134 (17), 7539-7544. 
[106] P. K. Eggers, P. Da Silva, N. A. Darwish, Y. Zhang, Y. Tong, S. Ye, M. N. 
Paddon-Row and J. J. Gooding, Self-Assembled Monolayers Formed using 
Zero Net Curvature Norbornylogous Bridges: The Influence of Potential on 
Molecular Orientation, Langmuir, 2010, 26 (19), 15665-15670. 
[107] M. N. Paddon-Row, Investigating long-range electron-transfer processes 
with rigid, covalently linked donor-(norbornylogous bridge)-acceptor 
systems, Acc. Chem. Res., 1994, 27 (1), 18-25. 
[108] R. N. Warrener, D. Margetic, A. S. Amarasekara, D. N. Butler, I. B. 
Mahadevan and R. A. Russell, Building BLOCK Strategies for the Synthesis 
of Molecular Clefts with Inside Functionality, Org. Lett., 1999, 1 (2), 199-
202. 
   Chapter 6 
193 | 
[109] M. R. Johnston, M. J. Latter and R. N. Warrener, Current Chemistry: 
Bisporphyrin Cavities: from Guest Complexation to Molecular Capsule 
Formation, Aust. J. Chem., 2001, 54 (10), 633-636. 
[110] M. R. Johnston and D. M. Lyons, Synthesis and Complexation Studies of a 
Convex Bis-porphyrin Tweezer—A Molecular Capsule Precursor, 
Supramol. Chem., 2005, 17 (7), 503-511. 
[111] M. Golić, M. R. Johnston, D. Margetić, A. C. Schultz and R. N. Warrener, Use 
of a 9,10-Dihydrofulvalene Pincer Cycloadduct as a Cornerstone for 
Molecular Architecture, Aust. J. Chem., 2006, 59 (12), 899-914. 
[112] S. Sinha, Z. Du, P. Maiti, F.-G. Klärner, T. Schrader, C. Wang and G. Bitan, 
Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-
Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular 
Tweezer CLR01, ACS Chem. Neurosci., 2012, 3 (6), 451-458. 
[113] P. R. Ashton, G. R. Brown, N. S. Isaacs, D. Giuffrida, F. H. Kohnke, J. P. 
Mathias, A. M. Z. Slawin, D. R. Smith, J. F. Stoddart and D. J. Williams, 
Molecular LEGO. 1. Substrate-directed synthesis via stereoregular Diels-
Alder oligomerizations, J. Am. Chem. Soc., 1992, 114 (16), 6330-6353. 
[114] N. Darwish, I. Díez-Pérez, P. Da Silva, N. Tao, J. J. Gooding and M. N. Paddon-
Row, Observation of Electrochemically Controlled Quantum Interference 
in a Single Anthraquinone-Based Norbornylogous Bridge Molecule, 
Angew. Chem., Int. Ed., 2012, 51 (13), 3203-3206. 
[115] L. D. Van Vliet, T. Ellis, P. J. Foley, L. Liu, F. M. Pfeffer, R. A. Russell, R. N. 
Warrener, F. Hollfelder and M. J. Waring, Molecular Recognition of DNA by 
Rigid [n]-Polynorbornane-Derived Bifunctional Intercalators:  Synthesis 
and Evaluation of Their Binding Properties, J. Med. Chem., 2007, 50 (10), 
2326-2340. 
[116] S. P. Gaynor, M. J. Gunter, M. R. Johnston and R. N. Warrener, Probing the 
dimensions of semi-rigid inner functionalised U-shaped bis-porphyrin 
cavities, Org. Biomol. Chem., 2006, 4 (11), 2253-2266. 
[117] R. N. Warrener, D. N. Butler and R. A. Russell, Fundamental Principles of 
BLOCK Design and Assembly in the Production of Large, Rigid Molecules 
with Functional Units (Effectors) Precisely Located on a Carbocyclic 
Framework, Synlett, 1998, 1998 (06), 566-573. 
Chapter 6 
| 194 
[118] F. Thalhammer, U. Wallfahrer and J. Sauer, 1,3,4-Oxadiazole als 
heteroctglische 4π-komponenten in diels-alder-reaktionen, Tetrahedron 
Lett., 1988, 29 (26), 3231-3234. 
[119] R. N. Warrener, D. N. Butler, W. Y. Liao, I. G. Pitt and R. A. Russell, The 
synthesis of polarofacial spacer molecules: a new twist in the coupling of 
ring strained olefins with oxadiazoles, Tetrahedron Lett., 1991, 32 (16), 
1889-1892. 
[120] G. H. Clever, S. Tashiro and M. Shionoya, Inclusion of Anionic Guests inside 
a Molecular Cage with Palladium(II) Centers as Electrostatic Anchors, 
Angew. Chem., Int. Ed., 2009, 48 (38), 7010-7012. 
[121] G. H. Clever, W. Kawamura, S. Tashiro, M. Shiro and M. Shionoya, Stacked 
Platinum Complexes of the Magnus’ Salt Type Inside a Coordination Cage, 
Angew. Chem., Int. Ed., 2012, 51 (11), 2606-2609. 
[122] D. M. Engelhard, S. Freye, K. Grohe, M. John and G. H. Clever, NMR-Based 
Structure Determination of an Intertwined Coordination Cage Resembling 
a Double Trefoil Knot, Angew. Chem., Int. Ed., 2012, 51 (19), 4747-4750. 
[123] S. Freye, J. Hey, A. Torras-Galán, D. Stalke, R. Herbst-Irmer, M. John and G. 
H. Clever, Allosteric Binding of Halide Anions by a New Dimeric 
Interpenetrated Coordination Cage, Angew. Chem., Int. Ed., 2012, 51 (9), 
2191-2194. 
[124] S. Sinha, D. H. J. Lopes, Z. Du, E. S. Pang, A. Shanmugam, A. Lomakin, P. 
Talbiersky, A. Tennstaedt, K. McDaniel, R. Bakshi, P.-Y. Kuo, M. Ehrmann, 
G. B. Benedek, J. A. Loo, F.-G. Klärner, T. Schrader, C. Wang and G. Bitan, 
Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of 
Assembly and Toxicity of Amyloid Proteins, J. Am. Chem. Soc., 2011, 133 
(42), 16958-16969. 
[125] F.-G. Klärner and B. Kahlert, Molecular Tweezers and Clips as Synthetic 
Receptors. Molecular Recognition and Dynamics in Receptor−Substrate 
Complexes, Acc. Chem. Res., 2003, 36 (12), 919-932. 
[126] F.-G. Klärner, B. Kahlert, A. Nellesen, J. Zienau, C. Ochsenfeld and T. 
Schrader, Molecular Tweezer and Clip in Aqueous Solution:  Unexpected 
Self-Assembly, Powerful Host−Guest Complex Formation, Quantum 
Chemical 1H NMR Shift Calculation, J. Am. Chem. Soc., 2006, 128 (14), 
4831-4841. 
   Chapter 6 
195 | 
[127] M. Lobert, H. Bandmann, U. Burkert, U. P. Büchele, V. Podsadlowski and F.-
G. Klärner, Dynamics in Host–Guest Complexes of Molecular Tweezers and 
Clips, Chem. Eur. J., 2006, 12 (6), 1629-1641. 
[128] P. Talbiersky, F. Bastkowski, F.-G. Klärner and T. Schrader, Molecular Clip 
and Tweezer Introduce New Mechanisms of Enzyme Inhibition, J. Am. 
Chem. Soc., 2008, 130 (30), 9824-9828. 
[129] B. Branchi, P. Ceroni, V. Balzani, M. C. Cartagena, F.-G. Klarner, T. Schrader 
and F. Vogtle, Fluorescent water-soluble molecular clips. Self-association 
and formation of adducts in aqueous and methanol solutions, New J. Chem., 
2009, 33 (2), 397-407. 
[130] B. Branchi, G. Bergamini, L. Fiandro, P. Ceroni, A. Alvino, G. Doddi, F. Vogtle 
and F.-G. Klarner, A molecular clip throws new light on the complexes 
formed by a family of cyclam-cored dendrimers with Zn(II) ions. Efficient 
energy transfer in the heteroleptic complexes, Dalton Trans., 2011, 40 (6), 
1356-1364. 
[131] F.-G. Klärner and T. Schrader, Aromatic Interactions by Molecular 
Tweezers and Clips in Chemical and Biological Systems, Acc. Chem. Res., 
2012, 46 (4), 967-978. 
[132] J. P. Mathias and J. F. Stoddart, Constructing a molecular LEGO set, Chem. 
Soc. Rev., 1992, 21 (4), 215-225. 
[133] G. I. Elliott, J. R. Fuchs, B. S. J. Blagg, H. Ishikawa, H. Tao, Z. Q. Yuan and D. 
L. Boger, Intramolecular Diels−Alder/1,3-Dipolar Cycloaddition Cascade 
of 1,3,4-Oxadiazoles, J. Am. Chem. Soc., 2006, 128 (32), 10589-10595. 
[134] R. Warrener, J. Malpass, D. Butler and G. Sun, Isoindole Cycloadditions. 
Part III: The Synthesis of "Windscreen Wiper" and Other N-Bridged Cavity 
Systems, Struct. Chem., 2001, 12 (3-4), 291-304. 
[135] R. N. Warrener, D. Margetic and R. A. Russell, The Preparation of Rigid 
Alicyclic Molecules Bearing Effector Groups from Alkene BLOCKs using s-
Tetrazines and 1,3,4-Triazines as Stereoselective Coupling Agents, Synlett, 
1998, 1998 (06), 585-587. 
[136] R. C. Foitzik, A. J. Lowe and F. M. Pfeffer, Microwave-accelerated 1,3-
dipolar cycloaddition for the formation of fused [n]polynorbornanes, 
Tetrahedron Lett., 2009, 50 (21), 2583-2584. 
Chapter 6 
| 196 
[137] R. N. Warrener, A. C. Schultz, D. N. Butler, S. Wang, I. B. Mahadevan and R. 
A. Russell, A new building block technique based on cycloaddition 
chemistry for the regiospecific linking of alicyclic sub-units as a route to 
large, custom-functionalised structures, Chem. Commun., 1997, (11), 
1023-1024. 
[138] A. Lowe, Norbornenes and [n]polynorbornanes as Molecular Scaffolds for 
Anion Recognition, Deakin University, 2010. 
[139] A. J. Lowe and F. M. Pfeffer, Binding of the terephthalate dianion by di- tri- 
and tetrathiourea functionalised fused [3] and [5]polynorbornane based 
hosts, Org. Biomol. Chem., 2009, 7 (20), 4233-4240. 
[140] A. J. Lowe and F. M. Pfeffer, Size matters-strong binding of the 
terephthalate dianion by thiourea functionalised fused 
[n]polynorbornane hosts, Chem. Commun., 2008(16), 1871-1873. 
[141] T.-a. Mitsudo, H. Naruse, T. Kondo, Y. Ozaki and Y. Watanabe, [2 + 2] 
Cycloaddition of Norbornenes with Alkynes Catalyzed by Ruthenium 
Complexes, Angew. Chem., Int. Ed., 1994, 33 (5), 580-581. 
[142] S. Inagaki, H. Fujimoto and K. Fukui, Orbital mixing rule, J. Am. Chem. Soc., 
1976, 98 (14), 4054-4061. 
[143] M. D. Johnstone, A. J. Lowe, L. C. Henderson and F. M. Pfeffer, Rapid 
synthesis of cyclobutene diesters using a microwave-accelerated 
ruthenium-catalysed [2+2] cycloaddition, Tetrahedron Lett., 2010, 51 
(45), 5889-5891. 
[144] C. Clark, P. Hermans, O. Meth-Cohn, C. Moore, H. C. Taljaard and G. van 
Vuuren, A powerful new stereo-controlled method for epoxidation of 
electrophilic alkenes, J. Chem. Soc., Chem. Commun., 1986, (17), 1378-
1380. 
[145] E. Weitz and A. Scheffer, Über die Einwirkung von alkalischem 
Wasserstoffsuperoxyd auf ungesättigte Verbindungen, Ber. Dtsch. Chem. 
Ges., 1921, 54 (9), 2327-2344. 
[146] F. M. Pfeffer and R. A. Russell, Synthesis of [n]polynorbornanes with 
differing edge substitution: a new class of regioselectively addressable 
framework, J. Chem. Soc., Perkin Trans. 1, 2002(23), 2680-2685. 
   Chapter 6 
197 | 
[147] S. Colonna and A. Manfredi, Catalytic asymmetric weitz-scheffer reaction 
in the presence of bovine serum albumin, Tetrahedron Lett., 1986, 27 (3), 
387-390. 
[148] W. Adam, P. B. Rao, H.-G. Degen, A. Levai, T. Patonay and C. R. Saha-Möller, 
Asymmetric Weitz−Scheffer Epoxidation of Isoflavones with 
Hydroperoxides Mediated by Optically Active Phase-Transfer Catalysts, J. 
Org. Chem., 2001, 67 (1), 259-264. 
[149] W. Adam, P. Bheema Rao, H.-G. Degen and C. R. Saha-Möller, Asymmetric 
Weitz–Scheffer epoxidation of conformationally flexible and fixed enones 
with sterically demanding hydroperoxides mediated by optically active 
phase-transfer catalysts, Tetrahedron: Asymmetry, 2001, 12 (1), 121-125. 
[150] A. J. Lowe, G. A. Dyson and F. M. Pfeffer, Factors Influencing Anion Binding 
Stoichiometry: The Subtle Influence of Electronic Effects, Eur. J. Org. Chem., 
2008, (9), 1559-1567. 
[151] A. J. Lowe, G. A. Dyson and F. M. Pfeffer, Steric and electronic factors 
influencing recognition by a simple, charge neutral norbornene based 
anion receptor, Org. Biomol. Chem., 2007, 5 (9), 1343-1346. 
[152] A. J. Lowe, F. M. Pfeffer and P. Thordarson, Determining binding constants 
from 1H NMR titration data using global and local methods: a case study 
using [n]polynorbornane-based anion hosts, Supramol. Chem., 2012, 24 
(8), 585-594. 
[153] F. M. Pfeffer, T. Gunnlaugsson, P. Jensen and P. E. Kruger, Anion 
Recognition Using Preorganized Thiourea Functionalized 
[3]Polynorbornane Receptors, Org. Lett., 2005, 7 (24), 5357-5360. 
[154] Y. Cohen, L. Avram and L. Frish, Diffusion NMR Spectroscopy in 
Supramolecular and Combinatorial Chemistry: An Old Parameter—New 
Insights, Angew. Chem., Int. Ed., 2005, 44 (4), 520-554. 
[155] P. Job, Formation and stability of inorganic complexes in solution, Annali. 
Chim. Appl., 1928, 9, 113-203. 
[156] M. J. Hynes, EQNMR: A computer program for the calculation of stability 
constants from nuclear magnetic resonance chemical shift data, J. Chem. 
Soc., Dalton Trans., 1993, 311-312. 
Chapter 6 
| 198 
[157] P. Thordarson, in Supramolecular Chemistry from molecules to 
nanomaterials, John Wiley and Sons Ltd, West Sussex, 2012, vol. 2, pp. 
239-274. 
[158] K. Hirose, A Practical Guide for the Determination of Binding Constants, J. 
Inclusion Phenom. Macrocyclic Chem., 2001, 39 (3-4), 193-209. 
[159] E. J. Olson and P. Buhlmann, Getting more out of a Job plot: determination 
of reactant to product stoichiometry in cases of displacement reactions 
and n:n complex formation, J. Org. Chem., 2011, 76 (20), 8406-8412. 
[160] C. Schmuck and S. Graupner, Amino acid binding in water by a new 
guanidiniocarbonyl pyrrole dication: the effect of the experimental 
conditions on complex stability and stoichiometry, Tetrahedron Lett., 
2005, 46 (8), 1295-1298. 
[161] W. Likussar, Computer approach to the continuous variations method for 
spectrophotometric determination of extraction and formation constants, 
Anal. Chem., 1973, 45 (11), 1926-1931. 
[162] M. Boccio, A. G. Asuero and A. Sayago, Spectrophotometric evaluation of 
stability constants of 1 : 1 weak complexes from mole ratio data using the 
bilogarithmic hyperbolic cosine method, J. Anal. Chem., 2007, 62 (9), 840-
844. 
[163] W. Likussar and D. F. Boltz, Theory of continuous variations plots and a 
new method for spectrophotometric determination of extraction and 
formation constants, Anal. Chem., 1971, 43 (10), 1265-1272. 
[164] D. P. Valencia and F. J. González, Estimation of diffusion coefficients by 
using a linear correlation between the diffusion coefficient and molecular 
weight, J. Electroanal. Chem., 2012, 681, 121-126. 
[165] N. J. Wheate, P. G. A. Kumar, A. M. Torres, J. R. Aldrich-Wright and W. S. 
Price, Examination of Cucurbit[7]uril and Its Host−Guest Complexes by 
Diffusion Nuclear Magnetic Resonance, J. Phys. Chem. B, 2008, 112 (8), 
2311-2314. 
[166] R. Mani, S. D. Cady, M. Tang, A. J. Waring, R. I. Lehrer and M. Hong, 
Membrane-dependent oligomeric structure and pore formation of a beta-
hairpin antimicrobial peptide in lipid bilayers from solid-state NMR, Proc. 
Natl. Acad. Sci. U. S. A., 2006, 103 (44), 16242-16247. 
   Chapter 6 
199 | 
[167] O. Mayzel and Y. Cohen, Diffusion coefficients of macrocyclic complexes 
using the PGSE NMR technique: determination of association constants, J. 
Chem. Soc., Chem. Commun., 1994(16), 1901. 
[168] K. S. Cameron and L. Fielding, NMR Diffusion Spectroscopy as a Measure 
of Host-Guest Complex Association Constants and as a Probe of Complex 
Size, J. Org. Chem., 2001, 66, 6891-6895. 
[169] R. Rymden, J. Carlfors and P. Stilbs, Substrate Binding to Cyclodextrins in 
Aqueous Solution: A Multicomponent Self-Diffusion Study, J. Inclusion 
Phenom. Macrocyclic Chem., 1983, 1, 159-167. 
[170] A. Einstein, On the movement of small particles suspended in stationary 
liquids required by the molecular-kinetic theory of heat, Ann. der Physik, 
1905, 17, 549. 
[171] A. J. Lennon, N. R. Scott, B. E. Chapman and P. W. Kuchel, Hemoglobin 
affinity for 2,3-bisphosphoglycerate in solutions and intact erythrocytes: 
studies using pulsed-field gradient nuclear magnetic resonance and 
Monte Carlo simulations, Biophys. J., 1994, 67 (5), 2096-2109. 
[172] L. Orfi, M. Lin and C. K. Larive, Measurement of SDS Micelle−Peptide 
Association Using 1H NMR Chemical Shift Analysis and Pulsed-Field 
Gradient NMR Spectroscopy, Anal. Chem., 1998, 70 (7), 1339-1345. 
[173] Y. K. Agrawal and H. Bhatt, Calixarenes and Their Biomimetic Application, 
Bioinorg. Chem. Appl., 2004, 2, 237-274. 
[174] E. E. Kim and H. W. Wyckoff, Reaction mechanism of alkaline phosphatase 
based on crystal structures: Two-metal ion catalysis, J. Mol. Biol., 1991, 
218 (2), 449-464. 
[175] L. Baldini, R. Cacciapaglia, A. Casnati, L. Mandolini, R. Salvio, F. Sansone and 
R. Ungaro, Upper Rim Guanidinocalix[4]arenes as Artificial 
Phosphodiesterases, J. Org. Chem., 2012, 77 (7), 3381-3389. 
[176] T. Velkov, P. E. Thompson, R. L. Nation and J. Li, Structure−Activity 
Relationships of Polymyxin Antibiotics, J. Med. Chem., 2009, 53 (5), 1898-
1916. 
[177] L. T. Nguyen, E. F. Haney and H. J. Vogel, The expanding scope of 
antimicrobial peptide structures and their modes of action, Trends 
Biotechnol., 2011, 29 (9), 464-472. 
Chapter 6 
| 200 
[178] L. C. Henderson, J. Li, R. L. Nation, T. Velkov and F. M. Pfeffer, Developing 
an anion host for lipid A binding and antibacterial activity, Chem. 
Commun., 2010, 46 (18), 3197-3199. 
[179] R. L. Soon, T. Velkov, F. Chiu, P. E. Thompson, R. Kancharla, K. Roberts, I. 
Larson, R. L. Nation and J. Li, Design, synthesis, and evaluation of a new 
fluorescent probe for measuring polymyxin–lipopolysaccharide binding 
interactions, Anal. Biochem., 2011, 409 (2), 273-283. 
[180] S. S. Leung, J. Tirado-Rives and W. L. Jorgensen, Vancomycin resistance: 
modeling backbone variants with D-Ala-D-Ala and D-Ala-D-Lac peptides, 
Bioorg. Med. Chem. Lett., 2009, 19 (4), 1236-1239. 
[181] S. S. Leung, J. Tirado-Rives and W. L. Jorgensen, Vancomycin analogs: 
Seeking improved binding of D-Ala-D-Ala and D-Ala-D-Lac peptides by 
side-chain and backbone modifications, Bioorg. Med. Chem., 2009, 17 (16), 
5874-5886. 
[182] C. C. McComas, B. M. Crowley and D. L. Boger, Partitioning the Loss in 
Vancomycin Binding Affinity for D-Ala-D-Lac into Lost H-Bond and 
Repulsive Lone Pair Contributions, J. Am. Chem. Soc., 2003, 125 (31), 9314-
9315. 
[183] R. J. Pieters, Synthesis and binding studies of carboxylate binding 
pocketanalogs of vancomycin, Tetrahedron Lett., 2000, 41, 7541-7545. 
[184] J. Zhang, J. Kemmink, D. T. S. Rijkers and R. M. J. Liskamp, Cu(I)- and Ru(II)-
Mediated “Click” Cyclization of Tripeptides Toward Vancomycin-Inspired 
Mimics, Org. Lett., 2011, 13 (13), 3438–3441. 
[185] J. Xie, J. G. Pierce, R. C. James, A. Okano and D. L. Boger, A redesigned 
vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding 
exhibits potent antimicrobial activity against vancomycin-resistant 
bacteria, J. Am. Chem. Soc., 2011, 133 (35), 13946-13949. 
[186] J. B. Bremner, P. A. Keller, S. G. Pyne, T. P. Boyle, Z. Brkic, D. M. David, A. 
Garas, J. Morgan, M. Robertson, K. Somphol, M. H. Miller, A. S. Howe, P. 
Ambrose, S. Bhavnani, T. R. Fritsche, D. J. Biedenbach, R. N. Jones, R. W. 
Buckheit, Jr., K. M. Watson, D. Baylis, J. A. Coates, J. Deadman, D. Jeevarajah, 
A. McCracken and D. I. Rhodes, Binaphthyl-based dicationic peptoids with 
therapeutic potential, Angew. Chem., Int. Ed., 2010, 49 (3), 537-540. 
   Chapter 6 
201 | 
[187] Y. Jia, N. Ma, Z. Liu, M. Bois-Choussy, E. Gonzalez-Zamora, A. Malabarba, C. 
Brunati and J. Zhu, Design and synthesis of simple macrocycles active 
against vancomycin-resistant enterococci (VRE), Chemistry, 2006, 12 
(20), 5334-5351. 
[188] R. E. Hancock and H. G. Sahl, Antimicrobial and host-defense peptides as 
new anti-infective therapeutic strategies, Nat. Biotechnol., 2006, 24 (12), 
1551-1557. 
[189] B. M. Crowley and D. L. Boger, Total synthesis and evaluation of 
[Ψ[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual 
D-Ala-D-Ala and D-Ala-D-Lac binding, J. Am. Chem. Soc., 2006, 128 (9), 
2885-2892. 
[190] C. Chamorro, J.-W. Hofman and R. M. J. Liskamp, Combinatorial solid-phase 
synthesis and screening of a diverse tripodal triazacyclophane (TAC)-
based synthetic receptor library showing a remarkable selectivity 
towards a D-Ala-D-Ala containing ligand, Tetrahedron, 2004, 60 (39), 
8691-8697. 
[191] Christopher J. Arnusch and Roland J. Pieters, Solid Phase Synthesis of 
Vancomycin Mimics, Eur. J. Org. Chem., 2003, (16), 3131-3138. 
[192] K. C. Nicolaou, R. Hughes, S. Y. Cho, N. Winssinger, C. Smethurst, H. 
Labischinski and R. Endermann, Target-Accelerated Combinatorial 
Synthesis and Discovery of Highly Potent Antibiotics Effective Against 
Vancomycin-Resistant Bacteria, Angew. Chem., Int. Ed., 2000, 112 (21), 
3981-3986. 
[193] C. Schmuck and J. Dudaczek, New guanidinium-based carboxylate 
receptors derived from 5-amino-pyrrole-2-carboxylate: synthesis and 
first binding studies, Tetrahedron Lett., 2005, 46 (42), 7101-7105. 
[194] A. Garas, J. B. Bremner, J. Coates, J. Deadman, P. A. Keller, S. G. Pyne and D. 
I. Rhodes, Binaphthyl scaffolded peptoids via ring-closing metathesis 
reactions and their anti-bacterial activities, Bioorg. Med. Chem. Lett., 2009, 
19 (11), 3010-3013. 
[195] C. E. Schafmeister, J. Po and G. L. Verdine, An All-Hydrocarbon Cross-
Linking System for Enhancing the Helicity and Metabolic Stability of 
Peptides, J. Am. Chem. Soc., 2000, 122, 5891-5982. 
Chapter 6 
| 202 
[196] T.-L. Sun, Y. Sun, C.-C. Lee and Huey W. Huang, Membrane Permeability of 
Hydrocarbon-Cross-Linked Peptides, Biophys. J., 2013, 104 (9), 1923-
1932. 
[197] G. H. Bird, N. Madani, A. F. Perry, A. M. Princiotto, J. G. Supko, X. He, E. 
Gavathiotis, J. G. Sodroski and L. D. Walensky, Hydrocarbon double-
stapling remedies the proteolytic instability of a lengthy peptide 
therapeutic, Proc. Natl. Acad. Sci. U. S. A., 2010, 107 (32), 14093-14098. 
[198] L. D. Walensky, A. L. Kung, I. Escher, T. J. Malia, S. Barbuto, R. D. Wright, G. 
Wagner, G. L. Verdine and S. J. Korsmeyer, Activation of Apoptosis in Vivo 
by a Hydrocarbon-Stapled BH3 Helix, Science, 2004, 305 (5689), 1466-
1470. 
[199] P. S. Kutchukian, J. S. Yang, G. L. Verdine and E. I. Shakhnovich, All-Atom 
Model for Stabilization of α-Helical Structure in Peptides by Hydrocarbon 
Staples, J. Am. Chem. Soc., 2009, 131 (13), 4622-4627. 
[200] B. Ku, C. Liang, J. U. Jung and B.-H. Oh, Evidence that inhibition of BAX 
activation by BCL-2 involves its tight and preferential interaction with the 
BH3 domain of BAX, Cell Res, 2011, 21 (4), 627-641. 
[201] H. Chapuis, J. Slaninová, L. Bednárová, L. Monincová, M. Buděšínský and V. 
Čeřovský, Effect of hydrocarbon stapling on the properties of α-helical 
antimicrobial peptides isolated from the venom of hymenoptera, Amino 
Acids, 2012, 43 (5), 2047-2058. 
[202] T. Okamoto, K. Zobel, A. Fedorova, C. Quan, H. Yang, W. J. Fairbrother, D. C. 
S. Huang, B. J. Smith, K. Deshayes and P. E. Czabotar, Stabilizing the Pro-
Apoptotic BimBH3 Helix (BimSAHB) Does Not Necessarily Enhance 
Affinity or Biological Activity, ACS Chem. Biol., 2012, 8 (2), 297-302. 
[203] C. Drahl, Stapled Peptides Hit Puberty, With Attendant Drama, Chem. Eng. 
News, 2013, 91 (5), 26-28. 
[204] F. Bernal, M. Wade, M. Godes, T. N. Davis, D. G. Whitehead, A. L. Kung, G. M. 
Wahl and L. D. Walensky, A Stapled p53 Helix Overcomes HDMX-Mediated 
Suppression of p53, Cancer Cell, 2010, 18 (5), 411-422. 
[205] L. K. Henchey, A. L. Jochim and P. S. Arora, Contemporary strategies for the 
stabilization of peptides in the α-helical conformation, Curr. Opin. Chem. 
Biol., 2008, 12 (6), 692-697. 
   Chapter 6 
203 | 
[206] F. Bernal, A. F. Tyler, S. J. Korsmeyer, L. D. Walensky and G. L. Verdine, 
Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 
Peptide, J. Am. Chem. Soc., 2007, 129 (9), 2456-2457. 
[207] S. A. Kawamoto, A. Coleska, X. Ran, H. Yi, C.-Y. Yang and S. Wang, Design of 
Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell 
CLL/lymphoma 9 (BCL9) Protein–Protein Interaction, J. Med. Chem., 2011, 
55 (3), 1137-1146. 
[208] Ø. Jacobsen, H. Maekawa, N.-H. Ge, C. H. Görbitz, P. l. Rongved, O. P. 
Ottersen, M. Amiry-Moghaddam and J. Klaveness, Stapling of a 310-Helix 
with Click Chemistry, J. Org. Chem., 2011, 76 (5), 1228-1238. 
[209] D. Y. Jackson, D. S. King, J. Chmielewski, S. Singh and P. G. Schultz, General 
approach to the synthesis of short .alpha.-helical peptides, J. Am. Chem. 
Soc., 1991, 113 (24), 9391-9392. 
[210] A. K. Galande, K. S. Bramlett, T. P. Burris, J. L. Wittliff and A. F. Spatola, 
Thioether side chain cyclization for helical peptide formation: inhibitors 
of estrogen receptor–coactivator interactions, J. Pept. Res., 2004, 63 (3), 
297-302. 
[211] A.-M. Leduc, J. O. Trent, J. L. Wittliff, K. S. Bramlett, S. L. Briggs, N. Y. 
Chirgadze, Y. Wang, T. P. Burris and A. F. Spatola, Helix-stabilized cyclic 
peptides as selective inhibitors of steroid receptor–coactivator 
interactions, Proc. Natl. Acad. Sci. U. S. A., 2003, 100 (20), 11273-11278. 
[212] N. E. Shepherd, H. N. Hoang, G. Abbenante and D. P. Fairlie, Single Turn 
Peptide Alpha Helices with Exceptional Stability in Water, J. Am. Chem. 
Soc., 2005, 127 (9), 2974-2983. 
[213] A. K. Galande, K. S. Bramlett, J. O. Trent, T. P. Burris, J. L. Wittliff and A. F. 
Spatola, Potent Inhibitors of LXXLL-Based Protein–Protein Interactions, 
ChemBioChem, 2005, 6 (11), 1991-1998. 
[214] S. M. Condon, I. Morize, S. Darnbrough, C. J. Burns, B. E. Miller, J. Uhl, K. 
Burke, N. Jariwala, K. Locke, P. H. Krolikowski, N. V. Kumar and R. F. 
Labaudiniere, The Bioactive Conformation of Human Parathyroid 
Hormone. Structural Evidence for the Extended Helix Postulate, J. Am. 
Chem. Soc., 2000, 122 (13), 3007-3014. 
[215] R. I. Lehrer, A. M. Cole and M. E. Selsted, θ-Defensins: Cyclic Peptides with 
Endless Potential, J. Biol. Chem., 2012, 287 (32), 27014-27019. 
Chapter 6 
| 204 
[216] D. L. Nelson and M. M. Cox, Principles of Biochemistry, Saea Tenney, USA, 
2005. 
[217] O. Khakshoor and J. S. Nowick, Use of Disulfide “Staples” To Stabilize β-
Sheet Quaternary Structure, Org. Lett., 2009, 11 (14), 3000-3003. 
[218] A. J. Lowe, B. M. Long and F. M. Pfeffer, Examples of Regioselective Anion 
Recognition among a Family of Two-, Three-, and Four-“Armed” Bis-, Tris-
, and Tetrakis(thioureido) [n]Polynorbornane hosts, J. Org. Chem., 2012, 
77 (19), 8507-8517. 
[219] A. J. Lowe, B. M. Long and F. M. Pfeffer, Conformationally preorganised 
hosts for anions using norbornane and fused [n]polynorbornane 
frameworks, Chem. Commun., 2013, 49 (33), 3376-3388. 
[220] S. H. Hilal, S. W. Karickhoff, L. A. Carreira and B. P. Shrestha, Estimation of 
Carboxylic Acid Ester Hydrolysis Rate Constants, QSAR Comb. Sci., 2003, 
22 (9-10), 917-925. 
[221] F. Rived, M. Rosés and E. Bosch, Dissociation constants of neutral and 
charged acids in methyl alcohol. The acid strength resolution, Anal. Chim. 
Acta, 1998, 374 (2–3), 309-324. 
[222] CRC handbook of chemistry and physics, 80th edn., D. R. Lide, CRC Press, 
Cleveland, Ohio, 2000. 
[223] D. L. Purich and R. D. Allison, Handbook of Biochemical Kinetics, Academic 
Press, 2000. 
[224] H. K. Hall, Correlation of the Base Strengths of Amines1, J. Am. Chem. Soc., 
1957, 79 (20), 5441-5444. 
[225] Blackman, Bottle, Schmid, Mocerino and Wille, Chemistry, John Wiley and 
Sons Australia Ltd, Milton, Australia, 2008. 
[226] X. Hou, Development of a New Signaling Methodology for Anion 
Recognition, Kochi University of Technology, 2006. 
[227] Spartan '08, Wavefunction, Inc., 2008 
[228] Spartan '10, Wavefunction, Inc, 2010 
[229] Discovery Studio Modeling Environment, Accelrys Software Inc., 2007 
[230] POV-Ray, Persistence of Vision Ray Tracer (POV-Ray), 2005 
[231] I. Fleming, Frontier Orbitals and Organic Chemistry Reactions, John Wiley 
& Sons, Ltd, Avon, Great Britain, 1976. 
   Chapter 6 
205 | 
[232] M. B. Smith and J. March, March's Advanced Organic Synthesis: Reactions, 
mechanisums and structure, 6th edn., John Wiley and Sons Inc, New Jersey, 
2007. 
[233] C. A. G. N. Montalbetti and V. Falque, Amide bond formation and peptide 
coupling, Tetrahedron, 2005, 61 (46), 10827-10852. 
[234] N. Ahmad, J. J. Levison, S. D. Robinson, M. F. Uttlky, E. R. Wonchoba and G. 
W. Parshall, in Inorganic Syntheses, John Wiley & Sons, Inc., 2007, pp. 45-
64. 
[235] A. Lévai, G. Tóth, J. Kovács, T. Patonay and E. B. Vass, Epoxidation of (Z)-3-
Arylidene-1-thioflavanones, Monatsh. Chem., 2001, 132 (6), 707-713. 
[236] C. D. Smith, Cycloaddition Reactions of “Quadricyclanes”1, J. Am. Chem. Soc., 
1966, 88 (18), 4273-4274. 
[237] K. Kirchner, M. J. Calhorda, R. Schmid and L. F. Veiros, Mechanism for the 
Cyclotrimerization of Alkynes and Related Reactions Catalyzed by CpRuCl, 
J. Am. Chem. Soc., 2003, 125 (38), 11721-11729. 
[238] A. R. Mulholland, P. Thordarson, E. J. Mensforth and S. J. Langford, 
Porphyrin dyads linked by a rotatable 3,3'-biphenyl scaffold: a new 
binding motif for small ditopic molecules, Org. Biomol. Chem., 2012, 10 
(30), 6045-6053. 
[239] J. Rigaudy and S. P. Klesney, IUPAC: Nomenclature of organic chemistry, 
Pergamon Press, 1979. 
[240] C. A. Citron, S. M. Wickel, B. Schulz, S. Draeger and J. S. Dickschat, A Diels–
Alder/Retro-Diels–Alder Approach for the Enantioselective Synthesis of 
Microbial Butenolides, Eur. J. Org. Chem., 2012, 2012 (33), 6636-6646. 
[241] M. Shang, R. N. Warrener, D. N. Butler, Y. Murata and D. Margetić, Synthesis 
of bis-peptides attached on poly[n]norbornene molecular scaffolds with 
well-defined relative positions and distances, Mol. Diversity, 2011, 15 (2), 
541-560. 
[242] J. Owens, Stabilizing staples, Nat. Rev. Drug Discovery, 2004, 3 (10), 830. 
[243] O. Torres, D. Yuksel, M. Bernardina, K. Kumar and D. Bong, Peptide tertiary 
structure nucleation by side-chain crosslinking with metal complexation 
and double "click" cycloaddition, ChemBioChem, 2008, 9 (11), 1701-1705. 
Chapter 6 
| 206 
[244] A. M. Spokoyny, Y. Zou, J. J. Ling, H. Yu, Y.-S. Lin and B. L. Pentelute, A 
Perfluoroaryl-Cysteine SNAr Chemistry Approach to Unprotected Peptide 
Stapling, J. Am. Chem. Soc., 2013, 135 (16), 5946-5949. 
[245] J. Garner and M. M. Harding, Design and synthesis of α-helical peptides and 
mimetics, Org. Biomol. Chem., 2007, 5 (22), 3577-3585. 
[246] K. Estieu-Gionnet and G. Guichard, Stabilized helical peptides: overview of 
the technologies and therapeutic promises, Expert Opin Drug Discov., 
2011, 6 (9), 937-963. 
[247] M. M. Madden, A. Muppidi, Z. Li, X. Li, J. Chen and Q. Lin, Synthesis of cell-
permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx 
interactions via photoinduced cycloaddition, Bioorg. Med. Chem. Lett., 
2011, 21 (5), 1472-1475. 
[248] Y. L. Angell and K. Burgess, Peptidomimetics via copper-catalyzed azide-
alkyne cycloadditions, Chem. Soc. Rev., 2007, 36 (10), 1674-1689. 
[249] V. D. Bock, H. Hiemstra and J. H. van Maarseveen, CuI-Catalyzed Alkyne-
Azide “Click” Cycloadditions from a Mechanistic and Synthetic 
Perspective, Eur. J. Org. Chem., 2006, 2006 (1), 51-68. 
[250] S. J. Miller and R. H. Grubbs, Synthesis of Conformationally Restricted 
Amino Acids and Peptides Employing Olefin Metathesis, J. Am. Chem. Soc., 
1995, 117 (21), 5855-5856. 
[251] J. L. Stymiest, B. F. Mitchell, S. Wong and J. C. Vederas, Synthesis of Oxytocin 
Analogues with Replacement of Sulfur by Carbon Gives Potent Antagonists 
with Increased Stability, J. Org. Chem., 2005, 70 (20), 7799-7809. 
[252] J. L. Stymiest, B. F. Mitchell, S. Wong and J. C. Vederas, Synthesis of 
Biologically Active Dicarba Analogues of the Peptide Hormone Oxytocin 
Using Ring-Closing Metathesis, Org. Lett., 2002, 5 (1), 47-49. 
[253] H. C. Kolb, M. G. Finn and K. B. Sharpless, Click Chemistry: Diverse 
Chemical Function from a Few Good Reactions, Angew. Chem., Int. Ed., 
2001, 40 (11), 2004-2021. 
[254] V. O. Rodionov, V. V. Fokin and M. G. Finn, Mechanism of the Ligand-Free 
CuI-Catalyzed Azide–Alkyne Cycloaddition Reaction, Angew. Chem., Int. 
Ed., 2005, 44 (15), 2210-2215. 
[255] M. D. Johnstone, M. Frank, G. H. Clever and F. M. Pfeffer, The rapid, solvent-
free, synthesis of pyridyl-functionalised [5]polynorbornane-based ligands 
   Chapter 6 
207 | 
for metal-organic rings and cages, Eur. J. Org. Chem., 2013, 2013 (26), 
5848-5853. 
[256] C. W. Tornøe, C. Christensen and M. Meldal, Peptidotriazoles on Solid 
Phase:  [1,2,3]-Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-Dipolar 
Cycloadditions of Terminal Alkynes to Azides, J. Org. Chem., 2002, 67 (9), 
3057-3064. 
[257] C. Simon, S. Hosztafi and S. Makleit, Application of the mitsunobu reaction 
in the field of alkaloids, J. Heterocycl. Chem., 1997, 34 (2), 349-365. 
[258] S. L. Mangold, R. T. Carpenter and L. L. Kiessling, Synthesis of Fluorogenic 
Polymers for Visualizing Cellular Internalization, Org. Lett., 2008, 10 (14), 
2997-3000. 
[259] A. S. Thompson, G. R. Humphrey, A. M. DeMarco, D. J. Mathre and E. J. J. 
Grabowski, Direct conversion of activated alcohols to azides using 
diphenyl phosphorazidate. A practical alternative to Mitsunobu 
conditions, J. Org. Chem., 1993, 58 (22), 5886-5888. 
[260] P. Rajakumar, R. Raja, S. Selvam, R. Rengasamy and S. Nagaraj, Synthesis 
and antibacterial activity of some novel imidazole-based dicationic 
quinolinophanes, Bioorg. Med. Chem. Lett., 2009, 19 (13), 3466-3470. 
[261] W. Yan, X. Xin, L. Yongjiu, L. Yingjie, Z. Rui and D. Dewen, A Facile and 
Efficient One-Pot Synthesis of Substituted Quinolines from α-Arylamino 
Ketones Under Vilsmeier Conditions, Eur. J. Org. Chem., 2009, 2009 (24), 
4165-4169. 
[262] J. J. Li, in Name Reactions, Springer Berlin Heidelberg, 2006, pp. 603-604. 
[263] H. Johansson and D. S. Pedersen, Azide- and Alkyne-Derivatised α-Amino 
Acids, Eur. J. Org. Chem., 2012, 2012 (23), 4267-4281. 
[264] M. Kitamura, M. Yano, N. Tashiro, S. Miyagawa, M. Sando and T. Okauchi, 
Direct Synthesis of Organic Azides from Primary Amines with 2-Azido-1,3-
dimethylimidazolinium Hexafluorophosphate, Eur. J. Org. Chem., 2011, 
2011 (3), 458-462. 
[265] M. Kitamura, N. Tashiro, S. Miyagawa and T. Okauchi, 2-Azido-1,3-
dimethylimidazolinium Salts: Efficient Diazo-Transfer Reagents for 1,3-
Dicarbonyl Compounds, Synthesis, 2011, 2011 (07), 1037-1044. 
Chapter 6 
| 208 
[266] E. D. Goddard-Borger and R. V. Stick, An Efficient, Inexpensive, and Shelf-
Stable Diazotransfer Reagent:  Imidazole-1-sulfonyl Azide Hydrochloride, 
Org. Lett., 2007, 9 (19), 3797-3800. 
[267] E. D. Goddard-Borger and R. V. Stick, An Efficient, Inexpensive, and Shelf-
Stable Diazotransfer Reagent: Imidazole-1-sulfonyl Azide Hydrochloride, 
Org. Lett., 2011, 13 (9), 2514-2514. 
[268] T. Böttcher, B. S. Bassil and G.-V. Röschenthaler, Complexes of Ge(IV)- and 
Sn(IV)-Fluorides with Cyclic and Acyclic Carbenes: Bis(dialkylamino)-
difluoromethylenes as Carbene Sources, Inorg. Chem., 2012, 51 (2), 763-
765. 
[269] O. Rathore and D. Y. Sogah, Self-Assembly of β-Sheets into Nanostructures 
by Poly(alanine) Segments Incorporated in Multiblock Copolymers 
Inspired by Spider Silk, J. Am. Chem. Soc., 2001, 123 (22), 5231-5239. 
[270] P. Soto, A. Baumketner and J.-E. Shea, Aggregation of polyalanine in a 
hydrophobic environment, J. Chem. Phys., 2006, 124 (13), 134904-
134907. 
[271] M. Amblard, J.-A. Fehrentz, J. Martinez and G. Subra, Methods and 
protocols of modern solid phase peptide synthesis, Mol. Biotechnol., 2006, 
33 (3), 239-254. 
[272] N. J. Greenfield, Applications of circular dichroism in protein and peptide 
analysis, TrAC, Trends Anal. Chem., 1999, 18 (4), 236-244. 
[273] D. M. Byler and H. Susi, Examination of the secondary structure of proteins 
by deconvolved FTIR spectra, Biopolymers, 1986, 25 (3), 469-487. 
[274] W. K. Surewicz, H. H. Mantsch and D. Chapman, Determination of protein 
secondary structure by Fourier transform infrared spectroscopy: A 
critical assessment, Biochemistry, 1993, 32 (2), 389-394. 
[275] J. M and M. HH, The use and misuse of FTIR spectroscopy in the 
determination of protein structure., Crit. Rev. Biochem. Mol. Biol., 1995, 30 
(2), 95-120. 
[276] E. Asenath-Smith, H. Li, E. C. Keene, Z. W. Seh and L. A. Estroff, Hydrogels: 
Crystal Growth of Calcium Carbonate in Hydrogels as a Model of 
Biomineralization, Adv. Funct. Mater., 2012, 22 (14), 2890-2890. 
   Chapter 6 
209 | 
[277] S. Matsuzawa, Y. Hondo, Y. Kawauchi, M. Kume, K. Yamaura, T. Tanigami 
and K. Ogasawara, Crystal growth in syndiotactic poly(vinyl alcohol) 
hydrogels, Colloid Polym. Sci., 1987, 265 (9), 810-814. 
[278] Y. Wang, L. Tang and J. Yu, Investigation of Spontaneous Transition from 
Low-Molecular-Weight Hydrogel into Macroscopic Crystals, Cryst. Growth 
Des., 2008, 8 (3), 884-889. 
[279] A. Palcic, B. Subotic, V. Valtchev and J. Bronic, Nucleation and crystal 
growth of zeolite A synthesised from hydrogels of different density, 
CrystEngComm, 2013, 15 (29), 5784-5791. 
[280] S. Sugiyama, M. Maruyama, G. Sazaki, M. Hirose, H. Adachi, K. Takano, S. 
Murakami, T. Inoue, Y. Mori and H. Matsumura, Growth of Protein Crystals 
in Hydrogels Prevents Osmotic Shock, J. Am. Chem. Soc., 2012, 134 (13), 
5786-5789. 
[281] Y. Inokuma, S. Yoshioka, J. Ariyoshi, T. Arai, Y. Hitora, K. Takada, S. 
Matsunaga, K. Rissanen and M. Fujita, X-ray analysis on the nanogram to 
microgram scale using porous complexes, Nature, 2013, 495 (7442), 461-
466. 
[282] Z. Zhang and P. R. Schreiner, (Thio)urea organocatalysis-What can be 
learnt from anion recognition?, Chem. Soc. Rev., 2009, 38 (4), 1187-1198. 
[283] W.-Y. Siau and J. Wang, Asymmetric organocatalytic reactions by 
bifunctional amine-thioureas, Catalysis Science & Technology, 2011, 1 (8), 
1298-1310. 
[284] T. R. Jahn, O. S. Makin, K. L. Morris, K. E. Marshall, P. Tian, P. Sikorski and 
L. C. Serpell, The Common Architecture of Cross-β Amyloid, J. Mol. Biol., 
2010, 395 (4), 717-727. 
  
Chapter 6 
| 210 
 
 211 | 
CHAPTER 7 
 
APPENDIX 
 
7.1 SINGLE ANION TITRATIONS (CHAPTER 2) 
Host 1a – [H]0 = 2.5mM in DMSO-d6 
Acetate  
 
Pimelate 
 
 
Malonate 
 
  
 Appendix 
| 212 
H2PO4-  
  
H2ppi2- 
 
 
Host 1b – [H]0 = 2.5mM in DMSO-d6 
Acetate  
 
Pimelate 
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Malonate 
 
H2PO4-  
 
H2ppi2- 
 
 
Host 2a – [H]0 = 2.5mM in DMSO-d6 
Acetate  
 
  
2 2
Appendix
| 214 
Pimelate 
 
 
Malonate 
 
H2PO4- 
 
 
H2ppi2- 
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Host 4b – [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
 
Pimelate 
 
Malonate 
 
H2PO4- 
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H2ppi2- 
 
 
7.2 DUAL ANION TITRATIONS (CHAPTER 2) 
Host 1a– [H]0 = 2.5mM in DMSO-d6 
Acetate/Pimelate 
Pimelate 0eq – 1eq Acetate 1eq – 9eq,  Pimelate 0eq – 0.5eq Acetate 0.5eq – 9eq 
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Acetate 0eq – 1eq Pimelate 1eq – 9eq,  Acetate 0eq – 0.5eq Pimelate 0.5eq – 9eq 
 
 
 
Acetate/Malonate 
Malonate 0eq – 1eq Acetate 1eq – 9eq,  Acetate 0eq – 1eq Malonate 1eq – 9eq 
 
 
  
2
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H2PO4/H2ppi 
H2ppi 0eq – 1eq  H2PO4 1eq – 9eq  H2PO4 0eq – 1eq H2ppi 1eq – 9eq 
 
  
 
Acetate/H2ppi 
H2ppi 0eq – 1eq  Acetate 1eq – 9eq,  Acetate 0eq – 1eq H2ppi 1eq – 9eq, 
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Host 1b– [H]0 = 2.5mM in DMSO-d6 
Acetate/Pimelate 
Pimelate 0eq – 1eq Acetate 1eq – 9eq,  Pimelate 0eq – 0.5eq Acetate 0.5eq – 9eq 
 
 
 
Acetate 0eq – 1eq Pimelate 1eq – 9eq,  Acetate 0eq – 0.5eq Pimelate 0.5eq – 9eq 
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H2PO4/H2ppi 
H2ppi 0eq – 1eq  H2PO4 1eq – 9eq H2PO4 0eq – 1eq H2ppi 1eq – 9eq  
 
  
 
Acetate/H2ppi 
H2ppi 0eq – 1eq  Acetate 1eq – 9eq  Acetate 0eq – 1eq H2ppi 1eq – 9eq 
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Host 2a– [H]0 = 2.5mM in DMSO-d6 
Acetate/Pimelate 
Pimelate 0eq – 1eq Acetate 1eq – 9eq,  Pimelate 0eq – 0.5eq Acetate 0.5eq – 9eq 
 
 
 
Acetate 0eq – 1eq Pimelate 1eq – 9eq,  Acetate 0eq – 0.5eq Pimelate 0.5eq – 9eq 
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Acetate/Malonate 
Malonate 0eq – 1eq Acetate 1eq – 9eq,  Acetate 0eq – 1eq Malonate 1eq – 9eq 
 
 
 
H2PO4/H2ppi 
H2ppi 0eq – 1eq  H2PO4 1eq – 9eq  H2PO4 0eq – 1eq H2ppi 1eq – 9eq 
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Acetate/H2ppi 
H2ppi 0eq – 1eq  Acetate 1eq – 9eq  Acetate 0eq – 1eq H2ppi 1eq – 9eq 
 
 
 
7.3 TITRATIONS AND JOB PLOTS (CHAPTER 3) 
Host 3a– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
H2PO4− 
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H2ppi 
 
Pimelate 
 
Terephthalate 
 
 
Host 4– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
Phosphate 
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H2PPi 
 
Pimelate 
 
Terephthalate 
 
 
Host 5– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
Phosphate 
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H2PPi 
 
Pimelate 
 
Terephthalate 
 
 
Host 7– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
Phosphate 
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H2PPi 
 
Pimelate 
 
Terephthalate 
 
 
Host 8– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
Phosphate 
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H2PPi 
 
Pimelate 
 
Terephthalate 
 
 
Host 1a– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
H2PO4-  
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H2ppi2- 
 
Pimelate 
 
Terephthalate 
 
 
7.4 NORBORNENE RECEPTOR TITRATIONS (CHAPTER 4) 
Host 114– [H]0 = 2.5mM in DMSO-d6 
Acetate 
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D-Alaninate  
 
 
Host 115– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
D-Alaninate  
 
 
Host 116– [H]0 = 2.5mM in DMSO-d6 
Acetate 
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D-Alaninate  
 
 
Host 117– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
D-Alaninate  
 
 
Host 118– [H]0 = 2.5mM in DMSO-d6 
Acetate 
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D-Alaninate  
 
 
Host 119– [H]0 = 2.5mM in DMSO-d6 
Acetate 
 
D-Alaninate  
 
 
Host 120– [H]0 = 2.5mM in DMSO-d6 
Acetate 
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D-Alaninate  
 
 
7.5 OBLATE ELLIPSOID APPROXIMATION 
 
 
Figure 123: Approximation of a host 7 and terephthalate 2:2 complex by an oblate ellipsoid for 
theoretical diffusion coefficient calculation.  
 
  
a = 30 Å 
b = 10 Å 
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